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Nitric oxide synthases (NOSs) catalyse the production of the physiological messenger 
molecule NO from L-arginine in a unique two step oxygenation reaction.  
Constitutive forms of NOS are activated by the binding of calmodulin (CaM) to a 20-
amino-acid inter-domain region in the presence of calcium ions, causing inter-domain 
electron transfer to occur from FAD to heme via FMN. This electron transfer step 
involves a large scale movement of the FMN-binding domain and is influenced by a 
number of structural features unique to NOS which include an autoinhibitory loop, a 
C-terminal extension, a number of phosphorylation sites, and the hinge region that 
connects the FAD- and FMN- binding domains.  X-ray crystallographic data indicate 
that all of these regulatory elements lie at the interface between the two domains, 
restricting their motion relative to each other.  The importance of this interface region 
in the CaM-dependent activation mechanism of neuronal NOS (nNOS) was 
investigated by site-directed mutagenesis of interface residues in the isolated 
reductase domain (nNOSrd).  A range of kinetic and thermodynamic analytical 
techniques were employed in order to determine which catalytic steps are affected by 
changes in domain mobility. 
The rate-limiting step in the turnover of nNOSrd has been speculated to be one of 
three catalytic events; the hydride transfer from NADPH to FAD, the electron transfer 
between the bound flavin cofactors, or the electron transfer between FMN and 
external electron acceptors such as cytochrome c.  In each case, the binding of CaM 
enhances the rate of reduction.  In wild-type nNOSrd, NADPH reduced the FAD by 
hydride transfer in what should have been a simple 1-step reaction but was in fact a 
biphasic process.  Isotope effects and the use of differing ionic strength indicated that 
different conformations of enzyme have different rates of reaction with NADPH.  The 
redox state of the FMN cofactor also influenced the rate of reduction of FAD, through 
the interaction with the peptide backbone in the interface region. 
A putative proton transfer pathway exists between the bound FAD cofactor and 
solvent, involving Ser1176, Asp1393, His1032 and Arg1229.  Mutation of the former 
three residues diminished the catalytic activity, specifically focused on the rate of 
hydride transfer, while the R1229E mutation had a much more dramatic effect.  
Arg1229 forms one of only two electrostatic contacts between the FAD and FMN- 
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binding domains in the interface region and the charge reversal substitution 
introduced a likely inter-domain repulsion.  This was expected to cause the two 
domains to separate, favouring a hinged-open conformation.  The hydride transfer 
step from NADPH to FAD was activated in the CaM-free enzyme, while FAD to 
FMN electron transfer was inhibited.  Electron transfer from reduced FMN to the 
artificial electron acceptor horse-heart cytochrome c was also activated in the CaM-
free state.  The effect on the three catalytic events meant that during steady-state 
turnover with cytochrome c, CaM deactivated the enzyme and caused cytochrome c-
dependent inhibition.  Evidently, domain-domain separation was large enough in the 
mutant to accommodate cytochrome c, a 12 kDa protein, in the space between the 
cofactors at the interface.   
The effects of this single charge-reversal on the three distinct catalytic events 
illustrated how each is differently dependent on the enzyme conformation.  FAD to 
FMN electron transfer was shown to occur exclusively in the hinged-closed form, 
consistent with the crystal structure of nNOSrd.  The remaining two events, hydride 
transfer from NADPH to FAD, and electron transfer from FMN to cytochrome c, 
occur in the hinged-open state.   
In the wild-type enzyme, the hinged-open and hinged-closed states are tightly 
regulated by a conformational equilibrium which is affected by CaM binding.  It 






Alanine  Ala  A Leucine  Leu  L 
Arginine  Arg  R Lysine   Lys  K 
Asparagine  Asn  N Methionine  Met  M 
Aspartatic acid Asp  D Phenylalanine  Phe  F 
Cysteine  Cys  C Proline   Pro  P 
Gluatmic acid  Glu  E Serine   Ser  S 
Glutamine  Gln  Q Threonine  Thr  T 
Glycine  Gly  G Tryptophan  Trp  W 
Histidine  His  H Tyrosine  Tyr  Y 




Amino acid mutations are represented as a code/number/code, where the first code 
and number represents the original residue and its position on the polypeptide chain, 
and the second code represents the corresponding residue in the mutant enzyme.  For 
example, the mutation of an arginine, residue number 1229, to a glutamate is 




Km    Michaelis constant 
Kd    Dissociation constant 
Ki    Inhibition constant 
kcat    Rate constant at saturation 
kobs    Observed rate constant 
k1,2 Rate constants for the first or second phase of a multi-
phase reaction 




Å    angstrom 
oC    degrees Celsius 
g    gram 
h    hour 
l    litre 
m    metre 
M    molar 
S    second 




A    Absorbance 
ACAD    Acyl-CoA dehydrogenase 
ADP    Adenosine diphosphate 
AI    Autoinhibitory loop 
ATP    Adenosine triphosphate 
CaM    Calmodulin 
cAMP    Cyclic adenosine monophosphate 
cGMP    Cyclic guanosine monophosphate 
cNOS    Constitutive NOS  
CO    Carbon monoxide 
CPR    Cytochrome P450 reductase 
CT    C-terminal tail 
Da    Dalton 
DEAE    Diethylaminoethyl 
DMSO    Dimethyl sulfoxide  
DNA    Deoxyribonucleic acid 
DTT    Dithiothreitol 
ε    Molar extinction coefficient 
EDRF    Endothelium-derived relaxation factor 
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EDTA    Ethylenediaminetetraacetic acid 
EGTA    Ethyleneglycoltetraacetic acid 
Em    Midpoint reduction potential 
ETF    Electron transfer flavoprotein    
eNOS    Endothelial NOS 
FAD    Flavin adenine dinucleotide 
FMN    Flavin mononucleotide 
FNR    Ferredoxin-NADP+ reductase 
FPLC    Fast protein liquid chromotography  
G-cyclase   Guanylate cyclase 
GTP    Guanosine triphosphate 
Hb    Hemoglobin 
H4B    Tetrahydrobiopterin 
I    Ionic strength 
iNOS    Inducible NOS 
IPTG    Isopropyl-β-D-thiogalactoside 
L-arg    L-arginine 
LB    Luria bertani 
MAO    Monoamine oxidase 
MB    Methylene blue 
NADPH   Nicotinamide adenine dinucleotide phosphate 
NAO    Nitroalkane oxidase 
NMN    Nicotine mononucleotide 
nNOS    neuronal NOS 
NO    Nitric oxide 
NOHA    N-hydroxy-L-Arginine 
NOS    Nitric oxide synthase 
NOSoxy   NOS oxygenase domain 
NOSrd    NOS reductase domain 
OTTLE   Optically transparent thin layer electrode 
PAGE    Polyacrylamide gel electrophoresis 
PDB    Protein data bank 
PDZ    Postsynaptic density-95 discs large / ZO-1 
 viii 
PHBH    p-hydroxybenzoate hydroxylase 
PMSF    Phenylmethylsulfonyl fluoride 
SOC    Super optimal catabolite 
SOD    Superoxide dismutase 
SDS    Sodium dodecyl sulphate 
SHE    Standard hydrogen electrode 
SI    Small insertion 
TB    Terrific broth 
Tris    Tris (hydroxymethyl) aminomethane 
UV    Ultraviolet 
Vis    Visible 
WT    Wild type 
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1.1 Nitric Oxide 
 
“Nitric oxide as a signalling molecule in the cardiovascular system” was the title of 
the 1998 Nobel Prize in Physiology or Medicine awarded to Furchgott, Ignarro and 
Murad [1].  Their work, both before the award and subsequently, has led to a field of 
research resulting in over 200,000 published papers on nitric oxide (NO) and its 
effects. 
Furchgott’s work initially involved studying the drugs affecting blood vessels, where 
muscarinic agonists gave differing effects depending on the experimental preparation 
[2].  This was found to depend on whether the surface of the blood vessel (the 
endothelium) was intact, with acetylcholine shown to cause dilation only if it was.  
The production of an unknown relaxing substance was thought to cause this, and it 
was later referred to as endothelial-derived-relaxation-factor (EDRF).  It was also 
observed that a rise in cyclic guanosine monophosphate (cGMP) accompanied the 
acetylcholine-induced relaxation.   
Ignarro’s early research concerned cGMP and the related molecule cAMP (cyclic 
adenosine monophosphate) which were known to mediate opposite effects on cellular 
function [3].  After the discovery that NO and nitro-compounds might cause NO-
stimulated cGMP production in tissues [4], experiments were performed to confirm 
that nitroglycerin and related organic nitrate and nitrite esters could release NO in 
aqueous solution.  These chemicals required an interaction with thiols to generate S-
nitrosothiols that decompose to liberate NO.  In addition to this, Ignarro reported that 
NO caused smooth muscle relaxation and activated guanylate-cyclase (G-cyclase), the 
enzyme that produces cGMP, isolated from the same tissue [5]. 
NO was identified as a potent inhibitor of platelet aggregation, mediated by cGMP, 
while the anti-platelet action of nitroprusside appeared to involve the action of S-
nitrosothiols.  NO activated G-cyclase from platelets by heme-dependent 
mechanisms, which was followed by G-cyclase being found to contain heme [6].  
Studies then revealed that binding of NO to the heme breaks the bond with the axial 
histidine ligand and causes a conformational change near to the catalytic site that 
increases the affinity for substrate (GTP) and increases production of cGMP [7]. 
Murad worked on G-cyclase and cGMP in the early stages of research in this area, 
where experiments with azide, hydroxylamine and nitrite activated many, but not all, 
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preparations of G-cyclase [8].  The activation by azide required oxygen and was 
enhanced by the addition of thiols.  Other smooth muscle relaxants such as 
nitroprusside and hydrazines increased cGMP levels and caused smooth-muscle 
relaxation that didn’t require catalase for activation and was inhibited by hemoglobin 
(Hb) and myoglobin.  This led to the suggestion that NO was the activator and this 
was proven by the direct action of the gas on G-cyclase [4].  L-arginine (L-arg) had 
been identified as activating G-cyclase, the action of which was blocked by Hb or 
methylhydroxylamine (that also blocked nitrovasodilators) [9].  This discovery would 
lead to the finding that NO is produced from L-arg.  The cytotoxic effects of 
macrophages on tumour cells could be correlated with accumulation of nitrite and 
nitrate, were increased with the addition of L-arg and were blocked by an analogue of 
it [10]. 
Hemoglobin and methylene blue (MB) were identified as inhibitors of endothelium-
dependent relaxation, with Hb inhibiting G-cyclase and relaxation of smooth muscle 
[11].  It was originally proposed that Hb binding to EDRF inhibited relaxation but 
when EDRF was identified as NO it was clear that HbO2 reacts with NO to produce 
nitrate.  MB was found to inhibit stimulation of G-cyclase by nitrovasodilators 
extremely quickly when added immediately after endothelium-dependent relaxation.  
This was eventually pinpointed as being caused by superoxide anions generated by 
MB in tissue [12].  Further evidence linking EDRF to NO was provided by 
superoxide dismutase (SOD) which stabilised EDRF released from endothelial cells 
or arteries [13]. 
The key piece of research from Furchgott’s laboratory was the use of acidified, rather 
than neutral, sodium nitrite which produced transient relaxations of the aorta.  NO gas 
gave the same results as this acidified nitrite and the similarity between these and 
acetylcholine-induced EDRF led to the proposal that they were the same thing [14].  
Experiments by Ignarro and colleagues revealed that EDRF activated G-cyclase by 
mechanisms inhibited by MB and enhanced by antioxidants.  The activation of G-
cyclase by EDRF was then found to be heme-dependent and this linked it to NO [15].   
Since those two independent discoveries, NO has been found to be involved in the 
central nervous system, the immune system, the gastrointestinal tract, the kidneys, the 
lungs along with the circulatory system and the heart [16].  It can function as a 
messenger due to its small size and free radical nature.  However, in all of the 
locations in which it is found, the effects of NO can be both harmful as well as 
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protective; for example, in the immune system the anti-microbial and anti-tumour 
actions can lead to septic shock and tissue damage.  In the blood vessels it is primarily 
anti-thrombotic and vasoprotective, but it can also lead to reperfusion injuries and 
inflammation.  The central nervous system uses NO for memory formation and neuro-
endocrine secretion but it can cause migraine and convulsions.  In all cases the 
production of NO must be tightly regulated [17].    
 
 
1.2 Nitric Oxide Synthases 
 
The pathway to the production of NO from L-arginine was discovered in 1988 and it 
was the first example of biological hydroxylation of the L-arg guanidinium moiety 
[18].  The family of enzymes responsible for carrying out this reaction in mammals 
are the Nitric Oxide Synthases (NOSs), which perform the sequential oxidation of L-
arg using nicotinamide adenine dinucleotide phosphate (NADPH) and molecular 
oxygen as substrates [19].  NOSs firstly catalyse the mono-oxygenation of L-arg to N-
hydroxy-arginine (NOHA) and in a second oxidation step produce NO and L-






























L-arginine              NG-hydroxy-L-arginine (NOHA)            L-citrulline
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1.2.1 Function and locality 
 
There are three isoforms of NOS found in mammalian systems, which carry out 
distinct functional roles.  Neuronal NOS (nNOS) was originally discovered in rat 
neurons [21, 22], endothelial NOS (eNOS) was first identified from bovine 
endothelial cells [23], and inducible NOS (iNOS) is synthesised in a wide range of 
cells and tissues in response to inflammatory or pro-inflammatory mediators [24].  
Both iNOS and nNOS are cytosolic enzymes while eNOS is membrane bound.  eNOS 
is also unique in that it is targeted to the caveolae of vascular endothelial cells, where 
it is dynamically regulated by interactions with caveolin [25].  
The genes encoding the NOS isoforms are located on 3 different chromosomes but 
have a similar genomic structure, suggesting a common ancestral NOS gene. The 
overall sequence homology across the NOS family is approximately 50-60% [26]. 
Two of the isoforms, nNOS and eNOS, are constitutively expressed and synthesise 
NO in response to increased calcium (Ca2+) concentration, or occasionally in response 
to Ca2+-independent stimuli such as shear stress.  These constitutive NOSs (cNOSs) 
are also indirectly regulated by tetrahydrobiopterin (H4B) synthesis and by other 
proteins through direct binding, subcellular localisation and phosphorylation.  nNOS 
and eNOS directly link changes in the level of intracellular Ca2+ to NO production, 
activating G-cyclase.  iNOS, on the other hand, is transcriptionally activated by 
endotoxins and cytokines in macrophages, hepatocytes and vascular smooth muscle 
[27]. 
The sensitivity to Ca2+ concentration in the cNOSs is achieved by the binding of the 
protein calmodulin (CaM).  nNOS and eNOS are activated by CaM binding, and 




1.2.2 Structure and arrangement 
 
Although the length of the polypeptide chain of each NOS isoform varies, they all 
share the same basic structure, being split into an N-terminal oxygenase domain and a 
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C-terminal reductase domain, and represented in Figure 1.2.  The two domains are 
linked by a short (approximately 20 amino acids long) region that forms the binding 
site for CaM.  The oxygenase domain binds a cysteine-thiol ligated heme, 
tetrahydrobiopterin (H4B) and L-arginine.  It is structurally unique and forms the 
active site where NO synthesis takes place [29]. 
The reductase domain binds flavin mononucleotide (FMN), flavin adenine 
dinucleotide (FAD), and NADPH, acquiring electrons from the nicotinamide moiety 
and transferring them through FAD and FMN and on to the heme iron [30].  It is 
structurally similar to cytochrome P450 reductase (CPR) [31], with two important 
differences marked on Figure 1.2; one loop within the FMN-binding domain of the 
cNOSs and the C-terminal residues of all three isoforms.  These form autoinhibitory 
features that are important in the regulation of electron transfer.  The di-flavin 
reductase arrangement allows the shuttling of electrons from a two-electron donor (in 
this case NADPH) to a one-electron acceptor (heme iron).  In the constitutive NOSs, 
flavin to heme electron transfer is triggered by the binding of CaM, and it is this step 




Figure 1.2 Schematic representation of the sequence alignment of CPR, iNOS, eNOS and nNOS.   
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489 510 710 1160 1202
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The first 220 residues of nNOS are not found in the other isoforms and are known as 
the PDZ domain.  PDZ stands for PSD-95 discs large/ZO-1 homology domain, and 
PSD is post synaptic density protein.  This domain targets nNOS to synaptic sites in 
the brain and in skeletal muscle (where it is responsible for mediation of the binding 
of nNOS to the skeletal muscle protein syntrophin), and mediates the membrane 
association of nNOS in neurones [32].  
All of the NOS isoforms are functional homodimers, with the dimer interface formed 
between the two oxygenase domains [33].  The presence of a Zn2+ ion stabilises the 
dimer by binding to two cysteines from each subunit, while each of the hemes 
functions independently in a NOS dimer and receives electrons from the reductase 
domain of the adjacent monomer [34, 35].  A representation of the possible dimeric 
structure of nNOS is shown in Appendix I. 
The differing localisation of the isoforms of NOS means that they are required to 
produce NO at different rates. iNOS produces NO fastest because of the most urgent 
need for NO production at the site of infection, nNOS is intermediate, and eNOS is 
the slowest with longer lasting effects on the cardiovascular system [36].  Chimeras of 
the different isoforms showed that the reductase domains can still transfer electrons to 
oxygenase domains of a differing isoform; however these chimeras had activities 
characteristic of the isoform of the reductase domain in the chimera, indicating that 




1.2.3 Catalysis of NO synthesis 
 
In both reaction steps of the NOS pathway, the hydroxylation of L-arg to NOHA and 
the oxidation of NOHA to L-citrulline and NO (from Figure 1.1), the active site of the 
enzyme proceeds through a similar cycle, as illustrated in Figure 1.3 [38].  The resting 
state of the heme iron is the ferric form, with H4B bound to the enzyme (species I).   
The binding of substrate (Arg or NOHA) in iNOS affects the reduction potential of 
the heme cofactor, shifting it to a more positive potential that is analogous to the 
effect in cytochrome P450s [39].  In the constitutive NOSs the effect is to ensure that 
all of the heme is in a five-coordinate state.  The ferric heme is then able to accept an 
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electron from the FMN hydroquinone in the reductase domain, to become the ferrous 
species (II).  This can bind oxygen to form an oxyferrous complex (III), which can 




The stability of the oxyferrous complex (III) is a crucial factor in the catalytic cycle, 
and in the role that H4B plays.  In solution studies, the presence of L-arg or NOHA 
has been found to stabilise the oxyferrous complex, while the addition of H4B 
destabilises it [41].  The first role of H4B in the catalytic cycle, therefore, is to activate 
the oxyferrous complex by donating an electron and possibly a proton to form the 
hydroperoxy species (V).  The pterin is re-reduced by the reductase domain, and it is 
believed that the reduction of the superoxide species by H4B and not directly by the 
reductase domain leads to more efficient reduction [42].  Furthermore, it decreases the 
possibility of the release of cytotoxic superoxide into the cellular environment, and 
thereby increases the coupling efficiency of the reaction.  The O-O bond in the 
hydroperoxy species is then cleaved which leads to a ferryl species with a π-cation 
radical on the porphyrin ring (VI) that is the active oxygen intermediate.  This goes on 
to hydroxylate L-arg, via a P450-like oxygen insertion reaction, producing NOHA (as 
shown in Figure 1.1) and the ferric enzyme (I). 
Figure 1.3 Schematic representation of the catalytic cycle of the heme cofactor in nNOS.  Adapted  
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The second mono-oxygenation reaction was thought to proceed via a different 
mechanism, as it only requires one electron which is insufficient to produce the ferryl 
species (VI) present in the first reaction.  However, it has recently been shown that the 
enzyme goes through the same cycle from (I)-(V) in Figure 1.3 [40].  The peroxy 
intermediate in this case does not undergo cleavage of the O-O bond; instead it 
undergoes a nucleophilic attack on NOHA to form L-citrulline, NO and a water 
molecule.  In this final step in the catalytic cycle H4B has a second role to play.  
Following on from the production of L-citrulline and radical NO, the NO will be 
bound to the ferrous form of the enzyme.  This ferrous nitrosyl complex is particularly 
stable and the NO would not readily dissociate.  In this scenario, a high potential 
electron acceptor would be required to form the ferric nitrosyl complex that is labile 
and able to release NO.  The H4B radical that is formed during catalysis is able to 
perform this role and complete the catalytic cycle [43]. 
The dissociation of NO is in competition with a non-productive pathway in the final 
step.  This “futile cycle” involves the re-reduction of the heme by the reductase 
domain, and subsequent reaction with oxygen to produce nitrate.  These conflicting 
cycles are presented in Figure 1.4, where kr represents the rate of heme reduction by 
the flavoprotein.  Increasing the magnitude of kr will increase the rate of formation of 
heme-NO complex but will also cause more of it to proceed through the unproductive 
cycle [44]. 
 




In comparison to the other isoforms, nNOS has a near-optimal kr, whereby any 
increase in the rate of heme reduction will limit the rate of NO release [45].  This was 
observed for an nNOS mutant that had an increased rate of electron transfer from the 
reductase domain.  Initially it was thought that the increase in electron flux would 
lead to an increase in NO synthesis, however this was not the case.  The rate of 
NADPH oxidation by the mutant was greater than wild-type nNOS, as was heme 
reduction in the pre-steady state, but the rate of NO synthesis was slower.  The rate of 
heme reduction was modified by the use of CaM from soybean sources rather than 
mammalian cells.  In wild-type nNOS all of the CaM variants slowed down the rate of 
heme reduction and also the rate of NO synthesis, while in the S1412D mutant, the 
decreased rate of heme reduction by certain CaM isoforms caused an increase in the 
rate of NO synthesis.  This correlated with the near-optimal heme reduction rate 







Figure 1.4 Schematic representation of the catalytic cycle of NOS 
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1.3 NOS oxygenase domain 
 
The X-ray crystal structure of full-length holo-NOS has yet to be solved. However, 
considerable insight has been gained from the publication of the structures of the 
isolated oxygenase domains (NOSoxy) of all three isoforms; mouse iNOS, human 
eNOS and rat nNOS [47 – 49].  Each of these is dimeric (Figure 1.5 shows nNOSoxy) 
and has a similar structure, with the domain being made up of one continuous α-β 
fold consisting of several winged β-sheets.  The distal pocket that forms the active site 
of the enzyme is present in related cytochrome P450s, peroxidases and catalases, all 
of which have a largely α-helical structure.  The β-sheet structure of the distal pocket 
in NOS makes it unique among these related systems.  Heme is present in each 
subunit of NOSoxy as iron protoporphyrin IX and is cysteine-thiol ligated by Cys415 
(rat nNOS numbering).  Substrate binding channels are formed in each monomer of 
nNOSoxy, near to the binding site for heme, which allow access to L-arginine and the 
release of L-citrulline. 
 




L-arg binds with its side-chain tightly bound in the channel (Figure 1.6), with one 
carboxylate oxygen H-bonding with Tyr588 and Gln478 and the other carboxylate 
oxygen within H-bonding distance of Asp597.  The α-amino nitrogen forms H-bonds 
bridging Glu592 and one heme propionate, and the specificity in this amino-acid 
binding region is such that the L-enantiomer is favoured; the H-bonding contacts 
could not accommodate the D-enantiomer.  The guanidine group of L-arg is held 
above the heme plane by further H-bonding interactions with Glu592 and the 
backbone carbonyl oxygen of Trp587. 
The structure of nNOSoxy with NOHA bound has also been published [50], and it 
shows NOHA bound with the same interactions as L-arg, in both the main amino-acid 
section and the guanidine group.  The hydroxyl group of NOHA is present over the 
heme plane and does not coordinate, but instead points toward the backbone amide of 
Gly586 to form a weak H-bond or a non-bonded contact. 
The binding of H4B occurs within the dimer interface and is anchored by protein 
structural elements that are involved in the dimeric interaction (Figure 1.6).  The 
Figure 1.5 Dimeric structure of nNOSoxy (PDB code 1OM4).  The monomers are coloured blue  
    and green, the bound heme cofactors in red, L-arginine in magenta, H4B in cyan, and       
    the zinc ion in yellow.    
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pterin makes H-bond contacts with Ser334 from its own subunit and Phe691 from the 
other subunit.  The positioning of H4B is such that its rings are positioned to the side 
of the heme, almost perpendicular to the plane, and it π-stacks with a conserved 
tryptophan, Trp678.  This residue is crucial for stabilisation of the pterin radical 
formed during catalysis.  Substitution by phenylalanine or alanine in full-length nNOS 
decreased the rate of NO synthesis and caused uncoupled NADPH oxidation, due to 




Further structural information about nNOSoxy has been provided in the form of the 
crystal structures of the CO- and NO- bound ferrous forms [52].  The only difference 
in structure in the distal heme pocket between the ferrous and the ferric forms is the 
presence of an additional water molecule.  This is within H-bonding distance of the 
guanidine nitrogen of L-arg and a second water molecule, present in the original ferric 
Figure 1.6 Active site of nNOSoxy (PDB code 1OM4).  Backbone residues are coloured green and  
    blue from the two subunits, the bound heme cofactor in red, L-arginine in magenta,  
    and H4B in cyan.  Interactions between named residues and the cofactors are presented  
    as black dashed lines 
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structure.  The binding of CO and NO to the heme pull the iron into the porphyrin 
plane as expected, without altering the distortion of the plane itself, and both diatomic 
ligands H-bond to the active site water.  It is speculated that this water may H-bond to 
bound oxygen in the active site, and ultimately act as a proton source for the O-O 
bond cleavage step.  There are instances of other P450-oxy and heme oxygenase 
structures where water is the direct proton donor to the oxygen [53, 54]. 
Another important structural feature of the NOS oxygenase domain is its interaction 
with the reductase domain.  In P450s, the protein surface near to the heme group 
contains cationic patches made up of arginines and lysines that form a docking site for 
anionic surface patches of CPR, specifically on the FMN domain close to where the 
cofactor is bound [55].  The ionic interaction between the two domains allows the 
electron transfer to the heme that is required for catalysis.  As the anionic residues 
from CPR are conserved in the NOS reductase domain, it is thought that the delivery 
of electrons in NOS occurs in the same manner.  Lys423 is a well conserved residue 
in the constitutive NOSs, solvent exposed in the crystal structure of nNOSoxy (Figure 
1.7).  Charge-reversal substitution of this residue by glutamate in full-length nNOS 
yielded an enzyme that was markedly slower in terms of NO synthesis, heme 
reduction and NADPH oxidation.  The interaction between the electron-delivering 
reductase domain and the heme domain was disrupted to the extent that efficient 
catalysis could not take place [56]. 
 
 
Figure 1.7 Surface exposed residue Lys423 of nNOSoxy (PDB code 1OM4). The two subunits are  
    coloured blue and green, the bound heme cofactor in red, L-Arginine in magenta, H4B  
    in cyan, Lys423 in grey. 
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1.4 Flavins and flavoproteins 
 
FMN and FAD are generated from riboflavin (vitamin B2) which can be synthesised 
by plants, bacteria and fungi but not by animals, which must obtain it from the diet 
[57].  The structure of FAD, FMN and riboflavin are shown in Figure 1.8, with the 
numbering system of the isoalloxazine ring highlighted.  This ring system consisting 
of fused benzene, pyrimidine and piperizine rings can exist in three oxidation states – 
fully oxidised (quinone), one-electron reduced (semiquinone) and two-electron 
reduced (hydroquinone).  These are also depicted in Figure 1.8. 
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Flavin-binding proteins are estimated to be encoded for by 1-3% of genes in 
eukaryotic and bacterial genomes.  Each of the redox, ionic, and electronic states of 
the flavin group has distinct chemical properties that can be modified by a protein 
environment, and this allows the protein-bound flavin to perform a huge variety of 
enzymatic reactions.  Simple flavoproteins are classified by the reactivity of the 
reduced enzyme with molecular oxygen.  The oxidases react with dioxygen rapidly, 
using it as an electron acceptor to produce hydrogen peroxide and oxidised 
flavoprotein.  Examples of this class include D-amino acid oxidase, glucose oxidase 
and glycolate oxidase.  Common properties of these enzymes include; stabilisation of 
the anionic red flavin semiquinone rather than the neutral blue version, formation of 
flavin N5-sulfite adducts, and production of the benzoquinoid anion form of 
substituted flavin.  These properties all mean that a positive region of the protein is 
interacting with the pyrimidine ring of the flavin [57]. 
Monoamine oxidase (MAO) is an unusual flavoprotein oxidase, as the flavin is 
covalently linked to the protein via the 8-methyl substituent, meaning the prosthetic 
group is an 8-α-S-cysteinyl-FAD.  Two forms of MAO, A and B, exist in the outer 
mitochondrial membrane and, while sharing around 70% amino acid identity, they 
differ greatly in their specificity and biological function [58].  Generally speaking, 
they catalyse the oxidative deamination of amines that is an extremely 
thermodynamically unfavourable reaction.  The redox potential of the normally high-
potential amines is lowered and that of the low-potential flavin is raised by protein 
environment to allow the reaction to proceed.  MAO B mostly acts on small 
exogenous amines, whereas MAO A carries out degradation of bulkier endogenous 
neurotransmitters such as serotonin.  For this reason they are a pharmacological target 
and inhibitors of MAO A and B have been used in the treatment of neurological 
disorders [59].  
The flavin mono-oxygenases use dioxygen to insert an oxygen atom into their 
substrate.  The reduced enzyme reacts with O2 to form a C(4a)-hydroperoxide 
intermediate, and the physiological reductant in this case is always NADH or NADPH 
[57].  In the absence of a further substrate the flavin-hydroperoxide decays to H2O2 
and oxidised flavin.  In the presence of such a substrate the flavin-hydroperoxide 
transfers an oxygen atom to the substrate which results in a C(4a)-hydroxyflavin, 
which dehydrates to the oxidised flavin for the next catalytic cycle.  An advantage of 
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the flavin hydroperoxide is that solvent elimination of peroxide is mostly prevented so 
the hydroperoxy species is able to react with a wide variety of electron-rich groups. 
An example of this class is p-hydroxybenzoate hydroxylase (PHBH), which is 
involved in the pathway of aromatic degradation. The aromatic substrate is 
hydroxylated at the position ortho to the activating para-substituent, and the enzyme 
exhibits a high degree of specificity for its one substrate [60].  An unusual property of 
PHBH is the kinetic stability of the complex between substrate and reduced flavin, in 
this case FAD.  The flavin actually moves in the active site to allow exchange of 
substrate with solvent and in a second conformation it tightly binds to the substrate, 
ensuring rapid hydroxylation.  The movement of the flavin is also important in the 
interaction with NADPH that produces reduced FAD in the first part of catalysis, as 
the enzyme has no discernable NADPH-binding domain [61].  
The electron transferases are a class of flavoproteins that react very slowly with 
dioxygen, producing the superoxide anion and flavin semiquinone, in a reaction that 
represents decoupling of their actual function.  They are involved in physiological 
single-electron transfers and include flavodoxin, ferredoxin-NADP+-reductase and 
cytochrome P450 reductase [57].  The semiquinone state of the flavin is 
thermodynamically stabilised as the blue neutral species, and there is no production of 
sulfite adducts or stabilised benzoquinoid formation.  Solution studies show that 
typically the benzene ring is the only part of the flavin accessible to solvent. 
Some families of flavoproteins are not as easy to classify under one of the three 
headings, for example Acyl-CoA dehydrogenases (ACADs) react with acyl-CoA 
substrates by proton-abstraction from the α-carbon by an enzyme base and subsequent 
hydride transfer from the β-carbon to the flavin [62].  The catalytic reaction cycle is 
completed by sequential electron transfers to the electron-transferring flavoprotein 
(ETF), which channels the reducing equivalents from the reduced flavin of ACAD 
into the mitochondrial respiratory chain.  The related enzyme nitroalkane oxidase 
(NAO) exhibits flavin-dependent covalent catalysis, by performing the oxidative 
degradation of nitroalkanes to generate nitrite, hydrogen peroxide and an aldehyde or 
ketone [63].  An active-site aspartate residue acts as the base that abstracts a proton 
from the substrate at the start of the catalytic cycle.  Following on from the formation 
of the covalent intermediate between the substrate and the N5 flavin atom, a 
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hydrophobic channel that extends from the protein surface to the flavin ring provides 
a binding site for the adduct. 
Flavoproteins are also found coupled to other redox centres.  Bacterial enzymes that 
are involved in the degradation of unactivated aromatic compounds, such as benzene 
and catechol, involve iron-containing dioxygenases and flavoproteins that mediate 
reduction of the dioxygenase by NADPH.  An example of this is phthalate 
dioxygenase reductase which contains FAD and an iron-sulfur centre [57]. 
Flavocytochromes contain heme groups in addition to flavins, the most studied of 
which is yeast L-lactate dehydrogenase, or flavocytochrome b2 [64].  This contains a 
b-type cytochrome domain along with an FMN group.  Similarly, flavocytochrome c3 
from Shewanella is a fumarate reductase that contains four heme groups in a c3 
domain, as well as FAD that forms the active site in catalysis [65].  Among the 
cytochromes P450, flavocytochrome P450-BM3 from Bacillus megaterium is a fusion 
of a cytochrome P450 domain and an NADPH-cytochrome P450 reductase that 




1.5 Cytochrome P450 reductase 
 
The cytochrome P450 super-family of enzymes typically catalyse the mono-
oxygenation of hydrophobic compounds for example long-chain fatty acids, inserting 
one atom of dioxygen into the organic substrate while the other atom is reduced to 
water [67].  Electrons are provided by NADPH in eukaryotes and NADH in 
prokaryotes.  The provision of the electrons is in the form of a hydride (H-) and leads 
to two differing modes of electron transfer; through an FAD-containing reductase and 
a diffusible electron carrier such as an iron-sulfur protein, or through an FAD- and 
FMN-containing reductase, cytochrome P450 reductase (CPR). 
The sequence homology among CPR found in different species is very high, 
indicating an evolutionary importance for the enzyme.  There are many similarities 
between nNOSrd and CPR; it is a 78 kDa membrane-bound protein which accepts a 
hydride from NADPH, passes an electron through FAD then FMN and onto a heme 
acceptor.  Furthermore it cycles between the one- and three-electron reduced states 
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and contains a stable semiquinone on FMN.  However, it has a small N-terminal 
hydrophobic anchor section unlike NOS, attached to the C-terminal hydrophilic 
catalytic domain.  The anchor attaches CPR to the endoplasmic reticulum and allows 
interaction with cytochromes P450.  Proteolytic removal of this domain leaves the 
solubilised catalytic domain which can transfer electrons to cytochrome c but not to 
cytochromes P450 [68].   
Figure 1.9(A) presents the crystal structure of the catalytic domain of rat liver CPR 
with its four component domains highlighted [69].  Seven residues at the N-terminus 
are disordered, indicating flexibility and motion relative to the membrane bound 
domain.  The next 170 residues, coloured red, form the FMN-binding domain which 
is similar in structure to flavodoxin [70], a bacterial electron carrier.  The green 
connecting domain is linked to the FMN-binding domain by a disordered section 
which is flexible and involved in the motion of the FMN-binding domain relative to 
the other sections.  The connecting domain is largely α-helical, in contrast to the other 
domains which bind cofactors through β-sheet interactions.  Adjacent to the C-
terminal end of the connecting domain is the FAD-binding domain, coloured blue, 
with the FAD cofactor bound close to NADPH and on the edge of its binding domain 
such that it is end-on to the FMN cofactor.  The structure of the enzyme appears to be 
poised for FAD to FMN electron transfer. 
The interface between the connecting and FMN-binding domains is mostly 
hydrophilic so the interaction between them is electrostatic.  On the other hand the 
interfaces between the FAD-binding and connecting domains, and the NADPH- and 
FAD-binding domains, are mostly hydrophobic and these three domains are 
interlinked indicating that they cannot be separated easily.  They also appear to have a 
bacterial ancestor, being similar in sequence and structure to Ferredoxin-NADP+ 
reductase (FNR) [71].  This enzyme works in the reverse direction to CPR, reducing 
NADP+ rather than oxidising NADPH, but the protein fold appears largely unchanged 
between the two. 
 




Figure 1.9 X-Ray crystal structures of (A) CPR (PDB code 1AMO), and (B) nNOSrd (1TLL).   
    Bound flavin cofactors are coloured yellow, NADPH orange, domains from N- to C-  
    terminus red (FMN-binding), green (connecting), blue (FAD-binding), magenta  
    (NADPH-binding).  Additional features on nNOSrd coloured cyan (CT) and grey (AI). 
A 
B 
Salt bridge  
at Arg1229 N-terminus (adjacent 
to CaM-binding site)  
at Arg1229 
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1.6 NOS reductase domain 
 
The C-terminal di-flavin reductase is the larger of the two NOS domains; in rat nNOS 
it is comprised of residues 695-1429, which includes the CaM-binding region.  
Sequence analysis was the first indication that it was structurally homologous to other 
di-flavin reductases, sharing 36% identity and 58% close homology with CPR [72].  
This is represented in Figure 1.10, where the sequences of the three NOS isoforms 
and CPR are simplified into binding-domain blocks and compared.  From N- to C- 
terminal ends the basic arrangement is the same throughout, with the additional 
features on the NOSs being primarily the extension at the C-terminus (CT) and for the 




The crystal structure of rat nNOSrd was first published using a proteolysed version 
that contained only the C-terminal sections of the enzyme, the FAD- and NADPH- 
binding domains [73].   As expected, this was very similar in structure to FNR and the 
Figure 1.10 Schematic representation of the sequence alignment of the reductase domains of CPR,  
      iNOS, eNOS and nNOS, expanded from Figure 1.2.  Colouring of domains is the same  
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corresponding parts of CPR.  A more complete structure, containing all of the 
constituent parts of nNOSrd without the CaM-binding region, is represented in Figure 
1.9(B), in comparison to its homologue CPR.  Clearly the arrangement and protein 
fold of the two enzymes are very similar, with the domains laid out in the same 
manner and the cofactors in the same relative positions.  Interestingly, the structure of 
nNOSrd was found to be dimeric and further investigation revealed that this was the 
case in solution [74].  This revelation has implications for the overall arrangement of 
holo-nNOS, where the dimer interface in the oxygenase domain was presumed to be 
the only such interaction. 
There are many conserved features between the structures of CPR and nNOSrd; the π-
stacking interaction between FAD and an aromatic residue (Trp677 in CPR, Phe1395 
in nNOSrd) is one of them, and is important in the regulation of catalytic activity.  
Also conserved is the network of residues around the FAD cofactor which form 
important H-bonding interactions.  The binding of NADPH is mainly through the 
adenosine moiety, with the nicotinamide moiety held unproductively relative to FAD.  
Furthermore, at the interface between the two flavin cofactors and their binding 
domains is a salt-bridging interaction, in CPR it is a single interaction between an 
arginine and an aspartate while in nNOSrd it is a double-bridge between the 
conserved arginine and one of three glutamates.  The additional features of nNOSrd, 
however, may be the most important in the structure.  The two autoinhibitory features, 
coloured cyan, are the focus of much research on the activation of electron transfer 
through the enzyme.  The flavin cofactors in nNOSrd are positioned only 4.8 Å apart, 
suggesting that this enzyme is also poised for interflavin electron transfer.  For FMN 
to heme electron transfer to occur, it is clear to see that large-scale motion of the 
FMN-binding domain would be required. 
 
 
1.6.1 Function and activity 
 
Isolated nNOSrd can transfer electrons to acceptors such as cytochrome c or 
ferricyanide, just as CPR can [75].  The electron transfer activity of isolated nNOSrd, 
and within holo-nNOS, is summarised in Table 1.1, where it can be seen that the 
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binding of CaM activates the reductase domain to the same extent as it does the 
reductase activity of the nNOS holoenzyme [76].  This activation by CaM can be 
regarded as a de-repression of function, as the activity of CaM-free nNOSrd is 
severely down-regulated compared to other di-flavin reductases and iNOSrd [77].  It 
is only upon binding CaM that the electron transfer activity of nNOSrd is comparable 
with its homologues. 
 
Table 1.1 Summary of activation of electron transfer through nNOSrd 
Study Enzyme -CaM / s-1 +CaM / s-1 CaM-effect 
Cytochrome c reduction 
nNOS 4 47 11.8-fold 
78 
iNOS n/a 42  
nNOSrd 4 48 12-fold 
76 
CPR n/a 38  
nNOSrd 6 52 8.7-fold 
77 
iNOSrd n/a 50  
79 nNOS 7 83 11.9-fold 
80 nNOSrd 7.6 66 8.7-fold 
81 nNOS 10 97 9.7-fold 
Ferricyanide reduction 
nNOS 9.5 16 1.7-fold 
78 
iNOS n/a 65  
nNOSrd 7.5 28.5 3.8-fold 
76 
CPR n/a 72  
79 nNOS 30 85 2.8-fold 
80 nNOSrd 25 84 3.4-fold 
Flash photolysis 
82, 83 oxyFMN – “output state” 22 262 11.9-fold 
84 nNOS 0 36  
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Cytochrome c reduction is consistently activated by CaM by approximately 10-fold, 
but the rates of electron transfer vary slightly.  Ferricyanide, on the other hand, has a 
smaller CaM-mediated activation effect, which is probably due to the ability of the 
smaller electron acceptor to access both the FAD and FMN cofactors.  The flash 
photolysis experiments on the so-called “output state”, a construct consisting of only 
the FMN-binding domain and the oxygenase domain, directly measure the electron 
transfer between the cofactors.  This also exhibited a 10-fold stimulation upon CaM 
binding but the analogous nNOS rates were much slower.  This indicates that the 
motion of the FMN-binding domain is crucial, having to access the FAD/NADPH-
binding domains (the “input state”) to perform interflavin electron transfer, as well as 
the oxygenase domain. 
Another reaction of nNOSrd that has been studied in detail is the reduction of the 
flavin cofactors, i.e. the direct interaction between NADPH and FAD in the absence 
of an electron acceptor.  This reflects not only the hydride transfer step but any 
subsequent electron transfer between FAD and FMN, and is summarised in Table 1.2. 
The exact analysis used across different studies varies but the binding of CaM clearly 
activates the flavin reduction. 
 
Table 1.2 Summary of flavin reduction kinetics in nNOSrd  
Study Enzyme -CaM / s-1 +CaM / s-1 
nNOS 1.5 32 
76 
nNOSrd 2.5 37 
79 nNOS 9.2 1.6 54 14 
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1.7 Regulation of catalytic activity 
 
The activation of nNOS by CaM that occurs within the reductase domain could 
manifest as a result of two major causes; by a structural domain rearrangement and/or 
by altering the midpoint reduction potentials of the bound flavin cofactors.  The 
reduction potential is a measure of the potential energy when half of the molecules are 
oxidised and half are reduced, therefore giving an indication of the ease of oxidation 
or reduction occurring [85].  These thermodynamic measurements have been made in 
nNOS and nNOSrd and are summarised in Table 1.3. 
 
Table 1.3 Summary of midpoint reduction potentials of nNOSrd cofactors / mV 










nNOSrd – electrochemical -49 -274 -232 -280 -320 
86 
nNOSrd + CaM -30 -267 -234 -284  
87 nNOS -120 -220 -250 -260  
nNOSrd + CaM – OTTLE -98 -300 -296 -320  
Isolated binding domains -179 -314 -291 -326  88 
FAD/NADPH-domains + NADP+   -304 -290 -356 
87 Heme: -320 mV substrate free, -280 mV L-arg bound 
 
From the values listed, it is clear that the FAD cofactor is poised to accept two 
electrons from NADPH as a hydride.  The FMN cofactor has a higher potential for the 
oxidised to semiquinone transition so it will cycle between the 1 and 2 electron 
reduced states, and it is also poised to transfer electrons to the heme in the oxygenase 
domain.  Notably, the binding of CaM has no effect on any of the reduction potentials 
in either the reductase domain or in the holoenzyme, indicating that it does not 
regulate electron transfer in this way.  The stability of the cofactors is, however, 
affected by the presence of other domains; the FMN cofactor has a lower reduction 
potential in the isolated FMN-binding domain and is therefore stabilised in the 
semiquinone state by the presence of the other binding domains.  This stabilisation 
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has not been observed in related systems (such as CPR) and highlights the importance 
of the interface region between the domains in nNOSrd.  
Discounting any effect of CaM on the thermodynamics of NOS catalysis means that 
much research into the CaM-mediated activation step has been focussed on structural 
features.  While this would most obviously be solved by obtaining the X-ray crystal 
structure of a CaM-bound form of nNOSrd or the holoenzyme, great insight has been 
achieved by mutagenesis at a key number of sites within the reductase domain and the 
consequent effects on electron transfer.  
 
 
1.7.1 Calmodulin binding 
 
The binding of CaM is essential for NO synthase activity in all of the NOS isoforms 
[89].  Heme reduction in nNOS in the absence of CaM is extremely slow and cannot 
support the production of NO from L-arg.  The apparent rate of flavin reduction in 
nNOS in the absence of CaM is similar to that of heme reduction in the presence of 
CaM, so it is potentially fast enough to support heme reduction and NO synthesis.  It 
is the case, however, that the electrons are not delivered efficiently to the heme; thus 
the binding of CaM must play an important role in facilitating electron transfer from 
the flavin domain to the heme domain.  Additionally, CaM stimulates both flavin 
reduction events; initial FAD reduction by NADPH and the transfer of electrons 
between the flavins [90]. 
De-repression by Calmodulin is a common mechanism by which it interacts with 
other enzymes; for example myosin light chain kinase, calmodulin kinase IV, and 
calcineurin [91 – 93].  In all of these cases the region of protein architecture denoted 
as the CaM-binding site, or an adjacent site, serves as a competitive inhibitor that 
blocks access to the natural substrate until it is displaced by binding CaM.  This is not 
the case for any of the substrates of NOS, or cytochrome c, but it was thought that the 
CaM-binding site could perform a similar function between the reductase domain and 
the oxygenase domain.  This would not explain, however, the fact that the electron-
transfer activity of the isolated reductase domain is activated by CaM [89].  
Furthermore, structural changes in nNOSrd were found to be induced by CaM-
binding, firstly by fluorescence spectroscopy [76], where an increase in flavin and 
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protein tryptophan fluorescence indicated a greater solvent exposure of the enzyme 
cofactors in the activated form. 
CaM is a 17 kDa dumbbell-shaped protein with N- and C- terminal globular domains 
connected by an α-helical linker.  Figure 1.11(A) shows the sequence and 1.7 
resolution X-ray crystal structure of recombinant bovine CaM, where the central helix 
is found to be in an elongated conformation [94].  Each of the globular domains, also 
called lobes, consists of two EF hands; a helix-loop-helix arrangement where each 
hand binds a Ca2+ ion that can also be clearly observed in the structure.  Figure 
1.11(B) shows the 2.05 resolution X-ray crystal structure of rat CaM bound to a 
synthesised eNOS peptide fragment, selected to represent the CaM-binding site of 
human eNOS (RKKTFKEVANAVKISASLMG) [95].  The overall structure of CaM 
can now be seen to be different to that of the unbound protein; it surrounds the peptide 
in a completely globular arrangement.  The question still remains, however, as to how 
this structure relates to the CaM-bound holoenzyme. The presence of the large 
oxygenase and reductase domains are likely to place constraints on the conformation 
of CaM, and force it to be bound in a specific conformation that is related to the 
activation step.  Furthermore, the binding to eNOS and nNOS may not be exactly the 








Certain facts are known about the binding of CaM; it is in an anti-parallel fashion, i.e. 
the C-terminal lobe of CaM binds to the N-terminal end of the binding site, adjacent 
to the oxygenase domain, while the N-terminal lobe of CaM binds to the C-terminal 
end of the recognition sequence, at the reductase domain.  Furthermore, these lobes 
have different affinities for Ca2+, with the C-terminal one displaying 10-fold higher 
affinity than its N-terminal counterpart [96].  This suggests that the C-terminal lobe 
Figure 1.11 Sequence of bovine CaM [143] and X-ray crystal structures of (A) recombinant bovine  
     CaM (PDB code 1CLL) and (B) rat CaM bound to a synthesised eNOS peptide  
      fragment (PDB code 1NIW).  Calmodulin residues are coloured blue, calcium ions  
      yellow, and eNOS peptide red. 
A 
B 
Bovine CaM : ADQLTEEQIA EFKEAFSLFD KDGDGTITTK ELGTVMRSLG 40
QNPTEAELQD MINEVDADGN GTIDFPEFLT MMARKMKDTD 80
SEEEIREAFR VFDKDGNGYI SAAELRHVMT NLGEKLTDEE 120
VDEMIREADI DGDGQVNYEE FVQMMTAK  148
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binds first but cannot activate the enzyme until the N-terminal lobe binds and causes 
activation.  It may be the case that the C-terminal lobe is bound even at low Ca2+ 
concentrations (recall that this is near to the oxygenase domain) and then the N-
terminal lobe binds at the reductase domain to cause the structural rearrangement that 
allows electron transfer through the holoenzyme to take place [97]. 
 
 
1.7.2 Autoinhibitory loop 
 
The ‘autoinhibitory loop’ (AI) is highlighted in Figure 1.12 as the only main 
difference in sequence comparison between the flavin domains of the cNOSs and 
iNOS [36].  It is a section of protein architecture 45 amino acids in length that is not 





When the loop was first identified, it was speculated to function as a possible 
autoinhibitory domain, similar to inserts in other CaM-regulated enzymes.  However, 
these inserts are normally acidic and hydrophobic, while the region in the cNOSs does 
not share those properties.  To test if the loop was binding to the CaM-recognition 
sequence, or an adjacent region, synthesised polypeptides based on the sequence of 
the AI were used as potential inhibitors of NOS activity.  The most effective 
inhibitors that were made all included the eNOS RRKRK motif, highlighted by 
asterisks in Figure 1.12, which correlates with the activity of eNOS being the slowest 
# 
***** 
Figure 1.12 Sequence alignment of CPR, iNOS, eNOS and nNOS within the FMN-binding  
      domain.  FMN-binding residues are coloured red, Autoinhibitory loop (AI) cyan. 
CPR       155   LQE- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -TDVDLTGVK
(rat)
iNOS      606   LFMMKE- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - LGHTFR
(human)
eNOS      589   LMEMSGPYNSSPRPEQHKSYKIRFNSISCSDPLVSSWRRKRKESSNTDSAGALGTLR
(human)
nNOS     825   LMEMRHPNSVQ- - -EERKSYKVRFNSVSSYSDSRKSSGDGPDLRDNFESTGPLANVR
(rat)
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among the isoforms.  These peptides inhibited both the NO synthase activity of nNOS 
and eNOS and CaM-binding to a similar extent.  The inhibition effect was fully 
reversed by the addition of excess CaM, indicating a competitive mode of inhibition.  
In addition, the binding of L-arg was unaffected, discounting any interference with the 
oxygenase domain and its substrate.  The polypeptide fragments had no effect on the 
regulation of other CaM-binding proteins, indicating specificity for the cNOSs, while 
iNOS activity was unaffected by any of the inhibitors.  This was attributed to the lack 
of an AI loop in iNOS and therefore a lack of any recognition site for it [98]. 
Further evidence for the competitive binding of the AI to nNOS came from the 
limited proteolysis of the holoenzyme.  In the absence of CaM the preferred cut was 
made at Arg727 in the centre of the CaM-binding region [99].  With CaM bound, and 
the protection of its binding site, the cut was made at Lys856 in the centre of the AI 
loop (marked by # in Figure 1.12).  Further analysis of the CaM-free digestion by gel 
electrophoresis revealed that Lys856 is the preferred cut site following the cleavage at 
Arg727.  It was concluded that this protection and exposure was being caused by 
CaM displacing the AI of cNOSs.  
Deletion of the RRKRK motif in eNOS [100] or substitution of the residues by 
alanines [101] activated CaM-bound NO synthase activity and CaM-free electron 
transfer to cytochrome c.  The removal of the entire loop in nNOS, highlighted by an 
arrow in Figure 1.12, had a similar effect but the mutant enzyme could also synthesise 
NO without the binding of CaM [102].  Furthermore, it was capable of electron 
transfer to the heme in the absence of CaM and tolerated lower levels of Ca2+ to 
maintain CaM-bound maximal activity.  This was an indication of the role of the AI in 
the suppression of CaM-free activity and the sensitivity to Ca2+/CaM binding.  
Other deletion studies involved the removal of the loop from chimeras containing 
eNOS reductase domains and oxygenase domains from the other isoforms [103].  
These loopless chimeras had lessened Ca2+ dependence which correlated with 
chimeras that contained the reductase domain of iNOS and therefore no loop.  The 
affinity for calcium in these constructs was up to 20-fold greater than that of wild-type 
eNOS or nNOS.   
Upon publication of the crystal structure of nNOSrd [74], the AI was observed to lie 
between two strands of β-sheet that interact with the FMN cofactor and was found to 
contain a central α-helix which makes interactions with other helices from both the 
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FMN- and NADPH-binding domains (Figure 1.13).  There were also a large number 




The structure represented in Figure 1.13 indicates that the AI does not interact with 
the CaM-binding site in CaM-free nNOS; this region would be on the other side of the 
FMN-binding domain, marked as the N-terminus.  There is the possibility, however, 
that there is an interaction between bound CaM and the AI; the disordered residues 
between Ser849 and Gly872, marked on Figure 1.13, could form a long enough linker 
region to allow the AI to move (to the right in the picture).  This movement could thus 
be part of the activation process that allows large-scale motion of the FMN-binding 
domain to trigger electron transfer to the heme.  The role of the AI would therefore be 
to suppress CaM-free activity of nNOS in the conformation presented, and to allow 




Figure 1.13 Autoinhibitory loop of nNOSrd (PDB code 1TLL).  Bound FMN is coloured yellow,  
      NADPH orange, FMN-binding domain red, NADPH-binding domain magenta and AI  
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1.7.3 C-terminal tail 
 
Sequence alignment between CPR and NOSs at the C-terminal end (Figure 1.14) 
reveals that all of the NOSs are longer by 21-42 amino acids [36].  This has been 
designated as the C-terminal extension, or tail (CT), and is shortest in iNOS (21 




Deletion of the tail affects the rate of electron transfer in all three isoforms.  In iNOS, 
the truncated mutant had enhanced activity for all electron transfer reactions 
measured; cytochrome c reduction, NADPH oxidation and NO synthesis.  
Furthermore, the reduction of FAD by NADPH was faster than for the wild-type 
enzyme, as was the electron transfer between the flavins [104].   
In the cNOSs the effect is slightly different; truncated nNOS was found to catalyse 
CaM-free cytochrome c reduction 21-fold faster than the wild-type enzyme.  This was 
then decreased by the binding of CaM, down to the activated wild-type level.  NO 
synthesis was observed in the absence of CaM, but the rate was decreased relative to 
the wild-type level in the presence of CaM, presumably due to uncoupled NADPH 
oxidation as the flavin cofactors reacted more rapidly with oxygen.  Ferricyanide 
reduction activity and flavin reduction by NADPH were both increased in the absence 
of CaM, and the FMN cofactor no longer formed an air-stable semiquinone species 
[105].  These results indicated that the CT plays an important role in the regulation of 
Figure 1.14 Sequence alignment of CPR, iNOS, eNOS and nNOS at the C-terminal end.  NADPH- 
      binding domain residues are coloured magenta, C-terminal tail (CT) residues cyan. 
CPR      671     RYSLDVWS
(rat)
iNOS    1119   RYHEDIFGAVFSYGVKKGNALEEPKGTRL
(human)
eNOS   1153    RYHEDIFGLTLRTQEVTSRIRTQSFSLQERQLRGAVPWAFDPPGSDTNSP
(human)  
nNOS   1389   RYHEDIFGVTLRTYEVTNRLRSESIAFIEESKKDADEVFSS
(rat)
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electron transfer between the flavins and also in the protection of the cofactors from 
solvent exposure and therefore access to oxygen. 
Further investigation involved the addition of the tails from each isoform of NOS to 
CPR [106].  In all cases the cytochrome c reduction activity of the chimeras was 
lowered relative to CPR, with the iNOS tail having less effect than the nNOS, and the 
eNOS the most disruption, consistent with their length and the activity of the isoform.  
The addition of the tails was also found to have an effect in fluorescence spectroscopy 
studies, indicating a conformational change.  A related investigation placed the 
reductase domain of CPR into a chimera with nNOS and this yielded an enzyme that 
was more active in electron transfer and NO synthesis than any other [107]. 
Deletion of the CT was coupled with deletion of the AI and this doubly truncated 
nNOS had no CaM dependence on reductase activity, which compares with inhibition 
for CT deletion and slight activation for AI deletion.  Removal of both of the features 
yielded a mutant that reduced cytochrome c at the activated wild-type rate [108].  
Ferricyanide reduction was investigated in detail and it was reported that previous 
measurements (i.e. those in Table 1.1) were not carried out at saturating 
concentrations.  The use of 2mM ferricyanide in this study resulted in rates of 
reduction greater than 500s-1.  Furthermore, the effect of CaM was ascribed to only 
lowering the binding constant, i.e. increasing the affinity of ferricyanide for nNOS; 
there was no change in the maximal rate.  Wild-type and AI-truncated nNOS 
exhibited this CaM-mediated effect, while the CT-truncated or double-truncated 
enzymes were equally accessible to ferricyanide in the absence and presence of CaM. 
NO synthesis in the double-truncated mutant still requires CaM for maximal activity, 
but this could be supported by a mutant of CaM that was a fusion of two C-terminal 
lobes.  This is the part of CaM that has higher Ca2+-affinity and binds near to the 
oxygenase domain of nNOS.  The mutant CaM did not activate wild-type nNOS, 
which effectively means that any interaction between the N-terminal end of CaM and 
nNOSrd is not required when the AI and CT are deleted.  All of this evidence led to 
the proposal that the AI and the CT interact with each other in the resting state, and 
then they interact with CaM, when it binds, to activate the enzyme. 
Referring to the crystal structure of nNOSrd [74], the CT contains an α-helix which 
fits into a negatively-charged groove across the FAD-FMN interface area, shielding 
the flavins from solvent (Figure 1.15).  The ordered CT residues extend from the last 
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β-strand of the NADPH-binding domain and form a right-angled turn followed by the 
α-helix.  The first four residues are tethered to the FMN- and NADPH- binding 
domains by hydrogen bonds and to the NADPH molecule through interactions 
between the 2’-phosphate group and Arg1400, an important residue that is conserved 




Following on from the crystallographic studies, the specificity of the effect of the CT 
has been assessed by varying degrees of truncation in nNOS and nNOSrd [109].  In 
addition to removing the entire CT (residues 1396 to 1429), only the residues that 
were disordered in the crystal structure (1413-1429), and the residues that form the α-
helix downstream from Arg1400 (1401-1429) were deleted.  For cytochrome c 
reduction activity, there were differing trends observed between the independently 
isolated reductase domain and the holoenzyme, an indication that the CT plays 
different roles depending on the presence of the oxygenase domain.  In general, 
increasing truncation caused greater rates of CaM-free cytochrome c reduction.  In 
Figure 1.15 C-terminal extension in nNOSrd (PDB code 1TLL).  Bound flavin cofactors are  
      coloured yellow, NADPH orange, FMN-binding domain red, NADPH-binding domain  
      magenta, AI loop blue, and CT cyan.  Key residues Arg1400 (cyan) and Phe1395  
      (magenta) are shown in stick conformation.  Other domains omitted for clarity. 
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particular, in nNOSrd the fully truncated mutant showed no difference between the 
CaM-free and CaM-bound states, while the holoenzyme construct was 2-fold faster in 
the absence of CaM.  This was consistent with the previous studies on the deletion 
mutant.  NO synthesis rates were slowed according to the degree of truncation when 
CaM was bound, due to increased uncoupled NADPH oxidation and therefore slower 
heme reduction, and only the completely tail-less mutant synthesised NO in the CaM-
free state.  The reduction of FAD by NADPH was analogous to wild-type nNOSrd in 
the two shorter truncations, while the complete deletion showed no regulation by 
CaM [109].  Apparently the latter half of the CT has no role in the suppression of 
catalysis; it is the α-helix that is the essential structural feature of the CT.  This is 
coupled with the action of the amino acids immediately upstream from it to fully 
suppress the CaM-free activity of nNOS.  
In summary, the CT is crucial to the regulation of electron transfer through nNOSrd.  
This is confirmed by the rapid activity of the truncated CaM-free mutants, the 
specificity of the tails from the different isoforms, and the speculated interactions 
between the CT, the AI and bound CaM. 
 
 
1.7.4 Phosphorylation and protein-protein interactions 
 
Both of the inherent structural inhibitory features in the reductase domain are targeted 
by post-translational modifications.  Protein kinase-catalysed phosphorylation occurs 
at Ser847 in the AI loop and Ser1412 in the CT of nNOS [110].  Phosphorylation at 
the analogous CT site in eNOS caused an increase in NO output, while substitution of 
the residue with alanine stopped phosphorylation [111].  Substitution of the CT serine 
by aspartate mimicked the negative charge placed on the residue by the kinase and 
replicated the effect of activation by phosphorylation, with increased NO synthesis 
and cytochrome c reductase activity [112].  Furthermore the Ca2+ affinity of the 
enzyme was increased, indicating an effect on CaM-binding affinity.  It was 
speculated that the phosphorylation site was a key target for regulation, linked to the 
action of the CT.  This was confirmed by an eNOS mutant that lacked the 27 amino-
acids downstream of the serine, which had similar properties to the aspartate mutant; 
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increased Ca2+ affinity, NO synthesis and cytochrome c reductase activity [113].  It is 
probable that the phosphorylation event serves to reposition the CT and therefore 
increase electron flux through the enzyme. 
The corresponding substitution was made in nNOS, S1412D, and this yielded an 
enzyme with reductase activities, both cytochrome c and ferricyanide, that were twice 
as fast as for the wild-type enzyme [46].  The rate of pre-steady-state flavin reduction 
was increased in the CaM-free state, while heme reduction was consistently faster 
than in the wild-type enzyme by 1.5-fold, and the mutant had an increased sensitivity 
to Ca2+. 
Modification of the serine within the AI loop has a more complicated effect than 
simple activation.  It was found to be phosphorylated by a number of CaM-dependent 
protein kinases, which led to a decrease in NO synthesis and cytochrome c reduction 
rates, an effect attributed to the suppression of CaM binding [114]. 
A further site was identified in eNOS, a threonine within the CaM-binding region 
where phosphorylation resulted in the inhibition of NO synthesis [115].  This 
implicates a balance of positive and negative effects regarding the phosphorylation of 
eNOS whereby multiple protein kinases and phosphatases may act on the enzyme to 
stimulate or inhibit NO production by Ca2+/CaM-independent methods. 
 
 
1.7.5 Hinge region 
 
The strand of protein linking the FMN domain and the connecting domain in the 
crystal structure of nNOSrd was found to be flexible and denoted as the “hinge” [74].  
Also of note in the connecting domain is a “small insertion” (SI) of 7 residues that 
forms part of a β-hairpin.  Both of these features are depicted in Figure 1.16. There is 
no homology in the SI region between the isoforms, and replacement of the eNOS SI 
by the iNOS version yielded a mutant that was activated at 5-fold lower Ca2+ 
concentration but did not have any significantly altered catalytic activity [116].  This 
would indicate that the SI is not as important as either the AI or the CT.  Complete 
deletion of the nNOS SI decreased cytochrome c reductase activity, while half 
deletion of the SI or the substitution of a key glycine gave a slight increase in 
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reductase activity with no change in CaM-sensitivity [117].  Again, these effects are 




The importance of the hinge region was investigated by creating an eNOS chimera 
containing the nNOS hinge. This results in a 4-fold increase in NO synthase activity, 
up to two-thirds of the nNOS level [118].  Also studied was a proline residue in eNOS 
that was substituted by isoleucine, while the corresponding isoleucine in nNOS was 
changed to proline.  The eNOS single mutant was more active than wild-type eNOS 
and the nNOS single mutant was less active than wild-type nNOS, consistent with the 
role of the proline in restricting flexibility.  NADPH oxidation and heme reduction 
correlated with NO synthesis and the coupling in the eNOS chimera was actually 
better than in wild-type eNOS. 
Flavin reduction rates in the hinge mutants were unaffected, while cytochrome c 
reduction activities were altered according to the same trend as NO synthesis but to a 
lesser extent, with the eNOS chimera more akin to eNOS than nNOS.  In contrast, its 
NO synthesis rate resembled that of an eNOS chimera with the entire nNOS reductase 
domain [37].  The other regulatory features in the reductase domain have a greater 
Figure 1.16 Hinge region of nNOSrd (PDB code 1TLL).  Bound flavin cofactors are coloured  
      yellow, NADPH orange, FMN-binding domain red, connecting/NADPH/FAD-binding  
      domains blue, hinge region magenta and small insertion (SI) cyan. 
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impact on specific reductase activities rather than NO synthesis.  The opposite case 
with the hinge region implies that its role is specifically centred on the interaction 
between the FMN-binding and oxygenase domains. 
 
 
1.7.6 FMN accessibility 
 
Activation of the holoenzyme by CaM is achieved by the triggering of flavin to heme 
electron transfer [30].  This has been further assigned to a specific motion of the 
FMN-binding domain relative to the other constituent parts of the reductase domain, 
allowing the electron acceptor access to the bound FMN cofactor [76].  This 
accessibility was investigated in the isolated reductase domain by the pre-steady-state 
reduction of cytochrome c by fully reduced (i.e. chemically 4-electron-reduced) wild-
type nNOSrd [119].  This first order reaction provides insight into the ease of 
interaction between the bound FMN cofactor and the exogenous cytochrome c 
molecule. It was found that the binding of CaM caused a 2.5-fold increase in the 
second order rate constant associated with the reduction of sub-stoichiometric 
amounts of cytochrome c, which suggested that there was an increase in the 
accessibility of FMN to the electron acceptor upon CaM-binding.  The more 
interesting results, however, came in experiments with NADPH added; when NADPH 
was bound to the CaM-free enzyme, the rate constant was 14-fold lower than in the 
corresponding NADPH-free experiment.  The CaM-bound enzyme was unaffected by 
the binding of NADPH, which indicated that the FMN is much less accessible to the 
electron acceptor when NADPH is bound, and that this “locked” conformation is 
relieved by the binding of CaM.  This was confirmed by performing the same 
accessibility experiment with the isolated FMN-binding domain.  The rate of electron 
transfer was the same in the smaller construct and in CaM-bound nNOSrd [120].  
According to the relative cytochrome c reduction rates the FMN is fully accessible 
when CaM is bound, 45% accessible in the absence of CaM, and only 3% accessible 
when NADPH is bound and CaM is not. 
The specificity of the inhibitory effect of β-NADPH was examined by comparing the 
binding effect of analogues [120].  α-NADPH and 2’5’-ADP only induced a 50% 
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drop in rate in comparison to the natural substrate, while 2’5’-ATP-ribose only lacks 
the nicotinamide substituent so had a greater effect, 75%.  β-NMN (nicotinamide 
mononucleotide) caused a 60% inhibition which was surprising given that it has no 
adenosine group.  Furthermore, the binding of CaM did not fully relieve this effect.  
β-NAADP+ contains nicotinic acid instead of the amide group, and failed to inhibit at 
all.  This means that the simple change of the nicotinamide to carboxylic acid 
abolishes the locking effect.  The full lock could not be replicated by any combination 
of analogues, even 2’5’-ATP-ribose with nicotinamide, or 2’5’-ADP plus β-NMN.  
Clearly in β-NADPH the weakly-bound nicotinamide substituent has an important 
role to play.  Further evidence of the specificity was found in a study with full-length 
nNOS and eNOS [121], where analogues with only the adenine moiety of NADPH 
competitively inhibited the binding of β-NADPH and activated NO synthesis activity. 
The binding of NADPH to the protein backbone of nNOSrd is clearly visible in the 
crystal structure [74], with contacts made between the adenosine group and the 
residues Ser1313, Arg1314, Tyr1322, and Arg1400, as presented in Figure 1.17.  The 
first three of these residues are a conserved triad that determine NADPH binding 
affinity and selectivity in related flavoproteins [122, 123].  The nicotinamide group of 
NADPH is solvent-exposed and is bound away from the FAD cofactor where it must 
stack to facilitate hydride transfer, meaning it is flexible and must rotate to deliver a 
hydride efficiently. 
 




Arg1400 is unique to the cNOSs (it is a serine in iNOS), and the effects of 
substitution by serine and glutamate were studied in both the holoenzyme and 
nNOSrd [124].  NO synthesis was slower in the Arg1400-substituted mutants of 
nNOS but the corresponding NADPH oxidation rates were higher.  Heme reduction 
was faster in the mutants, with the slowest NO synthesis rate correlating with the 
fastest rate of heme reduction (R1400E).  The build-up of ferrous heme-NO complex 
was faster than for wild-type nNOS, but this could be attenuated by the use of 
different forms of CaM which supported differing rates of heme reduction, in 
accordance with the global catalytic model predicted for the S1412D mutant (see 
section 1.2.3).     
Cytochrome c reduction was less repressed in the reductase domain mutants (4-fold 
and 2-fold activation by CaM), which could sustain a higher rate of turnover with 
NADH than with NADPH, with Km values for both nucleotides being higher.  Flavin 
reduction rates also reflected less repression in the CaM-free state for the R1400S 
mutant and no repression for R1400E.  NADPH binding caused an increase in the rate 
of pre-steady-state cytochrome c reduction for both mutants, rather than a decrease 
such as that observed for the wild-type enzyme [124].   
Figure 1.17 NADPH binding in nNOSrd (PDB code 1TLL).  NADPH and backbone residues are  
      shown in stick conformation and coloured orange and blue respectively.  The CT is  
      shown in blue ribbon format. 
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The interaction between the phosphate group of NADPH and Arg1400 causes 
specificity for the nucleotide over NADH, and also forms part of a longer-range effect 
on the suppression of electron transfer that starts at the hydride source, is mediated 
through the CT which includes Arg1400, and ultimately affects the movement of the 
FMN-binding domain and its accessibility to heme electron acceptors. 
 
 
1.7.7 Hydride transfer 
 
The first step in the catalytic action of nNOSrd is the transfer of hydride from the 
nicotinamide group of NADPH to the N5 position of the bound FAD cofactor.  This 
event is activated by CaM-binding (see Table 1.1) and also by the removal of the CT 
or charge reversal at Arg1400 in the CaM-free state.  In order to achieve the hydride 
transfer, the NADPH must re-orientate from the non-productive conformation 
observed in the crystal structure of nNOSrd [74], and π-stack to the re-face of FAD.  
The motion of the nicotinamide group must also occur in CPR and FNR, where the 
presence of a conserved aromatic residue was found to be important [125].  Figure 
1.18 presents the interaction between bound NADPH and FAD in CPR, with the 
highlighted residue Trp677 π-stacking with the re-face of FAD.  Deletion of the 
tryptophan, on the right hand side of the picture, allowed the nicotinamide to stack 
productively, where key residues Cys630 and Ser457 are within hydrogen bonding 
distance of the NADPH and FAD respectively.  The W677X mutant’s catalytic 
activity was unaffected in terms of electron transfer, but the NADPH affinity was 
altered [126]. 
 




In nNOS the aromatic residue, equivalent to Trp677, is Phe1395 which is the last 
residue in the NADPH-binding domain before the CT, and was observed to perform 
the same shielding role at the re-face of FAD in the first crystal structure of nNOSrd 
(the FAD/NADPH binding domains only [73]).  Mutational studies were made in the 
nNOS holoenzyme; F1395Y which only slightly altered the aromatic character of the 
side chain, and F1395S which completely abolished the π-stacking interaction [127].   
The properties and activity of the F1395Y mutant were very similar to wild-type 
nNOS, as expected.  The F1395S mutant caused an increase in CaM-free cytochrome 
c reduction activity, by a factor of 4 relative to the wild-type enzyme, and also had 
slow but detectable NO synthesis.  The binding of CaM to F1395S nNOS did not 
cause an increase in reductase activity, and only enhanced NO synthesis to 10% of the 
wild-type value.  NADPH oxidation was extremely rapid and uncoupled, while the 
rate of flavin reduction lacked any repression in the CaM-free state.  In contrast, heme 
reduction in the mutant was 800-fold slower than wild-type, indicating that the flavins 
are reacting with oxygen more rapidly [127].   
Further studies of the F1395S mutation were made in the isolated nNOSrd, where the 
mutant’s cytochrome c reductase activity was similar to that observed in the 
holoenzyme; 50% of the wild-type rate and showing no CaM-dependent enhancement 
[128].  Flavin reduction was also similar to that in the holoenzyme, with no repression 
of the rate in the absence of CaM.  Pre-steady-state reduction experiments were 
Figure 1.18 FAD-active sites of CPR mutants S457A/C630A/D675N (PDB code 1JA1, left) and  
      W677X (1JA0, right).  FAD is coloured yellow, NADPH orange, backbone residues  
      blue.  Key interactions are marked with black dashed lines 
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carried out using F1395S nNOSrd and it was found that the addition of NADPH did 
not fully repress electron transfer from the FMN hydroquinone species, which was a 
similar observation to that made in R1400E. 
The NADP+-affinity was measured and found to be increased relative to the wild-type 
enzyme, with a larger proportion stacked to the bound FAD cofactor.  Furthermore, 
the NADP+-dissociation rate was 8-fold slower in F1395S nNOSrd than in the wild-
type, where CaM has no effect on the rate.  This slow dissociation of NADP+ is 
responsible for limiting the electron transfer activity of the mutant.  The aromatic side 
chain of Phe1395 is an essential feature which represses the CaM-free activity of 
nNOS and also relieves the repression upon CaM-binding.  This is another interaction 
that can be assumed to be mediated through the adjacent CT extension [128].  
The π-stacking of Phe1395 to FAD in the crystal structure of nNOSrd [74] is 
represented in Figure 1.19, along with the cysteine and serine that are present in the 
same relative orientation as in CPR.  Following hydride transfer between NADPH and 
FAD, electron transfer occurs between the two flavin cofactors rapidly and easily, as 
they are only approximately 5 Å apart, which leaves a proton to be removed from N5 
of FAD before another catalytic cycle can occur.  Ser1176 is within hydrogen bonding 
distance of N5 and of another conserved residue, Asp1393, which in turns forms 
interactions with His1032 and Arg1229, the surface-exposed residue that forms salt-
bridging interactions at the FAD/FMN interface.  This network of residues therefore 
serves as a putative proton transfer pathway between FAD and solvent.  
 




The conserved residue Ser1176 was substituted in nNOS by threonine, which retained 
the H-bonding properties, and alanine which abolished any interactions [129].  As 
expected, the effect of the S1176A mutation was greater, with lower cytochrome c 
reductase activity that was still CaM-sensitive, 20-fold slower ferricyanide reduction 
and 3-fold slower NO synthesis.  S1176T, on the other hand, had similar NO 
synthesis rates to wild-type nNOS but 5-fold slower reductase activity.  Rate 
constants for flavin reduction in the mutants were severely decreased compared to 
wild-type, but again were activated by CaM-binding.  The midpoint reduction 
potentials of the flavin cofactors were measured by titration and there was little 
change for the threonine mutant, while S1176A nNOS destabilised the FAD 
semiquinone state.  Clearly the hydrogen-bonding properties of the serine, with 
possible interactions to the FAD cofactor or to Asp1393, are crucial for stabilising 
hydride transfer to FAD during catalysis. 
Asp1393 has been studied in both the holoenzyme and in nNOSrd.  In the full-length 
study, substitutions were made with valine, asparagine and glutamate [130].  The 
D1393V substitution was particularly severe, with practically no reductase activity or 
NO synthesis observed, along with 1000-fold lower flavin reduction than wild-type 
Figure 1.19 Interaction between bound FAD and backbone residues in nNOSrd (PDB code 1TLL).   
      FAD is coloured yellow, NADPH-binding domain residues blue.  Key interactions are  
      marked with black dashed lines. 
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nNOS.  Clearly, the hydride transfer step is compromised by the lack of hydrogen-
bonding ability in the D1393V mutant.  The D1393E and D1393N mutants had low 
cytochrome c reductase activity which was enhanced by the binding of CaM.  Their 
rates of NO synthesis were 3-fold lower than the wild-type enzyme, while they had 
good coupling of NADPH oxidation, and flavin and heme reduction rates showed a 
decrease in line with reductase activity. 
The asparagine and valine mutants were further characterised in nNOSrd.  In general, 
their activities were lower than in the wild-type enzyme, retained CaM-sensitivity, 
and were most affected in the D1393V mutant [80].  The D1393N mutant exhibited 
faster NADPH oxidation rates than wild-type nNOSrd in both the CaM-free and 
CaM-bound states, while its flavin reduction was affected in both the hydride transfer 
to FAD and the inter-flavin electron transfer step.  Pre-steady-state cytochrome c 
reduction rates revealed that the binding of NADPH failed to produce the locked 
conformation seen in wild-type nNOSrd.  The isolated FAD/NADPH-binding 
domains were used to characterise the thermodynamics of the bound FAD cofactor, 
and the D1393 mutants had a destabilised semiquinone state meaning that interflavin 
electron transfer would be less favourable than in the wild-type.  These effects of 
Asp1393 could be related to the hydrogen-bonding interactions around the bound 
FAD cofactor, or its proximity to Phe1395 that also affects the repression of activity. 
 
 
1.7.8 FAD/FMN interface 
 
The two bound flavin cofactors in nNOSrd, FAD and FMN, are held in close contact 
so that they are only 4.8 Å apart in the crystal structure of nNOSrd [74] and can 
transfer electrons directly between each other.  This means that the protein 
architecture that surrounds them must also come into close contact, and this 
interaction is stabilised by the presence of an electronegative patch of residues on the 
FMN-binding domain and a corresponding electropositive patch on the FAD domain.  
The electronegative region is analogous to the surface of the FMN-binding domain of 
CPR, where investigations into the interactions with oxygenase partners revealed the 
presence of two acidic clusters in the FMN-binding domain which were important for 
catalysis [131].  Cluster 1 was designated as three aspartates in succession and cluster 
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2 was a sequence of two glutamates and an aspartate.  Sequence alignment with the 
NOSs revealed the conservation of two of the cluster 1 residues, along with an 
upstream phenylalanine.  All three were found to be on the surface of the FMN-
binding domain in the crystal structure of CPR, and it was thought that they would 
have the same function of controlling electron transfer to the heme domain in nNOS.  
However, substitution of any of the residues (Phe892, Asp918, and Glu919) by 
alanine in nNOS destabilised the binding of FMN to the enzyme [79].  These mutants 
had clearly compromised catalytic activities, however some interesting properties 
were noticed; CaM-free ferricyanide reduction and CaM-free flavin reduction by 
NADPH were activated compared to wild-type nNOS.  This meant that the removal of 
the FMN cofactor at the interface affected hydride transfer to the FAD cofactor. 
The electronegative patch in nNOS was identified from the crystal structure [74] and 
consists of six residues; Glu762, Glu789, Glu790, Asp813, Glu816 and Glu819, all of 
which were substituted to either reverse their charge (substitution by arginine), 
neutralise it (asparagine) or to remove the functionality (alanine).  The cytochrome c 
reductase activities of the resulting nNOS mutants were all greater than wild-type in 
the CaM-free state and they were all sensitive to the binding of CaM [81].  There was 
a range of CaM-bound reductase activities relative to wild-type, from 65% up to 
180%, and they all oxidised NADPH at a faster rate than wild-type in the absence of 
CaM, but had no detectable CaM-free NO synthesis.  Only one mutant had greater 
CaM-bound NO synthesis activity than the wild-type enzyme, this being the E762N 
charge neutralisation mutant form.  Notably, all of the mutants had slower heme 
reduction rates than wild-type nNOS and some of them had extremely large 
uncoupling of NADPH oxidation. 
Overall, it was reported that the greatest effects were seen in the Glu762 mutants, 
followed by Glu816 and Glu819.  Referring back to the crystal structure [74], Figure 
1.20, it can be seen that these three residues are the ones in closest contact with 
Arg1229 from the FAD domain.  While Glu816 is closest to the arginine in the 
published version, a small motion of the FMN-binding domain would allow either of 
the other two residues to form salt-bridging interactions. 
 




In addition to direct interactions that can be observed in the crystal structure, the 
interface region between the FMN- and FAD- binding domains in nNOSrd includes 
the unique regulatory features; the SI, AI and CT, as well as the bound flavin 
cofactors themselves.  This infers that any motion at the interface can be linked to the 
regulation of hydride transfer by NADPH, through the CT, Arg1400, Phe1395 and 
phosphorylation events.  Additionally the H-bonding network from FAD to the 
surface at Arg1229 will be involved in this interface. 
Interactions between the AI and CT have been predicted to occur in the absence of 
CaM [108], while the binding of CaM to its recognition site may form new 
interactions, remove the regulatory features from the interface and cause motion 
which ultimately results in the “unlocking” of nNOSrd and the movement of the 
FMN-binding domain, a crucial step in the catalysis of NO from nNOS. 
 
 
Figure 1.20 Interface region between FAD- and FMN- binding domains in nNOSrd (PDB code  
      1TLL). Bound flavin cofactors are coloured yellow, FMN-binding domain red,  
      connecting/NADPH/FAD-binding domains blue.  Key residues Arg1229, Glu762,  
      Glu816, Glu819 are present in stick conformation. 
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1.8 Aims of the thesis 
 
The regulation of NO synthesis by the constitutive NOSs is fundamentally important, 
as the over- or under- production of NO in the central nervous system or the 
cardiovascular system could be fatal.  Due to the biological implications of the 
production of NO, the regulation of nNOS is an extremely complex sequence of 
events, where a key number of questions remain to be answered: 
 
1. How does CaM activate nNOS? 
It is known that the binding of CaM initiates the flow of electrons through 
nNOS as a consequence of a structural rearrangement in the di-flavin 
reductase domain.  However, the exact nature of this step remains unknown.  
Studies focussing on the effect of CaM on the reductase domain catalytic 
events will be used to address this. 
 
2. Which individual steps are affected? 
 Within the reductase domain, CaM has been reported to be able to activate the 
hydride-transfer step, the interflavin electron transfer step, and the flavin to 
heme electron transfer step.  Each of these has been speculated as being the 
rate-limiting step, but it could feasibly be another event such as productive 
stacking between nucleotide and flavin, which has also been investigated 
previously.  Detailed stopped-flow analyses and kinetic isotope effects in this 
study reflect on all of these events. 
 
3. How important is the FAD/FMN interface? 
 The interface region has been shown to contain the two flavin cofactors in 
close proximity, along with nNOS’s unique regulatory features.  These mobile 
pieces of protein architecture may interact with CaM and influence its 
activation of the reductase domain.  The interface must also be affected by the 
redox state of the FMN cofactor, as it makes interactions with the protein 
backbone.  Furthermore, the breaking of the salt bridge at Arg1229 affects the 
structure of the interface region, with knock-on effects on catalysis. 
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4. Proton transfer pathway? 
 The mechanism of hydride transfer is well understood, with NADPH moving 
from a non-productive to a productive conformation and the displacement of 
F1395.  Following on from electron transfer events, the proton attached to 
FAD must be removed.  The conserved residues S1176, D1393 and H1032 
have a role to play in this step, as they are all closely interacting near to the 
bound FAD cofactor.  Substitution of these residues to alter the H-bonding 
properties will alter the structure around the flavin cofactor, and affect the 
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2.1 Protein Expression 
 
2.1.1 Plasmid DNA 
 
The template used for the expression of mutants of recombinant rat nNOSrd was 
pCRNNR [77], which co-expresses residues 695-1429 of rat nNOS and bovine brain 
CaM, with carbenicillin resistance.  Full-length nNOS, wild-type and R1229E, was 
made using the pCWori expression vector [75] which has carbenicillin and 
chloramphenicol resistance.  Site-directed mutagenesis was carried out using the 
Stratagene QuikChange® XL site-directed mutagenesis kit.  The primers used are 
listed in Table 2.1, where mismatches are underlined.  pGroESL [132], which 
expresses chaperone proteins,  was co-transformed into the E. coli strain with the 
nNOS expression vector. 
 
Table 2.1 Primers and plasmids 
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2.1.2 Cell transformation 
 
Table 2.2 Media and agar 
LB-Agar 10 g/l bacto-tryptone 
5 g/l yeast extract 
5 g/l NaCl 
15 g/l agar 
Super Optimal Catabolite (SOC) 5 g/l bacto-tryptone 
5 g/l yeast extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgSO4 
10 mM MgCl2 
20 mM glucose 
Terrific Broth (TB) 20 g/l bacto-tryptone 
10 g/l yeast extract 
4 ml/l glycerol 
2.65 g/l KH2PO4 
5.3 g/l K2HPO4 
Preparation Millipore Q Ultrapure water  
Autoclave sterilised at 121oC, 20 mins 
(Kestrel LTE Scientific) 
 
30 µl of competent E. coli BL21 (DE3) cells were thawed on ice and mixed with 5 to 
10 ng of plasmid DNA in a volume of 1 to 5 µl.  The mix was incubated for 30 
minutes on ice before heat-shocking for 5 minutes in a 42 oC water bath and placing 
back on ice.  250 µl of warm SOC medium (Table 2.2) was added and this mixture 
was incubated at 37 oC for one hour at 225 rpm.   Two LB-agar plates were prepared 
with 25 µg/ml carbenicillin and to these 10 µl or 100 µl of the transformation mixture 
was added, before incubation overnight at 37 oC.  
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2.1.3 Cell growth 
 
Starter cultures were prepared with 35 ml of TB media, 50 µg/ml carbenicillin, and 
inoculated with single bacterial colonies using a sterile loop.  These were grown 
overnight at 37oC, 200 rpm, and the resultant culture was used to prepare DMSO 
freezer stocks (77 µl DMSO per 1 ml culture). 
Large scale growth was carried out in 1 litre baffled flasks, filled with 350 ml of TB, 
50 µg/ml carbenicillin.  These were inoculated with 1 ml of starter culture and grown 
at 37oC, 120 rpm.  Optimal growth conditions varied for nNOSrd and nNOS 
preparations, with the nNOSrd expression strain requiring no induction of expression.  
In this case the bacteria were grown for 24 hours before harvesting. 
In the preparation of nNOS, the antibiotics present were carbenicillin (25 µg/ml) and 
chloramphenicol (35 µg/ml), and the bacteria were grown until the optical density at 
600 nm was approximately equal to 1.  ATP and IPTG were then added to final 
concentrations of 1 mM and the temperature was decreased to 30 oC.  The cells were 
harvested after 40 hours of growth post-induction, by centrifugation at 8000 rpm 
(Sorvall RC-5B centrifuge fitted with an SLA-3000 rotor, at 4oC) for 10 minutes, and 
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2.2 Protein extraction and purification 
 
2.2.1 Cell lysis 
 
Table 2.3 Purification buffers 
Buffer A 50 mM Tris-HCl pH 7.5 
100 mM KCl 
5% glycerol 
10 mM DTT 
1 mM PMSF 
Buffer B 50 mM Tris-HCl pH 7.5 
100 mM KCl 
2 mM DTT 
Buffer C 50 mM Tris-HCl pH 7.5 
100 mM KCl 
10 % glycerol 
1 mM DTT 
Buffer D 50 mM Tris-HCl pH 7.5 
1 mM CaCl2 
Buffer E 50 mM Tris-HCl pH 7.5 
1 mM CaCl2 
500 mM NaCl 
Buffer F 50 mM Tris-HCl pH 7.5 
1 mM EGTA 
 
Frozen cell pellets containing nNOSrd, typically 25 g (wet weight), were defrosted 
and resuspended in 100 ml of buffer A (Table 2.3) containing 10 ml of protease 
inhibitor cocktail for non-His tagged proteins (Sigma-Aldrich) and 15 mM CaCl2.  
Cells were disrupted by sonication on ice (MSE soniprep 150, 12-15 microns) for 8 × 
10 seconds with 20 seconds rest between each burst.  Soluble protein was separated 
from cell debris by centrifugation at 20000 rpm (Sorvall RC-26 fitted with an SS-34 
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rotor) for 1 hour at 4oC.  The resulting supernatant had a further 2 ml of protease 
inhibitor cocktail added to it, along with 10 mM DTT, before further purification. 
The same sonication protocol was carried out for the preparation of nNOS, however 
the lysis buffer in this case was buffer C augmented with 1 mM PMSF, 4 mM H4B 
(Sigma-Aldrich) and 3 EDTA-free protease inhibitor tablets (Sigma-Aldrich). 
 
 
2.2.2 Purification of nNOSrd     
  
The purification of nNOSrd was carried out at 4oC, with the use of degassed buffer 
solutions and sealed columns such that they were always under a nitrogen 
atmosphere.  Additionally, the preparation was carried out from start (the cell lysis 
stage) to finish (purified protein) in as short a time as possible, typically 8-10 hours. 
Cell extracts were loaded onto a 15 ml 2’5’-ADP-agarose (Sigma-Aldrich) affinity 
column, pre-equilibrated with buffer A, 15 mM CaCl2.  Protein bound to the column 
in a dark green band was then washed with 50 ml buffer A plus 2 mM CaCl2 and 100 
ml buffer A with 1 mM EGTA to remove calmodulin bound to the reductase domain.  
This was followed by a further wash with 50 ml buffer A and 2 mM CaCl2 before 
elution using 20 ml buffer A containing 2 mM CaCl2, 20 mM NADP
+ (Sigma-
Aldrich) and KCl made up to 500 mM. 
The eluted protein was loaded directly on to a 10 ml calmodulin-agarose (Sigma-
Aldrich) affinity column, pre-equilibrated with buffer A and 2 mM CaCl2.  Two 
washes were carried out; 100 ml buffer A plus 2 mM CaCl2, and 50 ml buffer B.  
Elution was performed by using 20 ml buffer B supplemented with 0.5 mM EGTA 
and 400 mM KCl.  nNOSrd was concentrated to approximately 40 µM using a 
Vivaspin 20 concentrator (Vivascience, cut off 30 kDa), flash-frozen in liquid 
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2.2.3 Purification of nNOS 
 
This procedure was carried out at 4oC.  The cell lysate was passed through a 10 ml 
diethylaminoethyl (DEAE) sepharose (GE Healthcare Biosciences) column, pre-
equilibrated with buffer C.  CaCl2 was added to 5 mM prior to loading onto a 10 ml 
CaM-agarose column (as before).  The bound protein was washed with 100 ml of 
buffer C and 1 mM CaCl2, eluted with 50 ml buffer C plus 0.5 mM EGTA, 
concentrated and stored as for nNOSrd. 
 
 
2.2.4 Purification of calmodulin 
 
All of the washings collected from the 2’5’-ADP-column during the purification of 
nNOSrd were stored at -20oC and used in batches to extract the calmodulin that they 
contained. 
After thawing, all fractions were treated with CaCl2 to an approximate concentration 
of 10 mM prior to loading onto a 200 ml phenyl-sepharose column (Sigma-Aldrich), 
pre-equilibrated with buffer D (Table 2.3).  Washings were then carried out with 1 
litre of buffer D, 1 litre of buffer E and 1 further litre of buffer D.  Calmodulin was 
eluted using buffer F, with 2 ml fractions collected.  Fractions containing CaM were 
identified with SDS-PAGE (see section 2.3.1), pooled and dialysed against buffer D 
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2.3 Protein characterisation 
 
2.3.1 Gel electrophoresis 
 
Table 2.4 SDS-PAGE components 
Gel Pre-poured NuPAGE® 4-12% Bis-Tris 
Running buffer 
NuPAGE® MES SDS 
 
25 mM Tris-HCl pH 8.3 
192 mM Glycine 
0.1% Sodium dodecyl sulphate 
Sample buffer 
NuPAGE® LDS 
50 mM Tris-HCl pH 6.8 
100 mM DTT 
2% sodium dodecyl sulphate 
0.1% bromophenol blue 
10% glycerol 
Stain 0.25% (w/v) Coomassie Brilliant Blue 
40% (v/v) methanol 
10% (v/v) glacial acetic acid 
50% (v/v) dH2O 
Destain 40% (v/v) methanol 
10% (v/v) glacial acetic acid 
50% (v/v) dH2O 
 
The purity of prepared protein samples was assessed by SDS-PAGE (sodium dodecyl 
sulphate polyacrylamide gel electrophoresis) in pre-cast gels (Invitrogen), as per table 
2.4.  Sample buffer (5 µl) was added to a 20 µl solution of protein before boiling for 5 
minutes.  Protein samples of 5 – 10 µl were loaded into the gel, with at least one well 
containing SeeBlue Plus 2® molecular weight markers (5 µl).  The gel was resolved 
for 1 hour at 150V and stained using Coomassie Brilliant Blue. 
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2.3.2 UV-visible spectrometry 
 
For calculations of co-factor concentrations, full range UV-visible spectra were 
recorded (250 – 800 nm) using either a Shimadzu 1601 or Cary Scan 50 
spectrophotometer.   
Prepared aliquots of nNOSrd were fully oxidised by the titration of sub-stoichiometric 
additions of potassium ferricyanide (Fisher scientific) and the concentration was 
calculated using the molar extinction coefficient (ε456) of 20940 M
-1cm-1 [120]. 
Analysis of the heme bound to full-length nNOS was carried out using the CO-bound 
spectrum.  Enzyme samples were firstly fully reduced by addition of excess sodium 
dithionite (Fisher scientific) and the solution was then bubbled with CO gas (Sigma-
Aldrich).  The difference spectrum was calculated by subtraction of the reduced 
spectrum from the CO-bound, and the difference in absorbance between 444 nm and 
467 nm was used to calculate concentration, with the molar extinction coefficient 




2.4 Synthesis of NADPD 
 
Samples were prepared in Tris-HCl buffer, pH 9, typically containing 2 mM NADP+ 
(Sigma-Aldrich), 1 M d6-ethanol (Sigma-Aldrich) and 20 units of alcohol 
dehydrogenase from Thermoanaerobium brockii (Sigma-Aldrich) in a 5 ml sample.  
Incubation took place at 42oC for 45 minutes and the UV-visible spectra were 
recorded to assess the increase of deuterated substrate by the appearance of an 
absorption maximum at 340nm.  The enzyme in solution was removed by 
centrifugation at 3300 rpm (Falcon 6-300 centrifuge) with a Vivaspin 20 
(Vivascience) concentrator, 10kDa cut off.  The resulting mixture of NADP+ and 
NADPD was then purified using a 1 ml Q-sepharose Resource-Q column on an FPLC 
(Fast protein liquid chromatography) system (AKTA P-900).  The running buffer was 
10 mM NH4HCO3 and after binding the nucleotides were eluted using a 50 column 
volume gradient of 500 mM NH4HCO3, collecting fractions of 1ml volume.  The 
fractions were assessed for the presence of NADPD by recording their UV-visible 
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spectra and comparing the absorption at 260 nm (non-deuterated) and 340 nm 
(deuterated).  The extinction coefficients are (ε260) 18,000 M
-1cm-1 and (ε340) 6200 M
-
1cm-1 respectively [133], so all samples with a ratio of 260:340 less than 3 were 
pooled together for lyophilisation (Edward Super Modulyo) and storage at -20oC. 
 
 
2.5 Steady-state kinetics 
 
All steady-state kinetic experiments were performed at 25oC in 50 mM Tris-HCl 
buffer, pH 7.5, with the addition of 100 mM NaCl unless otherwise varied.  Data were 
plotted and analysed using Origin 7.5 (Microcal). 
 
 
2.5.1 Cytochrome c reduction 
 
Solid cytochrome c from horse-heart (Sigma-Alrdrich) was prepared in the assay 
buffer at a range of concentrations (typically 1-100 µM) and incubated in a water-bath 
at 25oC.  1 ml aliquots were then treated with NADPH (final concentration 1 mM) and 
if appropriate, Ca2+ / CaM (100 µM / 10 µM).  The reaction was initiated by addition 
of nNOSrd, typically at concentrations of 3 - 20 nM, but varying depending on the 
enzyme used.  Monitoring was carried out on a UV-visible photospectrometer (as 
before) at 550 nm where the appearance of an absorption maximum is characteristic 
of the heme being reduced from ferric to ferrous form.  The molar extinction 
coefficient for the absorbance change (ε550) is 22640 M
-1cm-1 [135], and the initial 
rate of turnover was used in each case to determine the observed rate constant at 
different concentrations of cytochrome c. 
Turnover experiments with NADPD were carried out using a stopped-flow mixing 
method (see section 2.6 below) [136].  Syringe A contained NADPH or NADPD (2-
10 µM) mixed with nNOSrd (0.1 µM) and syringe B contained ferric cytochrome c 
(100 µM).  The reaction was monitored using the single wavelength apparatus over 
approximately 1 minute at 550 nm.  The resultant traces of absorbance vs. time were 
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used to calculate the amount of substrate consumed in the reaction and this was 
converted to the rate of turnover by differentiating the graph using Origin 7.5 




2.5.2 Ferricyanide reduction 
 
Potassium ferricyanide (Fisher Scientific) was prepared in a similar manner to 
cytochrome c but a higher range of concentrations (typically 0.2 - 2 mM), while the 
amount of nNOSrd added to it in the assays was also higher (15 - 150 nM).  The 
reaction was monitored at 420 nm, where the disappearance of the absorption band 
occurs as the electron acceptor is reduced.  Initial rates were calculated with the molar 




2.5.3 NO synthesis 
 
The rate of NO synthesis was determined by the NO-mediated conversion of 
oxyhemoglobin to methemoglobin.  The assay consisted of 10 µM oxyhemoglobin, 
100 µM NADPH, 10 units/ml superoxide dismutase and catalase (Sigma-Aldrich), 10 
µM H4B, 0.1 mM DTT, 1 mM L-arginine, 50 µg/ml CaM, 1 mM CaCl2, in 50 mM 
Tris-HCl buffer, pH 7.5, and initiated with the addition of nNOS (20 nM).  
Monitoring of the reaction took place at 401 nm as an absorbance increase using a 







Chapter 2  Experimental 
 59 
2.6 Pre-steady-state kinetics 
 
Stopped-flow analysis allows the rapid mixing of two solutions and the immediate 
monitoring of any spectral changes over the initial reaction period, illustrated in 
Figure 2.1.  This method allows the measurement of reactions that occur on the 
millisecond timescale. 
All pre-steady-state kinetic experiments were carried out at 25oC in an anaerobic 
glove box (Belle Technology, oxygen level < 5 ppm) using an SX.18MV stopped-
flow spectrophotometer (Applied Photophysics) fitted with either a diode-array or 
single-wavelength detector.  The assay buffer was 50 mM Tris-HCl, pH 7.5, 100 mM 
NaCl, degassed for two hours on the bench by bubbling with nitrogen gas and left to 
equilibrate in the glove box overnight.  All reagents were put into the box in solid 
form and prepared in deoxygenated buffer, with the exception of nNOSrd which was 
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2.6.1 Cytochrome c reduction 
 
Syringe A contained ferric cytochrome c (from horse heart, as before), at a 
concentration of approximately 8 µM.  Syringe B contained nNOSrd that had been 
fully reduced to the 4-electron-reduced form by addition of excess sodium dithionite 
and passed down a 10 ml G25-Sephadex (GE Healthcare Biosciences) column to 
remove excess reductant, with the resulting nNOSrd concentration approximately 20 
µM.  After mixing, cytochrome c accepts one electron from the bound FMN of 
nNOSrd which manifests as an increase in absorption at 550 nm.  The single-
wavelength detector was used to monitor this increase and produce an exponential 
curve from which the rate of electron transfer was calculated. 
The enzyme was either reacted alone, or with the addition of NADPH (100 µM), Ca2+ 
/ CaM (600 µM / 60 µM) or both NADPH and CaM.  For the inhibition studies, 
ferrous cytochrome c was prepared using excess sodium dithionite and G25-Sephadex 
as for nNOSrd and added to syringe B prior to mixing. 
 
 
2.6.2 Flavin reduction 
 
Syringe A contained nNOSrd that was prepared in one of two ways.  For the fully 
oxidised form, stock enzyme was treated with excess potassium ferricyanide (as 
before) before being passed down a 10 ml G25-Sephadex column.  In the case of the 
one-electron reduced nNOSrd (FMN semiquinone form), the stock enzyme was 
initially passed down the G25-Sephadex column before stoichiometric titration with 
sodium dithionite until the absorbance at 592 nm was maximal (ratio of A456:A592 
approximately 4:1 in the case of the wild-type), using a Cary Scan 50 
spectrophotometer inside the glove box.  Typical enzyme concentrations were 20 µM 
prior to mixing and Ca2+ / CaM (600 µM / 60 µM) were added when required.  This 
was then mixed with syringe B that contained NADPH at a concentration of 200 µM.   
The reaction between NADPH and nNOSrd causes the reduction of the bound flavin 
co-factors that can be observed at both 457 nm and 592 nm using the diode-array 
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software.  For more accurate measurement of the rate of reduction at 457 nm the 
single-wavelength apparatus was used.  Inhibition studies again required the addition 





The OTTLE (Optically Transparent Thin Layer Electrode) method allows the 
coupling of spectral changes to the application of a known potential to calculate the 
midpoint reduction potential of the cofactors in solution.  The OTTLE cell is 
illustrated in Figure 2.2 and was constructed from a modified quartz EPR cell with a 
0.3 mm path length containing a Pt/Rh (95/5) gauze working electrode (wire diameter 
0.06 mm, mesh size 1024 cm-1, Engelhardt), a platinum wire counter electrode 
(Sigma-Aldrich) and an Ag/AgCl reference electrode (model MF2052, Bioanalytical 
Systems).  The reference electrode was calibrated against indigotrisulfonic acid (Em = 





Figure 2.2 Representation of the OTTLE cell used for spectroelectrochemical experiments 
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Preparation of the OTTLE cell was carried out in an anaerobic glovebox (as before).  
Concentrated enzyme samples (1 ml × 300 µM) were passed down a G25-Sephadex 
column pre-equilibrated with sample buffer (100 mM Tris-HCl pH 7.5, 500 mM KCl, 
10% glycerol) and had mediators added, as detailed in table 2.5.  The working 
electrode was added to the protein solution in the cell, before layering with buffer 
(100 mM Tris-HCl pH 7.5, 500 mM KCl) and addition of the counter and reference 
electrodes.  The OTTLE cell was then sealed and removed from the anaerobic 
environment before spectroelectrochemical titrations were performed using an 
Autolab PGSTAT10 potentiostat and a Cary Scan 50 spectrophotometer. 
 
Table 2.5 Mediators used in OTTLE potentiometry 
 Midpoint reduction 




used in ottle 
5-hydroxy-1,4-naphthoquinone -3 174 23µM 
Pyocyanine -34 210 19µM 
2-hydroxy-1,4-naphthoquinone -145 174 23µM 
Flavin mononucleotide (FMN) -200 478 8µM 
Benzyl viologen -311 409 10µM 
Methyl viologen -430 257 15µM 
 
The potential of the working electrode was decreased in 30 mV steps until the enzyme 
was fully reduced and increased stepwise until re-oxidation was complete.  During 
each equilibration the current and UV/Vis absorption spectrum were monitored until 
no further change occurred, a process that typically took 90-120 minutes.  Absorbance 
changes associated with the oxidised flavins (456 nm) and the FMN semiquinone 
(592 nm) were plotted against the applied potential and fitted simultaneously to the 
modified Nernst equation (Equation 2.1) using Origin 7.5 (Microcal).  
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Equation 2.1 a,b,c = absorbance of oxidised, semiquinone and hydroquinone flavin. 
         E = Potential of working electrode. E1, E2 = FMN transitions.  E3, E4 = FAD  


















































Wild-type and mutant forms of nNOSrd were purified as described in section 2.2.2, 
using ADP-agarose and CaM-agarose as reported previously [88, 119], with the 
additional use of de-oxygenated buffer solutions in order to maintain the bound FMN 
in the semiquinone form.  This was found to be essential to attaining the maximal 
activity of nNOSrd, as the unintentional oxidation of the FMN cofactor during 
purification produced an enzyme with only 60% of the cytochrome c reduction rate of 
a 1-electron reduced form.  During purification, the protein solution was green in 
colour, rather than the yellow of the fully-oxidised form, which allowed it to be easily 
monitored while bound to the affinity columns.  Figure 3.1 depicts the SDS-PAGE 
analysis of a typical preparation, where from the cell free extract (lane 2) and the 
flow-through from the ADP-agarose column (lane 3) it can be seen that the majority 
of proteins in the E. coli cells did not bind and were collected and discarded after the 
first step in purification.  The ADP-agarose wash with EGTA-augmented buffer 
removed CaM that was bound to nNOSrd and this was collected for subsequent 
purification (lane 4).  Elution of nNOSrd from the ADP-agarose column was followed 
by direct loading onto the CaM-agarose column, and the flow-through from this 
column contained no other proteins (lane 5).  The elution of nNOSrd from the CaM-
agarose column was achieved with EGTA-augmented buffer (lane 6), after which the 
purified protein solution was concentrated if necessary and stored at -80oC. 
 




Each of the nNOSrd mutants R1229E, S1176A, D1393E, H1032S and H1032Q were 
purified in the same manner as the wild-type enzyme and they all formed single bands 
on a gel, as presented in Figure 3.2.  The yields of protein prepared varied between 
wild-type and the mutant enzymes and are listed in Table 3.1.  The H1032E and 
H1032A nNOSrd mutants were not expressed well in the BL21(DE3) E. coli cells and 
were not further investigated in this study. 
 
Figure 3.1 SDS-PAGE analysis of nNOSrd. Lane 1 = MW marker.  Lane 2 = Cell free extract. 
     Lane 3 = ADP-agarose flow through.  Lane 4 = ADP-agarose wash with EGTA. 

























mass 16.7 kDa 




Table 3.1 Yield of wild-type and mutant forms of nNOSrd 
Enzyme wild-type R1229E S1176A D1393E H1032Q H1032S 
yield / mgl-1 
of culture 
9.1 7.5 6.0 4.5 3.2 3.0 
 
The UV-visible absorption spectrum of the bound flavin co-factors was used to 
determine the concentration of wild-type and mutant forms of nNOSrd.  The collected 
spectra are presented in Figure 3.3(A), where all of the mutants can be seen to have 
similar spectra compared to the wild-type enzyme.  Titration with sodium dithionite 
solution was used to prepare the one-electron reduced FMN semiquinone form, as 
highlighted in Figure 3.3(B).  Each addition of dithionite solution caused a decrease in 
absorption at 456 nm and an increase at 592 nm, to a maximum level where the ratio 
of the two peaks was approximately 4:1.  All of the nNOSrd mutants were prepared in 
the one-electron reduced forms in the same manner. 
 
Figure 3.2 SDS-PAGE analysis of nNOSrd mutants.  Lane 1 = MW marker.  Lane 2 = wild-type.  


























The wild-type and R1229E mutant forms of full-length nNOS were purified using 
DEAE-sepharose and CaM-agarose as described in section 2.2.3. The resulting 
enzyme samples were analysed using SDS-PAGE (Figure 3.4) and CO-binding UV-
visible absorption spectrometry (Figure 3.5).  The polyacrylamide gel shows the 
specificity of the CaM-agarose column; following the removal of a small number of 
proteins between the cell free extract (lane 2) and the DEAE-sepharose column (lane 
3), the majority of proteins do not bind to the CaM-agarose and were present in the 
flow-through (lane 4).  Elution of   R1229E nNOS (lane 5), yielded a heterogeneous 
sample containing a large band at approximately 160 kDa, and two smaller bands at 
approximately 80 kDa and 60 kDa, representing the two domains proteolysed during 
purification.  This was similar to a wild-type nNOS preparation (lane 6). 
 
Figure 3.3 UV-visible absorption spectra of (A) wild-type and mutant forms of nNOSrd and (B)  
    preparation of a one-electron reduced form of nNOSrd with the addition of 2 µl aliquots  
    of 10 mM sodium dithionite. 




Figure 3.5 is a plot the characteristic UV-visible absorption spectra of the ferrous 
form of nNOS before and after bubbling of CO gas to form the CO-bound spectrum.  
The difference spectrum, between the ferrous and ferrous-CO, was used to calculate 
the concentration of heme bound to nNOS.  
 
Figure 3.4 SDS-PAGE analysis of nNOS.  Lane 1 = MW marker.  Lane 2 = cell free extract. 
     Lane 3 = DEAE-sepharose flow-through.  Lane 4 = CaM-agarose flow-through 


















mass 160 kDa 
Reductase domain 
Oxygenase domain 







Bovine brain CaM is co-expressed with nNOSrd in the plasmid pCRNNR [77] and 
was purified from washings of the ADP-agarose column during purification as 
described in section 2.2.4.  Typically, 2 litres of solution were used to extract CaM in 
each purification.  The fractions eluted from the phenyl-sepharose column were 
analysed using SDS-PAGE and the lyophilised CaM was assessed for activity in the 
steady-state turnover of cytochrome c by nNOSrd.  Figure 3.6 shows the developed 
gel from a preparation, where the extracts from the nNOSrd preparation (lanes 1 and 
2) were passed down the phenyl-sepharose with the majority of proteins not binding 
to the column.  Following washes with high salt buffers to remove any other proteins 
bound (lanes 3, 4 and 5), buffer augmented with EGTA was applied to elute the 
purified CaM (lanes 6-11).  Dialysis with a calcium-rich buffer was then used before 
lyophilisation and storage at -20oC.  
 
 
Figure 3.5 UV-visible absorption spectra of nNOS before and after the addition of CO gas 







The preparation of NADPD was carried out as described in section 2.4.  Previous 
preparations [133, 137] using enzymatic methods have utilised a mixture of alcohol 
dehydrogenase and aldehyde dehydrogenase.  Repetition of these conditions produced 
a mixture of product and starting material that could not be separated by liquid 
chromatography at varying pH.  Thermophilic alcohol dehydrogenase (from 
Thermoanaerobium brockii) was used alone because the reaction that takes place 
produces only aldehyde product, rather than aldehyde and acid together.  By not using 
the aldehyde dehydrogenase the yield of NADPD was lowered, so the equilibrium 
position was altered by increasing an excess of d6-ethanol in the reaction.  Figure 3.7 
plots the UV-visible spectra obtained during a typical purification.  The crude reaction 
mixture contains absorption maxima at 260 nm and 340 nm, while purified fractions 
of NADPD contain the same peaks in the correct ratio. 
 
Figure 3.6 SDS-PAGE analysis of calmodulin.  Lanes 1,2 = crude extracts.  Lanes 3-5 = phenyl- 
    sepharose washes 1-3.  Lanes 6-11 = eluted fractions from phenyl sepharose containing  








































The rate of NO production in nNOS correlates with the rate at which electrons are 
transferred from the reductase domain to the oxygenase domain [30], while the 
binding of CaM activates the transfer of electrons through the reductase domain in the 
holoenzyme and activates the isolated nNOSrd to the same extent [76].  This is 
represented in Appendix I. 
The turnover of electrons through nNOSrd can essentially be divided into three steps, 
as illustrated in Figure 4.1.  Firstly hydride transfer from NADPH to FAD (species 1 
to 2), then internal electron transfer from FAD to FMN (2 to 3 and 4 to 5), and finally 
the transfer of an electron from hydroquinone FMN to an external electron acceptor or 
to the oxygenase domain of holo-nNOS (3 to 4 and 5 to 1).  Each of these has been 
speculated to be the rate-limiting step in nNOSrd catalysis and the event activated by 
CaM [76, 90, 119], however the deprotonation of the FAD cofactor (species 4 to 5) 
may be important in the catalytic cycle.  The aim of this chapter is to provide 





Figure 4.1 Schematic representation of electron transfer through nNOSrd during turnover reactions 
1. FAD   FMNH
2. FADH   FMNH












Interflavin e- transfer, 
deprotonation
e- transfer
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4.2 Steady-state turnover 
 
During the steady-state turnover of nNOSrd, cytochrome c reacts in the same manner 
as the oxygenase domain of nNOS, accepting a single electron from the bound FMN 
hydroquinone [75].  Ferricyanide, due to its smaller size, can accept electrons from 
both bound FAD and FMN [79], i.e. species 2 and 4, as well as 3 and 5 in Figure 4.1.  
Additionally, due to its high reduction potential (+430 mV vs. +250 mV for 
cytochrome c [138]), it can oxidise the stable FMN semiquinone and therefore 
probably react with all of the species present in Figure 4.1.  This may lead to the 
faster rate of reduction of ferricyanide observed, and a lesser CaM-mediated 
activation effect, as summarised in Table 1.1. 
 
 
4.2.1 Cytochrome c reduction 
 
Previous studies of the steady-state reduction of cytochrome c by nNOSrd have 
shown a 10-fold enhancement on binding of CaM (see Table 1.1).  This effect was 
consistent in the anaerobic preparation of nNOSrd from BL21 (DE3) E. coli in this 
study.  Figure 4.2 plots the measured rate constants of cytochrome c reduction against 
cytochrome c concentration in the CaM-free and CaM-bound states.  The data were 
fitted to the Michaelis Menten equation (Equation 6, Appendix Ι) and the derived 
kinetic parameters are listed in Table 4.1.  The enzyme here retained the 10-fold 
enhancement effect by CaM while performing electron transfer at a faster rate than 
reported previously for nNOSrd [80], but analogous to a recent study of nNOS [81]. 
 




The effect of increasing salt concentration in the assay was studied, the results of 
which are plotted in Figure 4.3.  Again the rate constants were fitted to equation 6 and 
the parameters are listed in Table 4.1.  In all cases the affinity for cytochrome c 
decreased as the ionic strength increased, similar to the effect in holo-nNOS [139].  
Increasing salt concentration in the assay buffer had little effect on the maximal rate 
of turnover when CaM was bound but an increase was seen in the CaM-free enzyme, 
which was 2-fold faster in the presence of 250mM NaCl.  Thus there is a large 
decrease in CaM-dependent enzyme activation at higher ionic strength, indicating that 
the rate-determining step for steady-state cytochrome c reduction in the absence of 
CaM is ionic strength dependent.  
 
 
Figure 4.2 Steady-state cytochrome c reduction by nNOSrd.  Assays were performed at 25oC in  
    50mM Tris buffer, pH 7.5 + 100mM NaCl.  Data points were fitted to the Michaelis- 
    Menten equation. 
Figure 4.3 Steady-state cytochrome c reduction by nNOSrd with 150mM NaCl buffer.  Assays  
    were performed at 25oC in 50mM Tris buffer, pH 7.5 + 150mM NaCl.  Data points  
    were fitted to the Michaelis-Menten equation. 
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Table 4.1 Steady-state cytochrome c reduction by nNOSrd 
Buffer – 50mM Tris pH 7.5 + Ca2+ / CaM kcat / s
-1 Km
cytc / µM 
100 mM NaCl 
- 
+ 
10.4 ± 0.4 
104 ± 6 
3 ± 1 
8 ± 2 
150 mM NaCl 
- 
+ 
15 ± 1 
105 ± 3 
8 ± 2 
10 ± 2 
250 mM NaCl 
- 
+ 
23 ± 1 
95 ± 6 
12 ± 2 
12 ± 3 
 
 
4.2.2 Ferricyanide reduction 
 
Rate constants for the steady-state reduction of ferricyanide by nNOSrd are plotted in 
Figure 4.4.  In both the CaM-free and CaM-bound states the rate of turnover increased 
linearly with the concentration of ferricyanide.  The gradient of the straight-line fit 
represents catalytic efficiency (kcat/Km), which was enhanced by CaM by 
approximately 1.5-fold (Table 4.2).  This is consistent with a previous report where 
rates in excess of 500 s-1 were reported and the binding of CaM altered the Km by a 
factor of 2.4 [108].  Both of the lines have a positive non-zero y-intercept, which is 
likely to be caused by the preferential reaction of ferricyanide at the FMN site.  It 
therefore gives an indication of the rate of transfer of electrons from FAD to FMN, 
whereas the electron transfer from FAD to ferricyanide causes the linear increase 
[79].  The intercept values, with and without bound CaM, correspond approximately 
to the rates of cytochrome c reduction and the binding of CaM is seen to cause an 
increase in electron-flux through the enzyme.  The rate of hydride transfer from 
NADPH to FAD is apparently fast enough to support ferricyanide reduction at rates in 
excess of 100 s-1 regardless of whether or not CaM is bound.  This suggests that 
electron transfer from FAD to FMN is slow and limits the turnover of nNOS with 
cytochrome c.  If this were the case, this step would then be the event activated by 
CaM. 





Table 4.2 Steady-state ferricyanide reduction by nNOSrd 




81 ± 2 
131 ± 4 
21 + 2 
60 ± 4 
 
 
4.2.3 Kinetic isotope effects 
 
Steady-state experiments using NADPD as substrate were performed using a stopped-
flow mixing method, where a catalytic amount of nNOSrd was pre-incubated with 
NADPH or NADPD and reacted with an excess of ferric cytochrome c.  The reaction 
was monitored by the formation of ferrous cytochrome c at 550 nm.  Figure 4.5, Panel 
A, plots the traces obtained for deuterated substrate and NADPH in the absence and 
presence of CaM, which are corrected for the concentration of substrate consumed in 
Figure 4.4 Steady-state ferricyanide reduction by nNOSrd.  Assays were performed at 25oC in  
    50mM Tris buffer, pH 7.5 + 100mM NaCl.  Data points were fitted to a straight-line  
    equation. 
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the reaction.  The derivatives of each trace, Panel B, give values for steady-state rate 
constants during the reaction.  These are plotted against the concentration of substrate 
and, although they do not reach saturation, they can still be used to give isotope effect 
ratios.  Each derivative plot (Panel B) was fitted to the Michaelis-Menten equation to 
obtain values for kcat, Km
NAPDH, and catalytic efficiency.  These were then compared 
to yield values of DV – the isotope effect on the maximal rate, and DV/K – the isotope 
effect on the catalytic efficiency, as listed in Table 4.3.  Both isotope effects are 
relatively low, between 1 and 2, and the binding of CaM has little impact on the 




Table 4.3 Steady-state kinetic isotope effects 




1.9 ± 0.2 
1.4 ± 0.2 
2.1 ± 0.3 
1.4 ± 0.1 
 
Primary kinetic isotope effects, i.e. those that have a value of greater than unity, 
indicate that the bond to the isotopic atom is broken [141].  This is clearly the case 
here, with deuteride being transferred from the nicotinamide moiety to the FAD 
cofactor of nNOSrd.  This transfer is not entirely rate-limiting however, as the value 
for a primary kinetic isotope effect can be up to eight or above.  Also, the similar 
Figure 4.5 Steady state cytochrome c reduction using NADPD and NADPH as substrate.   
    (A) Traces collected at 550 nm corrected for concentration of substrate.   
    (B) Corresponding derivative plots fitted to the Michaelis-Menten equation (green  
    lines). Assays were performed at 25oC in 50mM Tris buffer, pH 7.5 + 100mM NaCl. 
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effects on maximal rate and catalytic efficiency indicate that there is no change in 
affinity for the substrate when it is deuterated.   
4.3 Pre-steady-state kinetics 
 
The first step in nNOSrd catalysis is hydride transfer from NADPH to FAD, which 
can be monitored in vitro by UV-visible spectrometry as the reduction of the flavin 
cofactor.  This reaction has been carried out in many investigations, but with 
conflicting evidence and arguments. From Table 1.2, the binding of CaM appears to 
activate flavin reduction, however the rate constants obtained vary due to differing 
exponential fit-functions.  Another study [137] used a global analytical technique and 
reported no CaM-mediated activation, while the temperature also varies across 
different studies.  Furthermore, the enzyme preparations used were almost entirely 
fully oxidised, which is a non-physiologically relevant form, but may be formed in the 
steady-state reaction with ferricyanide.  The one-electron reduced form is a natural 
component of both the NO synthesis and cytochrome c reduction catalytic cycles; the 
FMN semiquinone cannot be oxidised by either of the ferric heme species involved in 
these reactions. Wild-type nNOSrd has been analysed here in the oxidised and one-
electron reduced forms, to assess the importance of the redox state of the bound FMN 
in the hydride transfer reaction.  
 
 
4.3.1 Flavin reduction by NADPH 
 
The stopped-flow mixing of nNOSrd with a 10-fold excess of NADPH allows 
investigation of the initial hydride transfer step in the catalytic cycle of nNOSrd, as 
represented in Appendix I.  Upon binding of NADPH, the nicotinamide moiety will 
π-stack with the bound FAD and transfer a hydride to the N5 position of the flavin 
(see section 1.7.7).  In these pre-steady-state experiments, the enzyme will react 
further depending on the oxidation state of the FMN, as illustrated in Figure 4.6.  If 
the enzyme is fully oxidised, the initial hydride transfer from NADPH to FAD will be 
followed by two consecutive electron transfers to the FMN.  The first of these 
electron transfers will be essentially irreversible, forming the stable FMN 
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semiquinone, whereas the second should reach an equilibrium indicated by formation 
and decay of a di-semiquinone species.  Reaction with a second equivalent of 
NADPH should complete the reduction process.  Inter-enzyme electron transfer 
reactions (FMN to FMN) are likely to complicate the latter stages of reduction leading 
to extended slow phases. 
When bound FMN is present as the air-stable one-electron reduced semiquinone, the 
reaction proceeds differently, and should primarily be with a single equivalent of 




The data for the reduction of the oxidised enzyme are shown in Figure 4.7, where 
panels A and B represent the CaM-free and CaM-bound states respectively.  The 
reduction of the flavins is observed as a decrease in absorbance at 457 nm and is 
plotted as a time-course in panel C.  Formation of flavin semiquinone is shown by an 
increase at 592 nm.  At 457 nm a large rapid decrease in absorbance is observed 
indicating that reaction with two equivalents of NADPH has occurred within 0.2s.  
These data fit well to double-exponential fitting functions over 1 second, and the 
corresponding parameters are listed in Table 4.4.  For the CaM-free enzyme, the two 
Figure 4.6 Scheme of electron transfer through oxidised and one-electron reduced nNOSrd  
    during pre-steady-state reduction by excess NADPH. 
1. FADox FMNox
2. FADH   FMNox
3. FADH   FMNH
4. FADox FMNH
5. FADH   FMNH
1. FADox FMNH
2. FADH   FMNH
3. FADH   FMNH
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hydride transfer steps occur in separate kinetic phases, the first being 10-fold faster 
than the second. When CaM is bound most of the absorbance change occurs in the 
fast phase, indicating that the two steps cannot be separated easily and are occurring 
in rapid succession.  
 
 
Table 4.4 Pre-steady-state reduction of oxidised nNOSrd by NADPH 







FMN oxidised - 
65 ± 2 
(40%) 
5.9 ± 0.1 
(60%) 
 + 
73 ± 2 
(79%) 
3.6 ± 0.1 
(21%) 
 
Figure 4.8 plots the time-courses at 592 nm for the same reactions as in figure 4.7.  
These show the appearance and the disappearance of the FMN semiquinone, where 
for the CaM-free enzyme FMN receives a first electron from FAD rapidly 
Figure 4.7 Stopped-flow reduction of fully oxidised nNOSrd (10µM) by NADPH (100µM).   
    Diode array spectra for (A) CaM-free and (B) CaM-bound oxidised nNOSrd, taken  
    at 2.5 ms intervals.  (C) Corresponding normalised reductive traces at 457 nm. 
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(semiquinone forms and absorbance increases) followed by a second electron 
(semiquinone becomes hydroquinone and absorbance decreases).  The gradual rise 
after 1 s is due to disproportionation with other enzyme molecules.  The process is 
essentially the same for the CaM-bound enzyme, with each step occurring more 
rapidly and further disproportionation towards the end of the time-course. 
Looking at the reaction as a whole, the fast initial decrease in absorbance at 457 nm 
indicates that hydride transfer (the first step in Figure 4.6) is rapid.  The initial 
increase at 592 nm is also fast which would indicate that the first interflavin electron 
transfer (the second step in Figure 4.6) is also rapid, but this is not a catalytically 
relevant step.  The next interflavin electron transfer (the third step in Figure 4.6) is 
slow in the absence of CaM and the rate is increased by CaM binding, indicating that 
this is the rate-determining step in the flavin reduction of nNOSrd. 
 
 
   
The reaction between the one-electron reduced form of nNOSrd and NADPH is the 
natural reaction that will occur in vivo during nNOS catalysis.  Only one equivalent of 
NADPH should react in this case, and the absorbance change at 457 nm should 
involve a single hydride transfer phase constituting the majority of the amplitude, 
Figure 4.8 Stopped-flow reduction of fully oxidised nNOSrd (10µM) by NADPH (100µM).   
    Traces at 592 nm from the same data as Figure 4.7 for (A) CaM-free and (B) CaM- 
    bound oxidised nNOSrd. 
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during which the FAD is reduced to the hydroquinone form.  The transfer of an 
electron to the FMN should have minimal effect on the absorbance.  Figure 4.9, 
panels A and B, shows the one-electron reduced wild-type nNOSrd reacting with 
NADPH in the absence and presence of CaM, respectively.  The resultant time-
courses at 457nm are shown in panel C, where a comparison with Figure 4.7 reveals 
that one-electron reduced nNOSrd has a much slower CaM-free reaction profile.  The 
binding of CaM has a much larger effect on this enzyme form.  As before, the traces 
were fitted to double-exponential fitting functions over 1 second and the derived 









Figure 4.9 Stopped-flow reduction of one-electron reduced nNOSrd (20µM) by NADPH  
    (100µM).  Diode array spectra for (A) CaM-free and (B) CaM-bound nNOSrd,  
    collected at 2.5 ms intervals. (C) Corresponding normalised reductive traces at 457 nm.  






Table 4.5 Pre-steady-state reduction of nNOSrd by NADPH 







FMN oxidised - 
65 ± 2 
(40%) 
5.9 ± 0.1 
(60%) 
 + 
73 ± 2 
(79%) 
3.6 ± 0.1 
(21%) 
FMN semiquinone  - 
35 ± 1 
(20%) 
6.5 ± 0.1 
(80%) 
 + 
93 ± 2 
(78%) 
5.2 ± 0.1 
(22%) 
 
The CaM-free enzyme is reduced by NADPH in a biphasic process with a large slow 
phase of rate constant 6.5 s-1.  This correlates with the steady-state rate constant for 
cytochrome c reduction (10.4 s-1), meaning that hydride transfer may be the overall 
rate-limiting step.  However, the small fast phase indicates that 20% of the enzyme 
molecules react with NADPH at a faster rate than the remainder.  After FAD 
reduction a semiquinone form of the enzyme persists, and further reduction appears to 
be prevented by the inability of the enzyme to transfer electrons between molecules. 
This is consistent with the theory that NADPH-binding “locks” the FMN into an 
inaccessible position in this enzyme form [119].  The effect of CaM is much more 
pronounced for this enzyme form than for the oxidised; CaM-bound one-electron 
reduced nNOSrd is rapidly reduced by hydride transfer from NADPH at a rate that 
again correlates with the turnover of electrons in the cytochrome c reduction 
experiments (93 s-1 vs 104 s-1).  This is followed by further slow reduction initiated by 
intermolecular electron transfer and disproportionation of flavin semiquinones, 
observed as a decrease in absorbance at 592nm in Figure 4.9, panel B. 
 
 




4.3.2 Ionic strength effects 
 
In order to investigate the biphasic nature of the CaM-free reduction observed for the 
one-electron reduced form of nNOSrd, the stopped-flow experiment with NADPH 
was repeated with varying concentrations of salt in the assay buffer.  Figure 4.10 plots 
the diode array spectra and reductive traces for a range of salt concentrations; the 
original 100mM NaCl along with two of higher ionic strength.  All of the traces have 
a similar profile to the original experiment where one equivalent of NADPH causes a 
decrease at 457 nm with no reduction of the FMN semiquinone.  The traces were 
again fitted to a double-exponential equation over 1 s and the resulting parameters are 
listed in Table 4.6.  These show that the rate constants for each ionic strength show 
little change, but an increase in ionic strength causes a greater fraction of the 
reduction to take place in the fast phase.  This is an indication that the enzyme may 
exist in two conformations that undergo hydride transfer at differing rates, and that the 
equilibrium between the two conformations can be altered by electrostatic 
interference associated with the increasing ionic strength in the surrounding 
environment. 




Table 4.6 Ionic-strength effect on pre-steady-state reduction of nNOSrd by NADPH 







wild-type – FMN semiquinone 
+ 100mM NaCl 
- 
41 ± 4  
(16%) 
6.3 ± 0.1 
(84%) 
+ 150mM NaCl - 
35 ± 2 
(30%) 
6.7 ± 0.1 
(70%) 
+ 250mM NaCl - 
30 ± 1 
(60%) 








Figure 4.10 Stopped-flow reduction of nNOSrd (10µM) by NADPH (100µM) at varying ionic  
      strength.  Diode array spectra for (A) 100 mM NaCl buffer, (B) 150 mM NaCl buffer,  
      (C) 250 mM NaCl buffer. (D) Corresponding reductive traces at 457 nm. 
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4.3.3 Kinetic isotope effects 
 
To further investigate the hydride transfer event, stopped-flow flavin reduction 
experiments were performed with NADPD as the reductant.  Figure 4.11 shows the 
data collected for both the fully oxidised and the 1-electron-reduced enzymes.  In 
comparison to Figures 4.7 and 4.9, the general profile of each experiment has similar 
spectral changes and similar amplitudes for fast and slow phases.  The only important 
difference is the length of time for reduction in panels C and D, which is reflected in 
the slower rate constants for both the fast and slow phases, Table 4.7.  It is apparent 
that isotopic substitution affects the rate of FAD reduction through the slowing of 
hydride transfer.  For the one-electron reduced enzyme, comparison of the values for 
NADPD vs. NADPH gives a kinetic isotope effect of approximately 1.5 for both 
phases in the presence and absence of CaM.  The fully oxidised enzyme gives a 
slightly larger value of approximately 2 in the fast phase which is consistent with a 
previous report [137]. 
 
 
Figure 4.11 Stopped-flow reduction of nNOSrd (10µM) by NADPD (100µM).  Diode array  
      spectra for (A) oxidised CaM-free and (inset) CaM-bound, and (B) 1-electron reduced  
      CaM-free and (inset) CaM-bound.  Corresponding reductive traces at 457 nm for (C)  
      oxidised and (D) 1-electron reduced.   
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Table 4.7 Pre-steady-state reduction of nNOSrd by NADPH and NADPD 







FMN oxidised NADPH - 
65 ± 2 
(40%) 
5.9 ± 0.1 
(60%) 
  + 
73 ± 2 
(79%) 
3.6 ± 0.1 
(21%) 
 NADPD - 
26 ± 1 (2.5) 
(49%) 
3.7 ± 0.1 (1.6) 
(51%) 
  + 
35 ± 1 (2.1) 
(73%) 
2.2 ± 0.1 (1.6) 
(27%) 
FMN semiquinone  NADPH - 
35 ± 1 
(20%) 
6.5 ± 0.1 
(80%) 
  + 
93 ± 2 
(78%) 
5.2 ± 0.1 
(22%) 
 NADPD - 
24 ± 1 (1.5) 
(30%) 
4.3 ± 0.1 (1.5) 
(70%) 
  + 
60 ± 1 (1.6) 
(80%) 




The primary kinetic isotope effects here are very similar to those observed in the 
steady-state reduction of cytochrome c (section 4.2.3).  Again the binding of CaM has 
very little effect, in either the fast or slow phase that was measured.  The largest 
isotope effect is seen in the fast phase of the oxidised enzyme, so hydride transfer has 
greater influence in this enzyme form.  However, the values are still low compared to 
those that would be determined for a rate-limiting step, indicating that the rate of 
hydride transfer is not the slowest step in the catalytic cycle of nNOSrd.  
 
 




Potentiometric studies of nNOSrd have previously shown that the FAD is reduced in 
two one-electron steps of similar potential (approximately -300 mV) and that the 
FMN is reduced in two one-electron steps with very different potentials 
(approximately -300 mV and -100 mV) [86].  The FMN semiquinone is 
thermodynamically stabilised towards oxidation (see Table 1.3), and it has 
considerable kinetic stability enabling the FMN to retain the semiquinone oxidation 
state during purification.  Similar reduction potentials have been observed in the 
presence and absence of CaM and even in the isolated FAD and FMN domains [88].  
The exception to this is that the FMN semiquinone loses some thermodynamic 
stability in the isolated domain and shifts to a lower potential.  Given that the FMN 
does not cycle through the semiquinone-oxidised redox states during catalysis, this is 
not functionally important.  However, it does indicate that the presence of the FAD 
domain affects the properties of the FMN.  
In order to examine recent reports suggesting that the binding of CaM shifts the 
reduction potential of both FMN transitions along with the FAD ox/sq transition by 
approximately 100mV more negative [142], the potentiometric titration of CaM-free 
wild-type nNOSrd was repeated using the OTTLE method (Fig. 4.12).  Previously, 
this was conducted by chemical reduction [86].  Panel A shows the UV-Visible 
spectra produced by stepwise reduction of the enzyme by incremental decreases of 30 
mV in the electrode potential.  The resultant plots of the absorbance at both 456 nm 
and 592 nm versus the applied potential (Panel B) were fitted using Equation 2.1, 
simultaneously fitting both sets of data, and yielding the midpoint reduction potentials 
given in Table 4.8.  The results are very similar to those reported previously, although 
equilibration of this enzyme was particularly slow, requiring 2 hours for each 
potential step. 
 




Table 4.8 Midpoint reduction potentials of nNOSrd / mV 
Enzyme FMN ox/sq FMN sq/hq FAD ox/sq FAD sq/hq 
Isolated Domains [88] -179 ± 3 -314 ± 3 -291 ± 3 -326 ± 3 
Wild-type (+CaM) [88] -98 ± 5 -300 ± 8 -296 ± 6 -320 ±10 
     







Figure 4.12 OTTLE potentiometry of wild-type nNOSrd in the absence of CaM.   
      Spectroelectrochemistry was carried out in 100mM Tris pH 7.5, 500mM KCl with  
      mediators added.  (A) Spectra recorded at 30mV intervals. (B) Corresponding  
      absorbance at 456 nm and 592 nm plotted against applied potential and fitted to a  
      modified Nernst equation (Equation 2.1).      
 




The fundamental step in the activation of nNOS is the binding of CaM, which is 
believed to induce motion of the FMN-binding domain away from the FAD-binding 
domain to enable the transfer of electrons to the heme.  Each of the three catalytic 
events in nNOSrd has been reported to be activated by CaM [76, 90, 119], however it 
is unclear which is the rate-limiting step.  From the steady-state cytochrome c 
reduction experiments (Table 4.1), it would appear that the CaM-free turnover is 
limited by a step that is dependent on ionic strength, while the rapid reduction of 
ferricyanide (Figure 4.4) indicates that hydride transfer is not rate-limiting but that the 
transfer of electrons between the flavin cofactors is the slowest step. 
By probing the hydride transfer from NADPH to FAD as an isolated event, further 
insight can be gained about this first catalytic step.  The hydride transfer to the fully 
oxidised enzyme is clearly activated by CaM (Table 4.4) but this is observed as a shift 
in the phases of reduction.  The rate constants retain approximately the same values 
either CaM-free or CaM-bound, but the fast phase in the CaM-free reaction makes up 
40% of the reduction.  This is enhanced to 80% in the CaM-bound state and would 
indicate that CaM increases the rate of flavin to flavin electron transfer, allowing two 
hydride transfers to occur in rapid succession.  This can also be observed as a faster 
appearance and decay of the FMN semiquinone (Figure 4.8). 
The transfer of hydride to the one-electron reduced enzyme better reflects on the 
events occurring during turnover, where only a single hydride transfer takes place.  
The data from these reactions (Table 4.5) indicate that hydride transfer is slow in the 
absence of CaM and fast with CaM-bound.  The paradoxical biphasic nature of the 
CaM-free reaction was initially thought to be due to partly truncated or damaged 
enzyme samples, however the effects were seen across a range of protein 
preparations.  The ionic strength dependence of the CaM-free hydride transfer (Table 
4.6) suggests that the enzyme adopts two conformations in solution; one that reacts 
rapidly with NADPH and the other that either reacts slowly, or is unreactive and 
therefore must undergo a slow conformational change to convert to the active form.  
These two conformations must be linked by an equilibrium that is dependent upon 
ionic-strength.  The effect of increasing the salt concentration on the pre-steady-state 
reduction kinetics of nNOSrd is similar to, but not as pronounced as, the effect of 
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binding CaM.  It would seem logical therefore that the active conformational form of 
CaM-free nNOSrd is related to the CaM-bound form and that CaM-binding affects the 
same conformational equilibrium.  This is represented in Figure 4.13 for a model of 
“closed” and “open” nNOSrd, where the conformational change is effectively the 




If only the hinged-open form is able to undergo rapid NADPH to FAD hydride 
transfer, then the pre-steady-state reduction kinetics would be biphasic, with the 
amplitudes of the two phases corresponding to the position of the conformational 
equilibrium, provided that the hinge-opening process (A) is slow.  The hinged closed 
form can conceivably be considered to be the same as the “locked” form of nNOSrd, 
the conformation that does not transfer electrons to cytochrome c in the presence of 
NADPH and the absence of CaM [119].  The kinetic behaviour of fully oxidised 
nNOSrd can be rationalised from the model in Figure 4.13, where presumably the 
fully closed form relies on the presence of the FMN semiquinone state, so the 
oxidised enzyme will be more open in the absence of CaM.  It is still activated by 
CaM, which pulls the equilibrium fully to the open form, but the effect is less 
pronounced.   
The kinetic isotope effects observed for nNOSrd are small, in both the steady-state 
and pre-steady-state experiments.  Values of between 1 and 2 indicate that the rate of 
hydride transfer from NADPH to FAD is slowed slightly due to the larger mass of 
Figure 4.13 Proposed scheme for the mechanism of CaM-activation of nNOSrd.  Binding of CaM  
      alters the position of equilibrium A between the hinged-open and hinged-closed forms  
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deuterium but kinetic isotope effects on hydride transfer can be as high as 8.  
Therefore it is unlikely that the hydride transfer step is entirely rate-determining in 
this case.  A step prior to the actual hydride transfer event probably influences the rate 
of FAD reduction, a conformational change occurring after NADPH binding.  The 
lack of a CaM effect on the kinetic isotope effect indicates that the transition state for 
hydride transfer is similar in both cases.  In other words, CaM does not increase the 
rate of FAD reduction by altering the affinity of FAD for the hydride, or the 
orientation of nicotinamide stacking above the FAD.  The logical conclusion is that 
CaM increases the rate at which NADPH can adopt the appropriate orientation for 


















The regulation of electron-transfer activity through nNOSrd is achieved by the 
binding of CaM, along with the presence of a number of structural regulatory features 
(see section 1.7).  The SI, AI, CT and phosphorylation sites can all feasibly be found 
at the FAD/FMN interface, where the flavin cofactors come into contact to transfer 
electrons in the “hinged-closed” state.  This interface in nNOSrd was affected in 
Chapter 4 by the redox state of the FMN cofactor; the fully oxidised enzyme did not 
form a completely “locked” state and was consequently only slightly regulated by 
CaM in pre-steady-state flavin reduction experiments.   The one-electron reduced 
enzyme is the catalytically relevant form and exhibited a more pronounced effect on 
hydride transfer upon CaM binding, which correlated with the activation step in the 
steady-state reduction of cytochrome c, attributed to conformational change.   
Another feature of the interface is a salt-bridge between Arg1229 and Glu762.  This is 
on the opposite side of the enzyme to the hinge (Figure 5.1) and close to the edge of 
the FAD cofactor.  Furthermore, there are two more glutamate residues close to 
Glu762 in the crystal structure [74], also highlighted in Panel B of Figure 5.1, which 
could form the salt bridge.  This indicates that the electrostatic attraction is an 
important interface interaction. 
 
 
Figure 5.1 Crystal structure of nNOSrd (PDB code 1TLL). (A) Overall structure showing the  
    position of the double salt bridge opposite to the hinge (black circles).  (B) Close-up on  
    the interaction between Arg1229 and Glu762, Glu816, Glu819.  Bound flavin cofactors     
    are coloured yellow, NADPH orange, FMN-binding domain red, other domains blue.  
    AI and CT are coloured cyan. 
   
A 
B 
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To break this salt-bridge, Arg1229 on the FAD-side was substituted by glutamate.  
The resulting R1229E mutant should retain the overall shape near to the bound FAD 
cofactor, as the two amino acids are similar in size, but introduce charge repulsion 
between the two halves of the interface.  This is likely to destabilise the hinge-closed 
form and be regulated by CaM differently to wild-type nNOSrd, represented in 
Appendix I.  This chapter presents the kinetic and thermodynamic analysis of R1229E 
nNOSrd in comparison to the wild-type enzyme for steady-state turnover reactions, 




5.2 Steady-state turnover 
 
5.2.1 Cytochrome c reduction 
 
The turnover of electrons through nNOSrd to cytochrome c is a characteristic 
measurement that is activated by CaM, as observed in section 4.2.1, by a 10-fold 
enhancement effect.  Rate constants for the steady-state reduction of cytochrome c by 
R1229E nNOSrd are plotted in Figure 5.2, in comparison to the wild-type enzyme 
(Panel A vs. Panel B).  In the CaM-free R1229E assay, the rate initially increases with 
the concentration of cytochrome c, to a maximum of 7.5 s-1, however it then decreases 
at concentrations of cytochrome c greater than 20µM.  This indicates that excess 
cytochrome c is inhibiting catalytic turnover.  When CaM is present the rate of 
cytochrome c reduction is much lower (< 2 s-1), and the inhibition is apparent at 
cytochrome c concentrations as low as 2µM.  The CaM-free data fit well to a model 
for substrate inhibition in which the substrate (here cytochrome c) binds to an 
unproductive form of the enzyme (Equation 10, Appendix Ι).  Inhibition occurs with 
the CaM-bound mutant even at low concentrations of cytochrome c, so these data are 
fitted to a simpler inhibition equation (Equation 11), and all of the derived kinetic 
parameters are listed in Table 5.1.  The difficulty in obtaining accurate rate constants 
at low concentrations of cytochrome c compromises the accuracy of these data; 
however it is clear that the rate of reduction is markedly slower for R1229E nNOSrd 
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when CaM is bound, an occurrence not seen in other reductase domain mutants.  The 
overall effect of this single mutation is particularly large; a decrease from 100 s-1 to 
around 2 s-1.  The mutation therefore appears to induce two separate effects; it 
decreases the rate of electron transfer through the CaM-bound enzyme and introduces 
substrate inhibition at high cytochrome c concentrations.  Both of these may be due to 




In order to test this theory, the assay was repeated at varying levels of ionic strength, 
i.e. increased NaCl concentration in the assay buffer.  Panel C of Figure 5.2 shows a 
linear dependence of the log of the rate constant of cytochrome c reduction at 15µM 
versus the square root of ionic strength.  According to Debye-Huckel theory (equation 
14, Appendix Ι), the primary kinetic salt effect obtained from the gradient of the plot 
gives the ionic charge interaction involved.  For both the CaM-free and CaM-bound 
Figure 5.2 Steady-state cytochrome c reduction by R1229E nNOSrd, in the absence (black points)  
    and presence (red points) of CaM.  Assays were performed at 25oC in 50mM Tris, pH  
    7.5. (A) wild-type turnover in buffer + 100mM NaCl (B) R1229E turnover in buffer +  
    100mM NaCl (C) R1229E turnover with varying ionic strength (D) R1229E turnover in  
    buffer + 1 M NaCl. 
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mutant there is a net unit charge interaction of 1.  It seems likely therefore that the 
high salt concentrations can compensate for the negative-negative repulsion across the 
interface caused by the mutated residue and increase the rate of interflavin electron 
transfer.  As expected, the electrostatic component of the interaction is unaltered by 
the binding of CaM. 
When the salt concentration was increased to 1 M (Panel D of Figure 5.2), the steady-
state kinetic data for R1229E nNOSrd fitted to the Michaelis-Menten equation, giving 
catalytic turnover rates of 24 s-1 (CaM-free) and 9 s-1 (CaM-bound).  It is interesting to 
note that the activity of the enzyme is still decreased by more than 2-fold upon 
binding of CaM, which is opposite to the effect seen in the wild-type enzyme.  Also, 
the CaM-free activity of R1229E nNOSrd is not activated relative to the wild-type 
enzyme, as the same activity was observed in Figure 4.3 for CaM-free nNOSrd with 




5.2.2 Ferricyanide reduction 
 
The reduction of ferricyanide by nNOSrd occurs at both the FAD and FMN cofactors, 
leading to faster rates of turnover and a smaller CaM-mediated activation step, as 
Table 5.1 Steady-state cytochrome c reduction by R1229E nNOSrd 
Enzyme Ca2+/ CaM kcat / s
-1 Km
cytc




10.4 ± 0.4 
104 ± 6 
3 ± 1 
8 ± 2 
n/a 




23 ± 1 
95 ± 6 
12 ± 2 





14.8 ± 1.8 
3.4 ± 1.8  
10 ± 2 
n/a 
44 ±9 
2 ± 2 
R1229E + 1M NaCl 
- 
+ 
24.3 ± 1.4 
8.8 ± 0.5 
14 ± 2 
5 ± 1 
n/a 
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observed in section 4.2.2.  Rate constants for the steady-state reduction of ferricyanide 
by R1229E nNOSrd are plotted in Figure 5.3, in comparison to wild-type.  The 
gradients of the straight-line fits, i.e. catalytic efficiency, and the y-intercepts are 




Table 5.2 Steady-state ferricyanide reduction by R1229E nNOSrd 




81 ± 2 
131 ± 4 
21 + 2 




30 ± 1 
31 ± 1 
2.6 ± 0.7 
1.6 ± 0.6 
 
The R1229E mutant turns over at a much lower catalytic efficiency than wild-type 
nNOSrd, approximately 2.5-fold, CaM-free.  This can be rationalised by the 
proximity of the mutation site to a site where ferricyanide would have to bind to 
receive electrons from FAD, where glutamate is less favourable than arginine (in 
Figure 5.3 Steady-state ferricyanide reduction by R1229E nNOSrd.  Assays were performed at  
    25oC in 50mM Tris buffer, pH 7.5 + 100mM NaCl.  Data points were fitted to a  
    straight-line equation. 
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wild-type) in interacting with the negative ferricyanide ion. The y-intercept is also 
decreased considerably, to 2 s-1, which can be interpreted as a severe decrease in 
electron flux through the mutant enzyme.  It is also of note that the binding of CaM 
does not have any effect on the mutant’s rate of turnover.  This indicates that the 
destabilisation at the interface allows the ferricyanide access to the FAD site to 
perform electron transfer in the absence of CaM, but this is retarded by the presence 
of the negative glutamate residue.  Furthermore, the binding of CaM does not allow 
any greater access for the ferricyanide, nor does it increase the rate of interflavin 
electron transfer. 
 
5.2.3 NO synthesis 
 
Full-length nNOS, both wild-type and the R1229E mutant, were assayed for NOS 
activity and the results are summarised in Table 5.3.  There was no CaM-free activity 
observed for R1229E nNOS, and the CaM-bound activity was reduced compared to 
the wild-type by approximately 5-fold.  NADPH consumption was reduced by less 
than the NOS activity, approximately 2.5-fold, indicating that R1229E nNOS has a 
greater degree of uncoupled NADPH oxidation.  Overall it is clear that R1229E nNOS 
is less efficient than the wild-type holoenzyme, which means that destabilisation at 
the interface does not activate electron transfer to the oxygenase domain of holo-
nNOS.  A partially hinged-open state would mean that the flavin cofactors have more 
access to solvent and therefore oxygen, which would explain the relative increase in 
the rate of NADPH oxidation.  These results are in good agreement with substitutions 
of the acidic residues on the FMN-binding domain at the interface in nNOS [81]. 
 
Table 5.3 Steady-state NO synthesis by R1229E nNOS 
Enzyme Ca2+ / CaM NO synthesis / min-1 NADPH oxidation / min-1 
wild-type - no activity  
 + 10.2 ± 0.6 27 ± 2 
R1229E - no activity  
 + 2.0 ± 0.4 9.3 ± 0.4 
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5.3 Pre-steady-state kinetics 
 
Wild-type nNOSrd is regulated by CaM for each of the three steps in turnover; 
hydride transfer (NADPH to FAD), interflavin electron transfer (FAD to FMN) and 
the transfer of an electron from FMN to heme.  This occurs through the adoption of 
two distinct conformations; open and closed.  These conformations should be present 
in the R1229E mutant and affected by the change at the interface.  Furthermore, the 
inhibition effect observed during steady-state cytochrome c reduction can be 
investigated in each of the catalytic events, in order to ascertain which individual step 
or steps are affected in the mutant’s turnover reactions. 
 
 
5.3.1 Cytochrome c reduction 
 
The transfer of an electron from hydroquinone FMN to cytochrome c is the final step 
in the turnover of nNOSrd, and provides a measure of the accessibility of the bound 
FMN.  It is measured by the stopped-flow mixing of chemically reduced enzyme with 
a sub-stoichiometric amount of cytochrome c, in the presence and absence of CaM 
and NADPH.  This experiment has previously been used to reveal that the CaM-free 
NADPH-bound wild-type enzyme is in a “locked” FMN-inaccessible conformation, 
where the binding of NADPH causes the second-order rate-constant to drop from 
15µM-1s-1 to 1µM-1s-1, while the binding of CaM enhances it to >35µM-1s-1, releasing 
the lock and allowing the rapid transfer of an electron from FMN to cytochrome c 
[119].  Furthermore, analysis of the isolated FMN domain under the same conditions 
highlighted the similarity in accessibility between FMN bound to this single domain 
and that bound to CaM-activated nNOSrd [120].  
Figure 5.4 plots the stopped-flow traces associated with cytochrome c reduction by 
R1229E nNOSrd under the same conditions.   
 
 




In all cases, in the presence or absence of NADPH and CaM, the reduction of 
cytochrome c occurs rapidly.  The associated rate constants were obtained by fitting 
the traces to a single exponential function and found to be dependent on the 
concentration of R1229E nNOSrd, as for wild type.  This is presented in Figure 5.5, 
where the rate of cytochrome c reduction by R1229E nNOSrd at a range of 
concentrations with the addition of NADPH is plotted. 
 
Figure 5.4 Pre-steady-state reduction of cytochrome c by R1229E nNOSrd.  Stopped-flow mixing  
        of pre-reduced enzyme (10µM) with ferric cytochrome c (4µM) was carried out at  
    25oC in the absence and presence of NADPH and CaM. 




The second-order rate-constant for the mutant is 39 µM-1s-1, which is analogous to 
activated wild-type enzyme (38 µM-1s-1, [119]) and the isolated FMN-binding domain 
[120] and indicates that the bound FMN in R1229E nNOSrd is always accessible to 
cytochrome c. The presence of NADPH in the absence of CaM is unable to induce a 
“locked” conformation in the mutant.  
In order to investigate the self-inhibition of cytochrome c during turnover reactions 
(section 5.2.1), the pre-steady-state reduction was repeated in the presence of 10µM 
ferrous cytochrome c.  This species would be present in the steady-state assays and 
could inhibit the reduction of further molecules of ferric cytochrome c.   The traces 
associated with this experiment are plotted in Figure 5.6 and the rapid reduction under 
all conditions is again apparent, with no inhibition effect observed in this part of the 
catalytic turnover of the mutant enzyme.  This indicates that ferrous cytochrome c 
does not inhibit the direct transfer of electrons to ferric cytochrome c during steady-
state turnover. 
 
Figure 5.5 Concentration dependence of pre-steady-state reduction of cytochrome c by R1229E  
    nNOSrd.  Stopped-flow mixing of pre-reduced enzyme (6-12µM) with ferric  
    cytochrome c (4µM) was carried out at 25oC with NADPH bound in each case. 





5.3.2 Flavin reduction 
 
The hydride transfer step in wild-type nNOSrd (section 4.3) was found to be regulated 
by CaM in the fully oxidised form of the enzyme, but there was a more pronounced 
effect in the one-electron reduced (FMN semiquinone) state.  These experiments were 
repeated for R1229E nNOSrd; Figure 5.7 shows the fully oxidised version, with 
Panels A and B representing the CaM-free and CaM-bound forms respectively.  The 
resulting time-dependent reduction traces are plotted in Panel C, where they are 
compared to the wild-type traces from Figure 4.7.  The data were fitted to the same 
double exponential function over 1 s and the derived kinetic parameters are listed in 
Table 5.4, in comparison to wild-type values from Table 4.4.  
 
Figure 5.6 Pre-steady-state reduction of cytochrome c by R1229E nNOSrd in the presence of  
    ferrous cytochrome c. Stopped-flow mixing of pre-reduced enzyme (10µM) with ferric  
    cytochrome c (4µM) + ferrous cytochrome c (10µM) was carried out at 25oC in the  
    absence and presence of NADPH and CaM.  




Table 5.4 Pre-steady-state reduction of oxidised R1229E nNOSrd by NADPH 







wild-type – FMN oxidised - 
65 ± 2 
(40%) 
5.9 ± 0.1 
(60%) 
 + 
73 ± 2 
(79%) 
3.6 ± 0.1 
(21%) 
R1229E – FMN oxidised - 
169 ± 5 
(52%) 
4.0 ± 0.1 
(48%) 
 + 
156 ± 6 
(57%) 
5.6 ± 0.1 
(43%) 
 
It is apparent that the traces for CaM-free and CaM-bound R1229E nNOSrd are very 
similar and are divided into two phases of almost equal amplitude.  The first one is 
Figure 5.7 Stopped-flow reduction of fully oxidised R1229E nNOSrd (10µM) by NADPH  
    (100µM).  Diode array spectra for (A) CaM-free and (B) CaM-bound oxidised  
    R1229E nNOSrd. (C) Corresponding normalised reductive traces at 457 nm  
    compared to wild-type, from Figure 4.7. 
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presumably the first hydride transfer and occurs more rapidly than that for the wild-
type enzyme, while the slower second step leads to an obvious change in the kinetic 
trace (Panel C).  This implies that the enzyme is unable to perform rapid interflavin 
electron transfer, which can be further observed from the semiquinone build-up and 
decay at 592 nm.  This is shown as a time-course in Figure 5.8, with Panels A and B 
replicated from Figure 4.8 for the wild-type experiments, and Panel C from the same 
CaM-free R1229E reaction as Figure 5.7 (A).  In the wild-type enzyme, the FMN 
rapidly receives a first and second electron from FAD and then disproportionates with 
other enzyme molecules, observed as a slow build up of semiquinone.  The R1229E 
mutant proceeds much more slowly, with the slow appearance and even slower 
disappearance of the semiquinone band occurring over a 4 s period.  Referring back to 
the scheme of electron transfer in Figure 4.6, this means that the first step, hydride 




The stopped-flow reaction for one-electron reduced R1229E nNOSrd is plotted in 
Figure 5.9, with Panels A and B showing the CaM-free and CaM-bound reduction 
Figure 5.8 Stopped-flow reduction of fully oxidised R1229E nNOSrd (10µM) by NADPH  
    (100µM).  Traces at 592 nm are replicated from Figure 4.8 for (A) CaM-free and (B) 
    CaM-bound wild-type.  (C) R1229E from the same data as Figure 5.7, Panel A. 
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respectively.  The resultant traces, in Panel C, are compared to wild-type equivalents 




Table 5.5 Pre-steady-state reduction of 1-electron-reduced R1229E nNOSrd by NADPH 







wild-type – FMN semiquinone  - 
35 ± 1 
(20%) 
6.5 ± 0.1 
(80%) 
 + 
93 ± 2 
(78%) 
5.2 ± 0.1 
(22%) 
R1229E – FMN semiquinone - 
138 ± 3 
(73%) 
5.6 ± 0.1 
(27%) 
 + 
162 ± 4 
(80%) 
4.3 ± 0.1 
(20%) 
Figure 5.9 Stopped-flow reduction of one-electron reduced R1229E nNOSrd (10µM) by NADPH  
    (100µM).   Diode array spectra for (A) CaM-free and (B) CaM-bound R1229E  
    nNOSrd.  (C) Corresponding normalised reductive traces at 457 nm compared to wild- 
    type, from Figure 4.9.   
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It is apparent that the hydride transfer occurs rapidly in both the CaM-free and CaM-
bound states, with the kinetic profile resembling that of the CaM-bound, activated 
form of the wild-type enzyme; fast flavin reduction is followed by further 
disproportionation events.  This means that the R1229E mutant has activated hydride 
transfer in the CaM-free state. 
All of the flavin reduction experiments with the R1229E mutant were repeated in the 
presence of ferrous cytochrome c, in order to investigate the possibility of inhibition 
in the steady-state turnover assays.  Figure 5.10 plots the stopped-flow mixing of 
oxidised R1229E nNOSrd, augmented with 10 µM ferrous cytochrome c, vs. 
NADPH.  A significant part of the absorbance trace is taken up by the more intense 
absorption of cytochrome c (Panel A); however the reduction of the flavin band at 457 




Figure 5.10 Stopped-flow reduction of oxidised R1229E nNOSrd (10µM), in the presence of  
     cytochrome c (10µM), by NADPH (100µM).  Diode array spectra for the CaM-free  
     reaction are shown in (A) broad-range and (B) close-up wavelengths to highlight the  
     flavin reduction occurring at 457 nm. (C) Traces for time-courses of flavin reduction. 
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The absorbance change in this experiment was only half of the magnitude of the 
analogous change in Figure 5.7 (0.06 vs. 0.125), although the concentration of 
enzyme was the same in both reactions.  This indicates that only the first hydride 
transfer occurred which means that the kinetic profile (Panel C) and the derived 
parameters (Table 5.6) of the oxidised enzyme are now similar to those obtained in 
the experiments with the one-electron reduced R1229E mutant where a single hydride 
transfer also occurs.  The fast rate constant in the initial reduction is retained, but the 
presence of cytochrome c clearly inhibits the inter-flavin electron transfer from FAD 
to FMN. 
 
Table 5.6 Summary of pre-steady-state reduction of R1229E nNOSrd by NADPH 







R1229E – FMN oxidised - 
169 ± 5 
(52%) 
4.0 ± 0.1 
(48%) 
 + 
156 ± 6 
(57%) 
5.6 ± 0.1 
(43%) 
R1229E – FMN oxidised + 
cytochrome c2+ 
- 
128 ± 2 
(71%) 
4.5 ± 0.1 
(29%) 
 + 
141 ± 2 
(74%) 
3.6 + 0.1 
(26%) 
R1229E – FMN semiquinone - 
138 ± 3 
(73%) 
5.6 ± 0.1 
(27%) 
 + 
162 ± 4 
(80%) 
4.3 ± 0.1 
(20%) 
R1229E – FMN semiquinone +  
cytochrome c2+ 
- 
139 ± 3 
(80%) 
5.4 ± 0.2 
(20%) 
 + 
160 ± 6 
(89%) 








The thermodynamic stability of the flavin cofactors was shown in section 4.4 not to 
be affected by CaM-binding to nNOSrd.  There was an effect observed, however, in a 
previous study of the isolated FMN-binding domain [88].  There, the FMN 
oxidised/semiquinone couple was more stabilised in nNOSrd (-100 vs -180 mV), 
indicating that the presence of the other binding domains has an effect on the stability 
of the bound FMN cofactor.  The R1229E mutant may have a related effect due to the 
change at the FAD/FMN interface region, but the residue is also in close proximity to 
the bound FAD cofactor so could affect more than one reduction potential.   
R1229E nNOSrd was analysed under identical conditions to the wild-type enzyme 
using OTTLE potentiometry.  Figure 5.11, Panel A, shows the UV-visible spectra 
obtained during the stepwise reduction of the mutant by 30 mV increments.  The 
spectra are very similar to those obtained for the wild-type enzyme in Figure 4.12.  
The resultant plots of the absorbance at 456 nm and 592 nm vs. applied potential 
(Panel B) were fitted simultaneously to Equation 2.1, yielding the midpoint reduction 
potentials listed in Table 5.7.  
 




Table 5.7 Midpoint reduction potentials of nNOSrd / mV 
Enzyme FMN ox/sq FMN sq/hq FAD ox/sq FAD sq/hq 
Isolated Domains [88] -179 ± 3 -314 ± 3 -291 ± 3 -326 ± 3 
Wild-type (+CaM) [88] -98 ± 5 -300 ± 8 -296 ± 6 -320 ±10 
     
Wild-type (-CaM) -101 ± 4 -271 ± 6 -289 ± 6 -301 ± 7 
     
R1229E (-CaM) -135 ± 4 -278 ± 9 -283 ± 9 -300 ± 9 
R1229E (+CaM) -140 ± 4 -246 ± 8 -268 ± 8 -270 ± 8 
 
Clearly none of the redox-active reduction potentials, i.e. the FMN semiquinone / 
hydroquinone pair or either of the FAD transitions, are affected by the introduction of 
the R1229E mutation, which indicates that the steady-state inhibition of electron 
Figure 5.11 OTTLE potentiometry of R1229E nNOSrd in the absence of CaM.   
      Spectroelectrochemistry was carried out in 100mM Tris pH 7.5, 500mM KCl with  
      mediators added.  (A) Spectra recorded at 30mV intervals. (B) Corresponding  
      absorbance at 456 nm and 592 nm plotted against applied potential and fitted to a  
      modified Nernst equation (Equation 2.1).      
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transfer is not caused by a thermodynamic change in the flavin cofactors.  
Furthermore, thermodynamic effects alone would not explain the activation of 
hydride transfer and electron transfer in the pre-steady-state experiments.  It is 
intriguing that a mutation close to the site of the bound FAD cofactor affects 
exclusively the reduction potential of the bound FMN cofactor; only the FMN 
oxidised/semiquinone couple is altered, just as for the isolated FMN-binding domain.  
The value for the R1229E mutant falls midway between the reductase domain and the 
FMN-binding domain, indicating that the interface is open such that the FMN 





The reduction of cytochrome c by nNOSrd is the measurement by which the electron 
transfer activity is most frequently studied.  Alteration of any of the structural 
regulatory features in nNOSrd activates this electron transfer through the CaM-free 
enzyme, but not necessarily to the oxygenase domain in the holoenzyme.  Table 5.8 
summarises previous data on the activation of steady-state cytochrome c reduction by 
CaM in nNOS mutants.  The mutations do not generally affect turnover in the 
presence of CaM, rationalised by the fact that nNOSrd is catalytically repressed in the 
absence of CaM.  Deletion of the CT, however, produces a truncated mutant that turns 
over slightly faster than wild-type in the presence of CaM [105].  This, as well as 
mutation of Phe1395 [128], which facilitates the reaction between NADPH and FAD, 
both also activate NO synthesis in the CaM-free state.  The effect of the R1229E 
mutation on steady-state cytochrome c reduction by nNOSrd is particularly severe.  In 
the presence of CaM, the enzyme is 30-fold slower than the wild-type and 4-fold 
slower than in the absence of CaM.  This unique shift in behaviour is particularly 
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Table 5.8 CaM-dependent activation factors for cyt. c reduction in nNOSrd 
Enzyme  Ratio CaM-bound / CaM-free 
wild-type 10 
SI deletion [117] 4 
AI deletion [102] 2.5 
R1400E [124] 1.4 
F1395S [128] 1.2 
CT deletion [105] 0.77 
R1229E 0.23 (with inhibition) 
R1229E + 1 M salt 0.37 
 
All of the mutations listed have multiple effects on the CaM-free enzyme, often 
characterised by increased cytochrome c reductase activity, faster rates of flavin 
reduction and decreased response to CaM.  It is likely that destabilisation of the 
FAD/FMN interface is a common cause of these effects.  Arg1229 is not part of an 
autoinhibitory feature, or of any other catalytic unit.  Therefore, its mutation reports 
directly on the importance of the interface to the different steps of catalysis. 
As discussed previously for the wild-type oxidised enzyme, the transfer of NADPH to 
FAD shows a complex CaM-effect, with two consecutive hydride transfers occurring 
in shifting phases.  For the R1229E mutant the results are more obvious, with two 
exponentials of equal amplitudes, it is clear that the first hydride transfer is fast and 
the second is slow.  The reason for this is a slow interflavin electron transfer step 
occurring between the two hydride transfers.  Note that it is apparent from Panel C of 
Figure 5.7 that removing CaM from nNOSrd and introducing the R1229E mutation 
clearly affects different steps of the reduction process. 
For the wild-type one-electron reduced enzyme, hydride transfer is slow in the 
absence of CaM and fast with CaM bound.  This was attributed in the previous 
chapter to a conformational equilibrium between “hinged-open” and hinged-closed” 
states, reproduced in Figure 5.12.  Presumably the R1229E mutant favours a hinged-
open conformation in which hydride transfer is rapid and interflavin electron transfer 
is slowed.  It is logical to consider that the converse is also true, i.e. that hydride 
transfer in the hinged-closed or “locked” conformation is slowed and interflavin 
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electron transfer is rapid (the two flavin rings are only 5 Å apart in the hinged closed 
state presented in the crystal structure and the NADP+ is bound in an unproductive 
conformation).  In the case of the wild-type, the stability of the domain-domain 
interface determines the rate of hydride transfer from NADPH to FAD by controlling 
the rate at which the enzyme can hinge open (approx 6.5 s-1 CaM-free).  The rate of 
electron transfer from FAD to FMN in the R1229E mutant conversely depends on the 
rate at which the enzyme can hinge close (approx 5 s-1), if it can access this state at 
all.   The values in Table 4.6 indicate that the rate constants for both hydride and 
interflavin electron transfer increase by at least an order of magnitude when the 




The fact that cytochrome c is able to inhibit interflavin electron transfer in the mutant 
enzyme suggests that the FAD and FMN domains separate enough to allow another 
protein to access the interface.  This indicates that the FMN domain is able to move a 
large distance during catalysis, which may be a feature of electron transfer to the 
nNOS heme in the holoenzyme.  In fact, the short-range nature of electrostatic 
interactions such as the salt bridge between R1229 and the acidic patch in nNOS 
means that once the contact is broken during domain-domain motion, wide separation 
such as that observed in the R1229E mutant is likely.  The pre-steady-state reduction 
of cytochrome c by nNOSrd is a second order process dependent on the collision 
frequency between cytochrome c and the FMN.  The rate constants measured for 
CaM-bound wild-type nNOSrd, the R1229E mutant and the isolated FMN domain are 
all very similar, indicating that the FMN is equally accessible in all three cases.  This 
Figure 5.12 Proposed scheme for the mechanism of CaM-activation of nNOSrd.  The R1229E  
      mutation disrupts the conformational equilibrium to form a predominantly open  
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indicates that CaM binding induces a mainly open form of the enzyme, in which the 
FMN and FAD are not usually in contact.  Electron transfer from FAD to FMN in the 
hinged-closed form is likely to be very rapid over the 5 Å distance reported in the 
crystal structure, such that the hinged closed form may only need to be sampled very 
briefly to maintain turnover. 
Mutation of the acidic patch interface residues Glu816 and Glu762 (in addition to 
Arg1229) has recently been shown to activate electron transfer through CaM-free 
nNOS and to slow the rate of electron transfer to nNOS heme [81].  It has been 
speculated that the same residues interact with a basic patch on the oxygenase 
domain, including Lys423.  Mutation of this residue has also been shown to affect the 
rate of NO synthesis [56].  None of these mutations, or the R1229E mutant described 
here, result in the activation of NO synthesis in CaM-free nNOS.  Thus, there is no 
correlation between the strength of interaction across the FAD-FMN interface and NO 
synthesis activity. 
In summary, the R1229E mutation disrupts the FAD-FMN domain interface in 
nNOSrd such that there is no regulatory interaction between the two domains.  
Electron transfer from FAD to FMN is severely retarded and hydride transfer from 
NADPH to FAD is accelerated, particularly when compared to the CaM-free wild-
type one-electron reduced enzyme.  This is consistent with a model for catalytic 
action of the enzyme in which it exists in two conformational states, “closed” and 
“open”, with distinct kinetic events happening in each state.  The “closed” form 
allows electron transfer from FAD to FMN, while the enzyme must be in the “open” 
form for both facile hydride transfer from NADPH to FAD and electron transfer from 
FMN to cytochrome c or nNOS heme.  The presence of the salt-bridge at 
Arginine1229 is clearly essential for the successful movement of the FMN binding 
domain from an electron-receiving position to an electron-donating one and can be 











Residues involved in  
hydride transfer 




Hydride transfer from NADPH to the bound FAD cofactor in nNOSrd is enabled by 
the movement of the substrate’s nicotinamide moiety from a non-productive to a 
productive conformation [125].  This is associated with the mobility of Phe1395 away 
from FAD, which forms part of a complex regulatory system of the subsequent 
electron transfer events [127, 128].  The area around the bound FAD cofactor is 
depicted in Figure 6.1 for the non-productive conformation in nNOSrd [74] and the 
productive conformation in a mutant of CPR [126].  This “FAD-active-site” includes 




Ser1176 is shown to be performing the same role in both conformations by H-bonding 
to the bound FAD cofactor, at the flavin N5 position where NADPH will transfer 
hydride to.  Substitution of the serine by alanine, S1176A, has been carried out to 
ascertain the importance of this interaction.  The alanine in place of the serine will be 
shorter and have no H-bonding capability. 
Asp1393 appears able to form H-bonding interactions to either Ser1176 or His1032 in 
the non-productive conformation, and to the nicotinamide group or His1032 in the 
productive conformation.  This implies that it may serve to position NADPH 
correctly, as well as stabilising the other FAD-active-site residues.  In the D1393E 
Figure 6.1 X-ray crystal structures of (A) nNOSrd (PDB code 1Tll) and (B) W677X CPR (1JAO).   
    FAD is coloured yellow, NADPH orange, NADPH-binding domain residues blue.  Key  
    interactions are marked with black dashed lines. 
A B 
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mutant that was made, the aspartate was replaced by a glutamate. This substitution 
retains H-bonding capabilities, as well as the charge and acidity, but the longer chain 
length of glutamate may affect the steric environment around the FAD cofactor.   
His1032 forms H-bonding interactions, with either Asp1393 or Ser1176, and its 
properties as a base could mean that it has a role in the proton removal from the FAD 
cofactor.  Furthermore, it is adjacent to Arg1229 which forms the salt-bridging 
interaction with the FMN-binding domain, meaning that it may be close to solvent 
exposure in the open conformation of nNOSrd.  Substitutions of the histidine were 
made to glutamine and serine.  The H1032Q mutant will retain a residue of 
approximately the same size, but with different H-bonding properties.  The H1032S 
mutant, on the other hand, will affect the size of the residue and possibly the 
conformation of the surrounding residues, along with the removal of the basic 
character of the residue. 
Each of the FAD-active-site mutants in this chapter has been investigated with regard 
to the activation step by CaM in steady-state turnover experiments and pre-steady-
state kinetic measurements.  The different properties of each residue in the H-bonding 
network are directly related to effects on catalysis and regulation. 
 
 
6.2 Steady-state turnover 
 
6.2.1 Cytochrome c reduction 
 
The rate of cytochrome c reduction is characteristically activated by CaM binding to 
wild-type nNOSrd (section 4.2.1) and this effect is reversed in the R1229E mutant 
which is coupled with substrate inhibition effects (section 5.2.1).  The same 
experiments were performed to assess the rate of turnover in the four other FAD-
active-site mutants.  Rate constants for steady-state cytochrome c reduction are 
plotted in Figure 6.2.  In each case, the data exhibited normal kinetic behaviour and 
were fitted to the Michaelis-Menten equation (Equation 6, Appendix Ι). The derived 
values for kcat and Km are listed in Table 6.1. 
 




Table 6.1 Steady-state cytochrome c reduction by nNOSrd mutants 
Enzyme Ca2+ / CaM kcat / s-1 Km




10.4 ± 0.4 
104 ± 6 
3 ± 1 





0.45 ± 0.03 
2.1 ± 0.1 
12 ± 5 





2.6 ± 0.2 
17 ± 0.5 
4 ± 1 





2.5 ± 0.1 
37 ± 2 
1.5 ± 0.5 





2.6 ± 0.1 
44 ± 2 
7 ± 1 
8 ± 1 
16.9-fold 
 
Figure 6.2 Steady-state cytochrome c reduction by nNOSrd mutants. Assays were performed at  
         25oC in 50mM Tris, pH 7.5 + 100mM NaCl.  Data are compared for (A) S1176A, (B)  
    D1393E, (C) H1032S and (D) H1032Q in the absence (black points) and presence (red  
    points) of CaM 
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The activity of each of the mutants is decreased relative to wild-type nNOSrd, with 
the greatest effects seen in S1176A.  The activity of this mutant is over 20-fold slower 
in the CaM-free and 50-fold slower in the CaM-bound state.  From the position of 
Ser1176, it would appear that the rate of hydride transfer to the FAD is severely 
slowed, but still retains CaM sensitivity in the mutant, to a lesser extent than wild-
type nNOSrd.  These results for the S1176A mutant are consistent with studies in the 
nNOS holoenzyme [129].  Adjacent to Ser1176 is Asp1393, and the D1393E mutant 
had the next slowest activity, 4-fold and 6-fold slower than the wild-type enzyme in 
the absence and presence of CaM respectively.  Again, these parameters are consistent 
with holo-nNOS studies [130], along with the lesser sensitivity to CaM, which 
implies that the D1393E mutant is affecting a similar step to S1176A nNOSrd. 
The two substitutions at His1032 have a different effect on the steady-state turnover 
of cytochrome c.  In the absence of CaM the rates of reduction were slowed to the 
same level as D1393E, however when CaM was present both H1032S and H1032Q 
nNOSrd transferred electrons at a rate only 2-fold slower than that of the wild-type 
enzyme.  Furthermore the CaM-activation in both of these mutants is greater than for 
wild-type, a feature that is not observed in other single residue substitutions of 
nNOSrd.  If the CaM-free activity is slowed due to a similar effect as in D1393E, then 
the CaM-bound enzymes must exhibit a different conformational change. 
 
 
6.2.2 Ferricyanide reduction 
 
The steady-state reactions of H1032S and H1032Q nNOSrd were further investigated 
using ferricyanide as the electron acceptor.  This does not occur in the same way as 
the cytochrome c reduction, because the ferricyanide ion can access the FAD cofactor 
in addition to the bound FMN.  This leads to a faster rate of reduction and a lesser 
CaM-mediated activation effect.  The observed rate constants are plotted in Figure 
6.3, where a linear increase in rate occurred over the concentration range, analogous 
to the wild-type experiments (section 4.2.2). The data were fitted to a straight-line 
function and the derived kinetic parameters are listed in Table 6.2. 
 




Table 6.2 Steady-state ferricyanide reduction by H1032S and H1032Q nNOSrd  




81 ± 2 
131 ± 4 
21 ± 2 





32 ± 5 
76 ± 5 
26 ± 5 





30 ± 3 
62 ± 5 
25 ± 3 
60 ± 5 
2.1-fold 
 
Compared to wild-type nNOSrd, the catalytic efficiency of the mutants is slowed by 
2.5-fold CaM-free and 2-fold CaM-bound, and the activation of both H1032S and 
H1032Q nNOSrd is again greater than the CaM-effect seen for the wild-type enzyme 
(1.5-fold).  The y-intercept values, on the other hand, show no deviation from the 
corresponding wild-type values.  In the wild-type enzyme these corresponded to the 
rate of cytochrome c turnover but for these mutants the CaM-free rate is significantly 
increased.  If these rates represent the transfer of electrons from NADPH to FAD to 
FMN, then H1032Q and H1032S must behave differently in turnover with 
ferricyanide vs. turnover with cytochrome c.  One reason for this may be that the 
ferricyanide oxidises the bound FMN cofactor before electrons arrive through the 
Figure 6.3 Steady-state ferricyanide reduction by (A) H1032S and (B) H1032Q nNOSrd.  Assays  
    were performed at 25oC in 50mM Tris buffer, pH 7.5 + 100mM NaCl.  Data points for  
    CaM-free (black) and CaM-bound (red) were plotted in Origin 7.5 (Microcal) and fitted  
    to a straight line equation. 
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enzyme, therefore the predominantly oxidised form is present which can transfer 
hydride at a faster rate, due to its partially open conformation. 
 
6.3 Pre-steady-state kinetics 
 
6.3.1 Cytochrome c reduction 
 
The accessibility of the bound FMN cofactor to sub-stoichiometric amounts of 
cytochrome c is inhibited by the binding of NADPH to wild-type nNOSrd [119].  This 
effect is completely abolished in the R1229E mutant, section 5.3.1, and for other 
mutations where the suppression of CaM-free electron transfer is partially relieved, 
such as R1400E [124] and F1395S [128].  Figure 6.4 presents the same experiment 




The initial rates of reduction were measured and corrected for enzyme concentration 
to give second order rate constants for each state, i.e. the absence and presence of 
NADPH and CaM.  Table 6.3 lists the derived rate constants in comparison to wild-
type from a previous study [119].  S1176A nNOSrd exhibits similar behaviour to the 
wild-type enzyme; NADPH causes a decrease in the accessibility of the bound FMN 
cofactor and this is relieved by the binding of CaM.  The effect is not as pronounced 
in the mutant however, as the uncomplexed mutant enzyme transfers electrons at a 
Figure 6.4 Pre-steady-state reduction of cytochrome c by (A) S1176A and (B) D1393E nNOSrd.   
    Stopped-flow mixing of pre-reduced enzyme (10µM) with ferric cytochrome c (4µM)  
    was carried out at 25oC in the absence and presence of NADPH and CaM. 
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slower rate than wild-type and the binding of NADPH only lowers the rate constant 
by 1.6-fold.  The CaM-bound rate constant, in both the NADPH-free and NADPH-
bound states, is analogous to the wild-type enzyme. 
D1393E nNOSrd is not regulated by NADPH in the same way as the wild-type 
enzyme as the rate constant for the uncomplexed enzyme is greater in the mutant and 
only has a small CaM-activation effect.  The binding of NADPH does slow the rate 
constant, but this is 10-fold faster than the corresponding wild-type value.  
  
Table 6.3 Pre-steady-state cytochrome c reduction by nNOSrd mutants 
Second order rate constants / µM-1s-1 
Enzyme -NADPH-CaM +NADPH-CaM -NADPH+CaM +NADPH+CaM 
wild-type 
[119] 
15.4 1.1 37.8 35.5 
S1176A 9.4 ± 0.7 5.8 ± 0.5 35.7 ± 0.9 38.0 ± 0.9 
D1393E 27.6 ± 0.7 11.7 ± 0.3 29.2 ± 0.4 36.7 ± 0.6 
 
 
6.3.2 Flavin reduction 
 
Reduction of the flavin cofactors in nNOSrd by NADPH occurs primarily as a 
hydride transfer from the nicotinamide group to FAD, followed by electron transfer 
between the flavin cofactors.  This reduction was differently regulated by CaM in the 
fully oxidised and one-electron reduced forms (section 4.3), by way of a 
conformational equilibrium between hinged-open and hinged-closed states.  This 
equilibrium was drastically affected in the hinged-open R1229E mutant, with 
activated hydride transfer and inhibited interflavin electron transfer (section 5.3.2).  
Figure 6.5 presents the flavin reduction reactions of S1176A nNOSrd, both oxidised 
and one-electron reduced.    From the spectral changes in Panel A, it is obvious that 
the reaction does not proceed as far as for the wild-type enzyme, there is no fully 
reduced state present after 8 seconds for the CaM-free mutant, or after 2 seconds in 
the presence of CaM.  The traces in Panel C were normalised according to their 
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apparent end-point and fitted to the same double-exponential function over the 
corresponding time period.  The associated kinetic parameters are listed in Table 6.4 
and the CaM-activation effect can be seen to be analogous to that for the wild-type 
enzyme.  There is a shift towards the fast phase of reduction, while the actual rate 
constants are slowed by a similar factor as that of the cytochrome c reduction activity.  
The binding of CaM to the oxidised mutant enzyme clearly activates the interflavin 
electron transfer, observed in the inset of Panel C.  The same absorbance change 
occurs over 8 seconds CaM-free and 2 seconds CaM-bound.  Also of note is that this 
is the formation of the FMN semiquinone only, a second electron is not transferred 




One-electron reduced S1176A nNOSrd in Panel B again proceeds very slowly, with 
the spectra representing 16 seconds of reaction in the absence of CaM and 4 seconds 
for the CaM-bound state.  The time-dependent traces in Panel D were treated in the 
same manner as the oxidised versions, and the kinetic parameters in Table 6.4 
Figure 6.5 Stopped-flow reduction of S1176A nNOSrd (10µM) by NADPH (100µM).   
    Diode array spectra for (A) oxidised CaM-free and (inset) CaM-bound, and (B) 1- 
    electron reduced CaM-free and (inset) CaM-bound.  Corresponding reductive traces  
    for (C) oxidised at 457 and (inset) 592 nm and (D) one-electron reduced at 457 nm.  
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highlight a similar pattern to the wild-type enzyme.  The large slow phase of the 
CaM-free reduction is of a similar rate constant to the CaM-free cytochrome c 
reductase activity (0.45 s-1) with a short phase at significantly faster rate.  The trace in 
the presence of CaM has the same profile to the oxidised CaM-bound enzyme and 
corresponds to the activated steady-state cytochrome c reduction rate (2.1 s-1). 
 
Table 6.4 Pre-steady-state reduction of S1176A nNOSrd by NADPH 







S1176A – FMN oxidised - 
3.3 ± 0.1 
(59%) 
0.46 ± 0.01 
(41%) 
 + 
3.5 ± 0.06 
(86%) 
0.40 ± 0.08 
(14%) 
S1176A – FMN semiquinone - 
1.9 ± 0.04 
(19%) 
0.11 ± 0.01 
(81%) 
 + 
3.2 ± 0.04 
(83%) 
0.39 ± 0.03 
(17%) 
 
The stopped-flow reduction of D1393E nNOSrd is represented in Figure 6.6, again 
comparing the oxidised and one-electron reduced forms of the enzyme.  The spectra 
in Panel A indicate that the oxidised D1393E enzyme proceeds further towards the 
fully-reduced state than S1176A in the oxidised form, but it does not reach the same 
stage as the corresponding wild-type reaction.  The data for the CaM-free and CaM-
bound forms here are extremely similar, and this is reflected in the traces plotted in 
Panel C.  Both of the traces were fitted to a double exponential function over 2 
seconds and the derived rate constants are compared in Table 6.5.  The phases of 
reduction are the same in both states, with the binding of CaM here seen to speed up 
the actual rate, a slight deviation from the wild-type CaM-effect.  Another difference 
is noticeable in the spectra in Panel A, where there is no apparent formation of the 
FMN semiquinone.  This would indicate that the di-semiquinone of the mutant 
enzyme is unfavourable and the transfer of two electrons from FAD to FMN happens 
simultaneously to allow the reaction to proceed. 
 




Panel B of Figure 6.6 shows the one-electron reduced form of D1393E nNOSrd being 
reduced, again to a greater extent than the corresponding S1176A experiment.  The 
spectra for the CaM-free state occurred over 4 seconds while the CaM-bound spectra 
represent 2 seconds.  The traces in Panel D were normalised and fitted to the same 
function as for the previous reactions, and the pattern of the rate constants again 
deviates slightly from that observed for the other enzymes (Table 6.5).  There is still a 
larger slower phase, however this comprises only 54% of the reduction here compared 
to 80% for wild-type and S1176A nNOSrd.  The rate constant of the slow phase is 
comparable to the cytochrome c reductase activity (2.6 s-1), as is the fast rate constant 
that makes up most of the CaM-bound reduction (17 s-1).  Another feature that is 
retained is that the CaM-bound traces for both oxidised and one-electron reduced 
D1393E nNOSrd have the same kinetic profile, i.e. the relative rates and magnitude of 
the phases of reduction are the same in both activated forms.   
 
Figure 6.6 Stopped-flow reduction of D1393E nNOSrd (10µM) by NADPH (100µM).   
    Diode array spectra for (A) oxidised CaM-free and (inset) CaM-bound, and (B) 1- 
    electron reduced CaM-free and (inset) CaM-bound.  Corresponding reductive traces  
    at 457 nm for (C) oxidised and (D) one-electron reduced. 
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Table 6.5 Pre-steady-state reduction of D1393E nNOSrd by NADPH 







D1393E – FMN oxidised - 
8.7 ± 0.05 
(73%) 
1.9 ± 0.08 
(27%) 
 + 
14.1 ± 0.1 
(74%) 
1.7 ± 0.05 
(26%) 
D1393E – FMN semiquinone - 
7.7 ± 0.1 
(46%) 
1.0 ± 0.02 
(54%) 
 + 
14.5 ± 0.1 
(79%) 
2.1 ± 0.1 
(21%) 
 
The reaction of H1032S nNOSrd with excess NADPH is plotted in Figure 6.7. The 
spectral changes in Panel A for the fully oxidised enzyme are similar to those 
recorded for the D1393E mutant, but in this case both the CaM-free and CaM-bound 
reactions took place over 1 second.  The corresponding traces in Panel C were 
normalised and fitted to a double exponential equation over 1 second and the kinetic 
parameters are listed in Table 6.6.  The rate constants for the oxidised H1032S 
enzyme are approaching the value of those for wild-type nNOSrd, with the CaM-
effect shifting more of the reduction into the fast phase in a similar manner.  As with 
the oxidised D1393E mutant there was very little formation of FMN semiquinone 
observed at 592 nm. 
 
 




CaM-free one-electron reduced H1032S nNOSrd (Panel B) reacted very slowly with 
NADPH compared to the oxidised form, with the spectral changes taking place over 8 
seconds, while the CaM-bound reaction was completed within 2 seconds.  The time-
dependent reductive traces in Panel D were analysed as for the other enzymes, and the 
kinetic parameters from Table 6.6 show a similar pattern to those observed 
previously.  The size of the larger, slower CaM-free phase is midway between the 
percentages for the wild-type and D1393E enzymes, indicating an intermediate effect 
on the conformational equilibrium.  The value of the rate constant in this case does 
not exactly concur with the rate of CaM-free cytochrome c reduction, but is of the 
same order of magnitude.  The kinetic profile in the presence of CaM was as expected 




Figure 6.7 Stopped-flow reduction of H1032S nNOSrd (10µM) by NADPH (100µM).   
    Diode array spectra for (A) oxidised CaM-free and (inset) CaM-bound, and (B) 1- 
    electron reduced CaM-free and (inset) CaM-bound.  Corresponding reductive traces  
    at 457 nm for (C) oxidised and (D) one-electron reduced. 
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Table 6.6 Pre-steady-state reduction of H1032S nNOSrd by NADPH 







H1032S – FMN oxidised - 
43 ± 2 
(29%) 
4.6 ± 0.1 
(71%) 
 + 
51 ± 2 
(59%) 
6.1 ± 0.1 
(41%) 
H1032S – FMN semiquinone - 
2.4 ± 0.1 
(36%) 
0.5 ± 0.02 
(64%) 
 + 
47 ± 1 
(74%) 
1.7 ± 0.1 
(26%) 
 
Figure 6.8 plots the reaction between H1032Q nNOSrd and NADPH, where the 
spectra for the fully oxidised enzyme in Panel A are comparable to those for the fully 
oxidised H1032S enzyme.  Again, the reduction was completed over 1 second for 
both CaM-free and CaM-bound with very little absorbance change for the FMN 
semiquinone at 592 nm.  The traces in Panel C are also comparable to those for 
H1032S nNOSrd, as are the kinetic parameters in Table 6.7.  The only difference 
between the two sets of numbers is that the percentage of absorbance change 
occurring in the CaM-free fast phase is higher for the H1032Q enzyme. 
 




Spectra collected for the stopped-flow reaction of one-electron reduced H1032Q, in 
Panel B of Figure 6.8, appear to exhibit a change in the absorbance profile at 457 nm, 
however this was not observed during the preparation of the samples and may indicate 
the presence of a contaminant within the apparatus.  This did not have any effect on 
the rate of reduction, as the CaM-free reaction with NADPH took place over 4 
seconds, and 2 seconds in the presence of CaM.  The traces in Panel D were affected 
by a high signal-to-noise ratio, but fitted well to a double exponential function and 
yielded a set of kinetic parameters comparable to all of the other enzymes.  Here, the 
CaM-free slow phase is now slightly smaller than the fast phase, however this is 
consistent with the oxidised H1032Q experiment, which reflects on a subtle 
conformational change between the glutamine and serine residues.  One common 
feature of the two substitutions of His1032 is that the CaM-bound traces for the 
oxidised vs. one-electron reduced forms do not exactly match with each other.  There 
is a lesser proportion in the fast phase for the fully oxidised enzyme, which may be an 
Figure 6.8 Stopped-flow reduction of H1032Q nNOSrd (10µM) by NADPH (100µM).   
    Diode array spectra for (A) oxidised CaM-free and (inset) CaM-bound, and (B) 1- 
    electron reduced CaM-free and (inset) CaM-bound.  Corresponding reductive traces  
    at 457 nm for (C) oxidised and (D) one-electron reduced. 
Chapter 6  Residues involved in hydride transfer 
 128 
indication that the conformational equilibrium is differently modified by CaM in these 
mutants relative to the wild-type enzyme.     
 
Table 6.7 Pre-steady-state reduction of H1032Q nNOSrd by NADPH 







H1032Q- FMN oxidised - 
30 ± 1 
(49%) 
4.6 ± 0.1 
(51%) 
 + 
49 ± 1 
(59%) 
6.1 ± 0.1 
(41%) 
H1032Q – FMN semiquinone - 
10 ± 0.1 
(57%) 
1.0 ± 0.1 
(43%) 
 + 
33 ± 0.3 
(84%) 







The effect of CaM-binding on the midpoint reduction potentials of the bound flavin 
cofactors in nNOSrd is negligible, as highlighted in section 4.4, while destabilisation 
of the FAD/FMN interface (section 5.4) destabilises only the non-catalytically-active 
FMN oxidised/semiquinone couple.  The FAD-active-site substitutions at Ser1176 
and Asp1393 affect electron transfer in nNOSrd in differing ways to the R1229E 
mutant so could feasibly have an effect on any of the thermodynamic parameters. 
OTTLE potentiometry was utilised to assess the midpoint reduction potentials in 
S1176A and D1393E nNOSrd, as shown in Figure 6.9.  Panel A and C represent the 
incremental potential decrease and resulting plots for S1176A, while Panel B and D 
correspond to the D1393E mutant.  Simultaneous fitting to equation 2.1 in both cases 
yielded the values listed in Table 6.8. 
 




Table 6.8 Midpoint reduction potentials of nNOSrd / mV 
Enzyme (-CaM) FMN ox/sq FMN sq/hq FAD ox/sq FAD sq/hq 
wild-type -101 ± 4 -271 ± 6 -289 ± 6 -301 ± 7 
R1229E -135 ± 4 -278 ± 9 -283 ± 9 -300 ± 9 
S1176A -125 ± 6 -280 ± 7 -339 ± 13 -298 ± 15 
D1393E -117 ± 3 -307 ± 3 -350 ± 7 -316 ± 7 
 
 
The potential for the FMN oxidised/semiquinone transition is negatively shifted 
compared to wild-type nNOSrd in both the S1176A and the D1393E mutants.  This 
effect is not as large as for the hinged-open R1229E mutant but it is again intriguing 
that residues extremely close to the bound FAD cofactor can affect the stability of the 
FMN cofactor.  The biggest change in both sets of data, however, is in the FAD 
Figure 6.9 OTTLE potentiometry of (A) S1176A and (B) D1393E nNOSrd in the absence of CaM. 
     Spectroelectrochemistry was carried out in 100mM Tris pH7.5, 500mM KCl with  
    mediators added.  Spectra were recorded at 30mV intervals and corresponding traces for  
    absorbance at 456 nm and 592 nm were plotted against applied potential for (C)  
    S1176A and (D) D1393E and fitted to a modified Nernst equation (Equation 2.12) 
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oxidised/semiquinone transition which is also negatively shifted relative to wild-type 
nNOSrd.  This means that the FAD semiquinone species is destabilised which in turn 
means that the enzyme is more likely to transfer 2 electrons from FAD to FMN at the 
same time.  This was observed in the flavin reduction experiments of the D1393E 
mutant but not in S1176A nNOSrd.  Clearly the thermodynamic properties of the 
cofactor are only one aspect of the catalytic cycle and the S1176A mutant is 
kinetically hindered during turnover.  Furthermore, the two electron couple for the 
FAD cofactor (the average of the two values) is more negative in both cases 
indicating that it is more difficult thermodynamically for NADPH to reduce the FAD, 
which is clearly the case in both mutants.  The S1176A mutant appears to affect solely 
the FAD ox/sq transition, where as the D1393E mutant shifts the other potentials 
which would correlate with Asp1393 having multiple roles to play in the regulation of 
electron transfer. 
These findings are in contrast to other reports of reduction potentials for similar 
mutations.  S1176A was previously characterised in holo-nNOS [129], where the 
chemical titration data indicated that the FMN oxidised/semiquinone was positively 
shifted to greater than +40mV.  Furthermore the FAD semiquinone state could not be 
fitted from the experimental data, and the two electron transition from oxidised to 
hydroquinone was also reported to be positively shifted.  The different environments 
in nNOSrd and the holoenzyme may result in the broad shifts reported, however the 
positive shift was not observed in these spectroelectrochemical studies. 
The thermodynamics of the D1393N mutant in nNOSrd were assessed in the FAD 
and NADPH-binding domains only, the construct that resembles FNR [80].  This 
mutant had very similar kinetic properties to the D1393E mutant in the holoenzyme 
[130] and the chemical titration of the D1393N FAD cofactor showed a 
destabilisation in the semiquinone state such that a two electron transition from 
oxidised to hydroquinone was reported.  This was negatively shifted by approximately 










The transfer of a hydride from NADPH to the bound FAD cofactor is activated by the 
binding of CaM to both holo-nNOS and the isolated nNOSrd [76].  In the previous 
chapters of this thesis, hydride transfer was shown to be differently regulated in the 
fully oxidised vs. one-electron reduced forms of the reductase domain, occurring 
rapidly when the enzyme is in the hinged-open conformational form.  Following the 
hydride transfer step, electrons can be passed directly from FAD to FMN as the 
cofactors are only 5 Å apart in the crystal structure [74].  This leaves a proton to be 
removed from the flavin N5 of the FAD cofactor which is not solvent accessible, and 
instead requires a conserved H-bonding network at its si-face to carry out this event. 
The alteration of this network to slightly change the H-bonding properties of the 
residues decreased the turnover activity in each of the mutants studied.  The data in 
Table 6.1 indicate that increased proximity to the FAD cofactor had a larger effect on 
steady-state cytochrome c reduction, but that each activity was enhanced by CaM 
binding.  S1176A nNOSrd had the slowest rate of steady-state electron transfer to 
cytochrome c, which correlates with its slow hydride transfer reactions observed in 
the pre-steady-state experiments (Table 6.4).  Here, the size of the kinetic phases was 
affected by CaM binding in the same way as wild-type nNOSrd, with the decreased 
magnitudes of the rate constants matching that of the activity relative to the wild-type 
enzyme.  There was no drastic effect on the pre-steady state reduction of cytochrome 
c for the S1176A mutant (Table 6.3), so the role of Ser1176 appears to be centred on 
stabilising the reduced forms of FAD and facilitating hydride transfer, rather than 
affecting subsequent electron transfer events. 
The D1393E mutant had reduced activity and a decreased CaM-mediated activation 
effect compared to wild-type nNOSrd, but not as pronounced as that in the S1176A 
mutant (Table 6.1).  This can be interpreted as causing an analogous effect through H-
bonding to the FAD cofactor via Ser1176.  In the pre-steady-state experiments, 
however, D1393E nNOSrd showed slightly different CaM-mediated regulation.  In 
Table 6.5, the shift in phases of the one-electron reduced enzyme is less than that of 
wild-type nNOSrd and the S1176A mutant, indicating that more of it is found in the 
hinged-open conformation.  Furthermore, the characteristic locking effect of NADPH 
is not present in the D1393E mutant (Table 6.3), indicating that Asp1393 plays a role 
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in the accessibility of the FMN-binding domain and the regulation of electron transfer 
by CaM.   
The S1176A and D1393E mutants were found to have a small effect on the 
thermodynamic parameters of the flavin cofactors (Table 6.8).  The reduced states of 
the FAD cofactor were negatively shifted, with the FAD oxidised/semiquinone 
transition affected more, presumably due to the changes directly in the protein 
environment.  Interestingly, the semiquinone state of the FMN cofactor was also 
destabilised, which could mean that the change in the hydrogen-bonding network in 
the mutants is transmitted to the FAD/FMN interface region where a slight disruption 
increases exposure of the FMN cofactor. 
Substitution of His1032 by glutamine and serine produced two mutants that have a 
very different CaM-mediated effect compared to other mutants and even wild-type 
nNOSrd.  Their CaM-free cytochrome c turnover rates (Table 6.1) were the same as 
those for D1393E nNOSrd, so the removal of the functionality of both residues causes 
an analogous change in the H-bonding network.  In the presence of CaM, however, 
both H1032S and H0132Q nNOSrd are 3-fold faster than D1393E, and only slower 
than the wild-type enzyme by a factor of 2.  This larger CaM-mediated activation 
effect is unique to these two reductase domain mutants and could feasibly be a result 
of a change in the conformational equilibrium.  This is reflected in the pre-steady-
state flavin reduction experiments where the activation by CaM, in both the oxidised 
and one-electron reduced forms, departed from the wild-type behaviour (Tables 6.6 
and 6.7).  The relatively fast observed ferricyanide reduction by the H1032Q and 
H1032S mutants (Table 6.2) can be explained by the fast hydride transfer to the 
oxidised enzymes which will be predominantly present in the turnover experiments 
with ferricyanide.   
The importance of His1032 is further highlighted by the fact that neither H1032E nor 
H1032A nNOSrd could be expressed under the same conditions as the other mutants.  
Clearly the complete removal of the histidine side chain (alanine) or the introduction 
of acidic functionality (aspartate) causes a change in the tertiary structure of the 
folded protein.   
A structural change that could effect the conformational equilibrium is the proximity 
of His1032 to Arg1229, which is responsible for a large part of the regulation between 
the hinged-open and hinged-closed states.  If the removal of the bulky side chain of 
the histidine residue allowed the arginine to move closer to the other residues around 
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the FAD cofactor then this would cause more CaM-free hinge-opening.  Furthermore, 
in the presence of CaM the arginine would be free from making salt-bridging 
electrostatic interactions and able to stabilise the FAD-active site.  Although the 
Arg1229 residue itself could not directly perform the proton removal role, it could 
stabilise a water molecule in place of His1032, providing an alternative pathway to 
solvent. 
In terms of the rate limiting step in the turnover of nNOSrd, the conformational 
equilibrium can still be viewed as essential in all of the FAD-active-site mutants.  In 
S1176A nNOSrd, the rate of hydride transfer is severely decreased due to the removal 
of the functionality of the serine residue, but the binding of CaM still causes hinge-
opening and activation of electron transfer through the enzyme.  The substitutions of 
Asp1393 and His1032 produced mutants that appear to have activity limited by the 
rate of hydride transfer.  However, these can be regarded as causing differing effects 
on the position of the conformational equilibrium.  For Asp1393, this could be 
mediated through its proximity to Phe1395 and the CT while His1032 could cause an 













The fundamental question on the function of nNOS addressed in this thesis is how 
activation occurs upon the binding of calmodulin, mediated by intracellular calcium.  
This activation step is centred on the reductase domain, and has been mechanistically 
investigated in detail. 
 
The isolated nNOSrd characteristically transfers electrons to cytochrome c in the 
same way as it does to the oxygenase domain of holo-nNOS.  This exhibits a 10-fold 
enhancement in the rate of electron transfer upon binding CaM.  The CaM-free 
experiment was shown to be ionic-strength dependent, with less suppression of 
activity when salt concentration was increased.  This leads to the conclusion that the 
CaM-mediated activation step must be ionic-strength dependent. 
 
To further investigate the mechanism of activation, the hydride transfer event from 
NADPH to FAD was studied by pre-steady-state experiments.  This is the first step in 
the turnover of cytochrome c and was found to be differently regulated in the oxidised 
enzyme compared to the one-electron reduced enzyme.  CaM-binding affected both 
forms, but to a greater extent the physiologically relevant one-electron reduced 
enzyme.  This contains the semiquinone state of the FMN cofactor, the presence of 
which has a large effect on the neighbouring FAD cofactor where the hydride transfer 
takes place.  A conformational change takes place upon oxidation of the FMN 
semiquinone, confirmed by the ionic-strength dependency and small magnitude of 
kinetic isotope effects for the hydride transfer reactions.  The binding of CaM has the 
same, but larger, effect as increasing the ionic strength and so must affect the same 
equilibrium, between the “hinged-closed” and “hinged-open” forms.  It is the hinged-
open form which must be accessed for fast hydride transfer, so the interconversion 
between two states becomes rate-determining in turnover experiments.  In the 
oxidised form the equilibrium position is such that the fully closed form is unable to 
be produced, and CaM binding leads to a predominance of a more open form.  
 
Thermodynamic analysis of the flavin cofactors in CaM-free nNOSrd was repeated 
using OTTLE potentiometry.  This technique allows the measurement of current in 
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the cell to provide an accurate equilibrium point for electron transfer to the redox 
cofactors.  The experimental data here highlighted again the lack of an effect of the 
binding of CaM on the midpoint reduction potentials of either flavin cofactor bound 
to nNOSrd. 
 
The crystal structure of nNOSrd shows that the FAD and FMN cofactors are held in 
close contact, stabilised by electrostatic contacts between the FMN-binding domain 
and the other subdomains.  This interface region is perturbed by the oxidation of the 
FMN semiquinone, which forms contacts with the protein structure.  The salt bridge 
formed between Arg1229 and Glu762 is another key part of the interface and the 
significance of the salt bridge was investigated by the substitution of Arg1229 with 
glutamate.  The resulting charge reversal R1229E mutant had a severe effect on the 
rate of steady-state cytochrome c reduction, which was inhibited by increasing 
concentration of the electron acceptor, while CaM binding increased the inhibition 
effect and decreased the observed rate of reduction. 
 
The hydride transfer step to R1229E nNOSrd did not exhibit any CaM-mediated 
regulation, and was extremely rapid in both the oxidised and one-electron reduced 
forms.  The subsequent electron transfer from FAD to FMN can be observed in the 
same stopped-flow experiments, and was severely slowed compared to the rates 
observed for the wild-type enzyme.  The addition of ferrous cytochrome c to these 
experiments blocked the interflavin electron transfer step in the R1229E mutant. 
 
The final step in the cytochrome c turnover experiment is an electron transfer from 
hydroquinone FMN to the heme, and this was investigated under pre-steady-state 
conditions using R1229E nNOSrd.  A similar experiment  with the wild-type enzyme 
previously revealed that it was “locked” by the addition of NADPH, preventing 
access of the FMN cofactor to cytochrome c, but this was completely abolished for 
the R1229E mutant.  The FMN cofactor is always accessible in solution, to the same 
extent as CaM-bound activated wild-type nNOSrd and even the isolated FMN-binding 
domain.    
 
The accessibility of the flavin cofactors in R1229E nNOSrd was also assessed by the 
use of OTTLE potentiometry.  The value for the first reduction of the FMN cofactor 
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(oxidised/semiquinone) reflects its stabilisation by the presence of other sections of 
protein structure, and was seen to be destabilised in the mutant compared to the wild-
type enzyme.  The nature of the OTTLE cell setup could be used to allow further 
investigations on the separation of the FAD and FMN cofactors by spectroscopy such 
as EPR and ENDOR. 
 
Clearly, the effects on the conformational equilibrium in this mutant form of nNOSrd 
mean that the hinged-closed form is inaccessible and the interflavin electron transfer 
step is disfavoured.  This is why substrate inhibition is observed during cytochrome c 
turnover, with the possible added effect of the cytochrome c protein binding in the 
space in the interface.  The inhibited form of the mutant enzyme, with cytochrome c 
and CaM bound, was subjected to crystallisation assays where the rationale was that 
the mobility of the FMN-binding domain may be lessened compared to the CaM-
bound activated wild-type enzyme.  Initial screening of conditions, however, proved 
unsuccessful but further investigation here may lead to the discovery of a CaM-bound 
nNOSrd structure. 
 
Steady-state ferricyanide reduction by nNOSrd occurs differently to cytochrome c 
reduction, in that electrons can be transferred to ferricyanide from the FAD cofactor 
in addition to the FMN.  For the wild-type enzyme, the rate of reduction was 
enhanced by CaM binding, but the rates were well in excess of those observed for 
cytochrome c reduction.  This can be rationalised by the ability of the ferricyanide ion 
to oxidise the FMN semiquinone state, and the subsequent faster hydride transfer 
reactions of the oxidised enzyme form.  CaM still activates the oxidised enzyme, and 
so activates ferricyanide reduction. 
For the R1229E mutant, the rate of ferricyanide reduction was decreased compared to 
wild-type nNOSrd and was unaffected by the binding of CaM.  Although the 
ferricyanide ion now has complete access to the open form of the enzyme, there will 
be a charge repulsion near to the site it must occupy to receive an electron from the 
FAD cofactor.  Furthermore, the decreased rate of interflavin electron transfer in 
R1229E nNOSrd also makes the FMN cofactor an unfavourable location. 
 
The R1229E holo-nNOS mutant was assayed to ascertain whether the removal of the 
salt bridge could activate electron transfer to the oxygenase domain.  This was found 
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not to be the case, because the mutant exhibited a lack of CaM-free NO synthase 
activity and was slowed relative to wild-type nNOS in the presence of CaM.  This 
lesser efficiency can be ascribed to the inaccessibility of the hinged-closed form to 
accept electrons from the FAD cofactor, and the increased exposure of both flavins to 
oxygen which increased the decoupling of the reaction.  
 
In addition to its salt-bridging interaction, Arg1229 forms part of a well conserved 
network of residues around the FAD cofactor.  These residues have been shown to 
also be important in nNOSrd catalysis.  Ser1176 H-bonds to the FAD cofactor and 
removal of this functionality in the S1176A mutant severely limited the cytochrome c 
turnover rate.  There was still a CaM-mediated activation effect that was also 
observed in the hydride transfer reactions.  S1176A nNOSrd was regulated by CaM, 
in the oxidised and one-electron reduced forms, in the same way as the wild-type 
enzyme, indicating that Ser1176 has a role in hydride transfer.   
 
Asp1393 H-bonds to Ser1176 but also to the nicotinamide moiety of NADPH, so it 
has a more complex effect on the regulation of nNOSrd.  The D1393E mutant had a 
slower, but CaM-activated, cytochrome c reduction rate but was regulated by CaM 
differently to the wild-type enzyme in pre-steady-state reduction experiments.  In 
addition to affecting the hydride transfer step, Asp1393 plays a role in the subsequent 
electron transfer events. 
 
The role of His1032 is the least-well characterised in related flavoproteins, and the 
H1032S and H1032Q mutants were found to be regulated by CaM differently to the 
wild-type activation step.  The binding of CaM has a larger effect on the steady-state 
cytochrome c reduction rates of these mutants which has not been observed for other 
single residue substitutions.  Coupled with differences in the pre-steady-state 
experiments, this indicates a structural change between the hinged-closed and hinged-
open conformations.  It is interesting to speculate that Arg1229 could be part of this 
structural change when it is released from its electrostatic interaction bridging the 
domains.  Clearly, crystallographic work on the substitutions at His1032 would reveal 
the nature of the interactions around the FAD cofactor and its possible facilitation of 
proton removal. 
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To re-address the main question of CaM-mediated activation, the hinged-open and 
hinged-closed states can be assigned different steps in the catalytic cycle of nNOSrd.  
FAD to FMN interflavin electron transfer must occur in the hinged-closed form, while 
electron transfer from FMN to heme must occur in the hinged-closed form, as alluded 
to in the previous discovery of the NADPH-dependent locked conformation.  The 
productive binding of NADPH to allow the transfer of hydride to FAD depends on the 
movement of an aromatic residue, which can now be seen to be coupled to the 
adoption of the hinged-open form.  The equilibrium between the two conformations is 
controlled by the binding of CaM to the enzyme.  In the absence of CaM, hydride 
transfer is slowed and electrons are not released.  Once CaM is bound, the mobile 
FMN-binding domain can move between the hinged-open and hinged-closed forms, 
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Appendix Ι 





Possible dimeric structure of nNOS, based on crystal structures of nNOSoxy (PDB code 1OM4) 
and nNOSrd (1TLL).  Electrons are transferred from the reductase domain of one monomer to the 















Calmodulin activation of nNOSrd.  Binding of CaM releases the reductase domain from a 
conformational lock, allowing the FMN to transfer electrons to the oxygenase domain or artificial 
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Stopped flow reduction of fully oxidised reduced nNOSrd 
Breaking the salt bridge at Arg1229 introduces an electrostatic repulsion and likely destabilised 















Electron transfer is inhibited in R1229E nNOSrd (left) and the separation introduces the possibility 
of cytochrome c binding in an unproductive conformation to inhibit binding (right) 
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Appendix ΙΙ 




Equation 1 shows the basis of simple Michaelis-Menten kinetics.  E is the enzyme, S 
the substrate, P the product, and ES the complex produced between enzyme and 
substrate binding together.  The equation relies on a number of assumptions; that the 
substrate binding is rapid and reversible, that k2 is slow and rate-determining, and that 




Based upon these assumptions, equation 2 is obtained, where v is equal to the overall 
rate, [E0] is the total concentration of the enzyme and [S] is the concentration of free 




When the substrate concentration is very high, the entire enzyme is present as the 
enzyme-substrate complex and the limiting velocity Vmax is reached.  Under these 












[E][S]           
[ES]





k2[E0]Vmax = Equation 5 
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Defining the Michaelis constant, Km, as the value of [S] that gives an initial velocity 
equal to half of the maximal velocity, the equation can be simplified further to 
equation 6.  In limiting cases, the Michaelis constant is a measurement of how well 
the substrate binds to the enzyme.  The equilibrium assumption is regarded as being a 





A Michaelis-Menten plot is obtained by determining the first-order rate constants at a 
range of substrate concentrations.  Fitting these data to equation 6 produces the 
Michaelis parameters kcat, and Km.  The maximal rate of reaction under saturating 
conditions, kcat, is the same as k2 in equation 1 and is determined by extrapolation.  
The catalytic efficient of the enzyme is a second-order rate constant and defined in 




The effect of an inhibitor, I, on the enzymatic reaction is shown in Equation 7.  ESI is 
a dead-end complex formed when the inhibitor binds to the ES complex.  Ki is the 
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Arranging these in the same manner as equation 4 gives equation 9, for general 




In the case of more severe inhibition, where the inhibitor binds to the enzyme only, 
equation 11 can be utilised.  This is based on the Michaelis-Menten assumption, 
equation 6, where Vmin is the velocity reached when all of the enzyme molecules are 







The activity of an ion in solution can be determined by means of the concentration 
and the activity coefficient, .  The activity of a species A, ActA, is shown in Equation 
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The Debye-Huckel equation enables the determination of the activity coefficient of an 
ion in an aqueous solution of known ionic strength according to equation 13, where A 
is a temperature- and solvent- dependent constant, zi is the integer charge of the ion 




By combining equation 13 with the Bronsted relation, equation 14 represents the 
Debye-Bronsted equation.  k2 is the second order rate constant and k0 is the second 
order rate constant at I=0.  A plot of log k2 vs. I generates a straight line allowing the 




Equation 13 log  = -Azi2I
Equation 14 log k2 = log k0 + 2Az+z-I
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